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Acute insulin-induced hypoglycaemia in humans is known to interfere with cognitive function
through the effect of neuroglycopenia on the brain. However, the effect of acute
hypoglycaemia on specific brain functions remains largely unexplored. The literature relevant
to the effects of acute and recurrent hypoglycaemia on general cognitive processes is
reviewed. The research described in this thesis includes studies involving experimentally
induced hypoglycaemia, and a clinical study of children with type 1 diabetes.
The effect of acute insulin-induced hypoglycaemia on basic sensory information processing
was examined. The principal studies performed were: Study 1 - an examination of the effect
of acute hypoglycaemia on visual information processing, and; Study 2 - an examination of
the effect of acute hypoglycaemia on auditory information processing. During 60 minutes of
exposure to moderate hypoglycaemia significant impairments of both visual and auditory
information processing were documented. It was also noted that hypoglycaemia did not
significantly impair visual acuity for high contrast visual images but did disrupt ability to
distinguish between low contrast visual images.
Acute hypoglycaemia induces, in general, a negative mood state. The effect of hypoglycaemia
on mood and emotion in human subjects was further explored. Hypoglycaemia was found to
induce a small, but significant increase in anger-state that could not be predicted from
measures of anger-trait or general anger-expression {Study 3). Hypoglycaemia also induced a
negative mood-state characterised by increased tension and decreased happiness, lead to more
negative appraisals of a life event, but did not effect a change in personality traits {Study 4).
In addition, studies ofwere performed on different aspects of the symptomatic response to
hypoglycaemia. These included: the symptoms of hypoglycaemia induced by different
experimental models of hypoglycaemia {Study 5); and the symptoms of hypoglycaemia
reported by children with type 1 diabetes {Study 6). The symptoms generated during
hypoglycaemia induced by either the one-step hyperinsulinaemic glucose clamp or a
controlled insulin-infusion do not differ substantially in their frequency, intensity or latent
structure. Children with type 1 diabetes differ from adults in their reporting of the symptoms
of hypoglycaemia by describing more symptoms indicative of behavioural change.
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The introduction of insulin in the 1920's to treat type 1 diabetes transformed the
management of this disorder. However, as early as 1922, Elliot Joslin observed that
insulin is "...a potent preparation, alike for evil and for good", emphasising that it is
potentially a dangerous drug. These early observations stimulated researchers to
examine in more detail the clinical and physiological aspects of hypoglycaemia. In
the following section the literature on the frequency of hypoglycaemia in the insulin-
treated population, risk factors for its development, and its morbidity, will be briefly
reviewed. I will then review our current understanding of the physiological
mechanisms involved in the hypoglycaemic response. Finally, I will review our
current knowledge of the effects of both acute and chronic hypoglycaemia on
cognitive function. These reviews provide the historical background that lead to the
development of this thesis.
Frequency of hypoglycaemia
The true frequency of hypoglycaemia in the diabetic population is difficult to
estimate, and is probably much higher than is documented by individual patients.
This is related to the frequent occurrence of asymptomatic biochemical
hypoglycaemia (only identified by blood glucose testing), the common clinical
problem of loss of awareness of hypoglycaemia, and nocturnal hypoglycaemia,
which is often undetected, during sleep. Considerable variation in estimated rates of
severe hypoglycaemia exists between published studies because of differences in
definition, methodology of ascertainment, and heterogeneity of the patient
populations. Recent studies have estimated the frequency of severe hypoglycaemia
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as this is a more consistent, robust, and clinically relevant measure with respect to
the morbidity of this common therapeutic side effect. The cardinal factor in the
definition of severe hypoglycaemia is the need for external assistance to resuscitate
the patient, irrespective of how low the blood glucose concentration falls or the
method of resuscitative treatment. This definition has now received wide consensus.
When severe hypoglycaemia is defined as an episode that the patient is unable to
self-treat, retrospective studies of the frequency of severe hypoglycaemia have
produced consistent estimates of around 1.1 - 1.6 episodes /patient /year (MacLeod
et al. 1993; Pramming et al. 1991; Reichard et al. 1991). In a one year prospective
study from Edinburgh 31 type 1 diabetic patients with normal symptomatic
awareness of hypoglycaemia had a frequency of severe hypoglycaemia of 0.48
episodes /patient /year (Gold et al. 1994b). Interestingly, 60% of the episodes of
severe hypoglycaemia in this group occurred between the hours of 2400 and 0800.
Similarly, in a 6 month prospective study of an unselected group of type 1 diabetic
patients (n=78) the frequency of severe hypoglycaemia was reported to be 1.6
episodes /patient /year (Cox et al. 1994).
Recently some large prospective studies have been reported which have provided
important information regarding the frequency of severe hypoglycaemia. In the
Stockholm Diabetes Intervention Study (Reichard and Pihl, 1994) 102 type 1
diabetic patients were randomised to receive either intensified therapy (n=48) or
conventional therapy (n=54). This study was designed to assess the impact of
lowering the prevailing HbAlc concentration on diabetic microangiopathy. Subjects
also reported all episodes of severe hypoglycaemia that had occurred in the period of
time preceding each assessment (every 4 months). Severe hypoglycaemia occurred
with a frequency of 1.1 episodes /patient /year with intensified therapy and 0.4
episodes /patient /year with conventional therapy over the 7.5 years of follow-up
(Reichard and Pihl, 1994).
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Findings from a much larger trial, the Diabetes Control and Complications Trial
(DCCT) (The Diabetes Control and Complications Trial Research Group, 1991; The
Diabetes Control and Complications Trial Research Group, 1997), have recently
been reported. Again this trial was principally designed to assess the impact of
intensive insulin therapy with multiple injection regimens or continuous
subcutaneous insulin infusion devices on diabetic microangiopathy. Prompted by the
observation of a three-fold increase in the frequency of severe hypoglycaemia with
intensified vs. conventional therapy in the feasibility phase of the study (The
Diabetes Control and Complications Trial Research Group, 1987), the DCCT
investigators conducted a detailed investigation of the factors associated with
hypoglycaemia based on 817 type 1 diabetic subjects followed up for an average of
21 months. The definition of severe hypoglycaemia used in the DCCT was " an
event with symptoms consistent with hypoglycaemia, in which the patient needed
the assistance of another person and which is associated with a blood glucose
concentration of < 2.8 mmol/L or prompt recovery after oral carbohydrates,
intravenous glucose or glucagon administration" (The Diabetes Control and
Complications Trial Research Group, 1991). The DCCT reported a rate of severe
hypoglycaemia of 0.61 episodes /patient /year with intensified therapy and 0.19
episodes /patient /year with conventional therapy. The cumulative incidence of those
subjects who experienced their first episode of severe hypoglycaemia over the
duration of the trial was 73% with intensified therapy and 41% with conventional
therapy (The Diabetes Control and Complications Trial Research Group, 1997).
Interestingly, the frequency of severe hypoglycaemia after the first year of the study
remained relatively constant with an annual incidence of -25% with intensified
therapy despite the subjects becoming more familiar with this form ofmanagement.
Certain groups seemed particularly prone to hypoglycaemia and it was of note that
82% of the adolescent type 1 diabetic patients had experienced at least one episode
of severe hypoglycaemia during the trial period.
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Some difficulties in estimating the frequency of severe hypoglycaemia are
highlighted by appraisal of the results of the DCCT (The Diabetes Control and
Complications Trial Research Group, 1997). The patients who were recruited for the
DCCT were young (age <40 years), had diabetes of relatively short duration (<15
years), were highly motivated and were supervised intensively by a dedicated
specialist team. Patients who had significant microvascular disease were excluded,
as were those who had experienced more than two episodes of hypoglycaemic coma
without warning symptoms in the two years preceding enrolment. The application
of these exclusion factors will have removed many patients who would be most at
risk of severe hypoglycaemia. It is likely, therefore, that by studying this highly
selected group of patients the results of the DCCT are not typical of the frequency of
severe hypoglycaemia observed in an unselected diabetic population. This premise
is supported by the much higher estimates reported both in retrospective and
prospective studies in Northern Europe.
In 1997 the results of a multi-centre uncontrolled prospective German study on the
frequency of severe hypoglycaemia with intensive therapy was reported (Bott et al.
1997). A group of 636 type 1 diabetic patients were followed up for a total of 6
years. Unlike the DCCT, subjects were not excluded if they had experienced severe
hypoglycaemia prior to study entry, and were only excluded if they were aged over
40 years and had advanced diabetic complications. This group reported a frequency
of severe hypoglycaemia which decreased from 0.28 episodes /patient / year prior to
entry into the trial to 0.17 episodes /patient /year in the follow-up period (Bott et al.
1997). This is a figure that is considerably lower than that reported by the DCCT,
but the definition of severe hypoglycaemia was different. The German group only
recorded events in which glucagon or intravenous glucose was given. In the DCCT
the rate of coma /seizure reported with intensified therapy was 0.16 episodes /patient
/year, which is comparable. In the German study the incidence of severe
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hypoglycaemia decreased with time whereas in the DCCT it remained constant,
despite additional training designed to avoid hypoglycaemia. This discrepancy may
have arisen because overall HbAlc actually rose during the duration of the trial (Bott
et 1. 1997), and because subjects were seen much less frequently (at 1,2,3 and 6 years
of follow-up) and therefore the reliability of reporting may not have been as good.
Comparison of retrospective and prospective estimates of severe hypoglycaemia has
demonstrated the validity of retrospective assessment over 12 months only
(Pramming et al. 1991).
It is very difficult to estimate with accuracy the frequency of episodes ofmild
hypoglycaemia or the frequency of asymptomatic hypoglycaemia unless they are
estimated prospectively (Pramming et al. 1991). The relationship between actual
blood glucose concentrations and subjective symptoms of hypoglycaemia is tenuous
(Pramming et al. 1990). Nocturnal hypoglycaemia is also very common, although
often unrecognised (Lerman and Wolsdorf, 1988). Using mathematical modelling,
Thorsteinsson et al. (1986) has shown that a diabetic patient with good glycaemic
control might be expected to have blood glucose <3.0 mmol/L every second day.
Risk factors for hypoglycaemia
The causes of hypoglycaemia are protean (e.g. changes in insulin sensitivity and
bioavailability, change in insulin pharmacokinetics, inadequate carbohydrate
exchange, co-existing endocrine disease). Most episodes can probably be attributed
to errors in the management of diabetes which is not surprising given the difficulties
of the daily balancing act undertaken by the diabetic patient treated with insulin.
Sleep is also a potential risk factor as symptomatic awareness is obtunded during
sleep. Pregnancy, with its attendant push to normalise blood glucose levels, carries a
higher risk of severe hypoglycaemia and it has recently been reported that 71% of
pregnant type 1 diabetic women will experience severe hypoglycaemia during the
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gestational period (Rosenn et al. 1995). In the DCCT, nocturnal hypoglycaemia was
responsible for nearly half of all documented episodes and 70% of episodes of
severe hypoglycaemia occurred between midnight and 0800 a.m. (The Diabetes
Control and Complications Trial Research Group, 1997). Hypoglycaemia
unawareness is a particularly important risk factor and may underlie many episodes
in which no cause is apparent. In a prospective study in our own centre, the
frequency of severe hypoglycaemia was found to be six times higher in type 1
diabetic patients who had a history of diminished awareness ofhypoglycaemia than
in those who had normal awareness (Gold et al. 1994b).
Analysis of the DCCT (The Diabetes Control and Complications Trial Research
Group, 1997) has provided further information. Those subjects who experienced
severe hypoglycaemia tended to be male, have longer duration of disease, have a
lower stimulated C-peptide, a higher daily dose of insulin and a lower HbAlc (The
Diabetes Control and Complications Trial Research Group, 1997). Interestingly, a
proportional hazards model found that only about 7.4% and 2.4% of the variance in
the risk for experiencing a first episode of severe hypoglycaemia with conventional
and intensive therapy respectively could be explained when all the factors listed
above were included in the model. When amultiplicative intensity model was used
to explore the relationship between 'current' HbAlc as a function of time and other
factors simultaneously in the risk of severe hypoglycaemia, then 12% and 6% of the
risk of severe hypoglycaemia with conventional and intensive therapy respectively
could be explained. The main predictive variables were prior number of episodes of
severe hypoglycaemia and current HbAlc. Similar findings were reported by Bott et
al. (1997) in their multicentre study of type 1 diabetic patients. Patients who
experienced severe hypoglycaemia during the period of the study had on average
longer disease duration, a lower C-peptide, a lower HbAlc and a higher total daily
insulin dose (Bott et al. 1997). It was also suggested in this trial that those subjects
who experienced severe hypoglycaemia had lower coping abilities than those who
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did not, although the absolute values reported (15.3±3.9 for those who had
experienced severe hypoglycaemia versus 14.6±3.6 for those who had not; with a
high score indicating low coping abilities) suggest that this would explain a tiny
proportion of the variance in the risk of severe hypoglycaemia.
Recently, Cox et al. (1994) have suggested that the variability in daily blood glucose
monitoring was more predictive of severe hypoglycaemia than HbAlc. Seventy-
eight type 1 diabetic subjects were enrolled in a prospective trial to determine risk
factors for severe hypoglycaemia. Subjects were asked to record 50 finger-prick
blood glucose recordings over a 2-3 week period and record these on a hand held
computer. Episodes of severe hypoglycaemia over the next 6 months were then
recorded. Those subjects who recorded both more variable, and lower, blood glucose
recordings suffered more frequent episodes of hypoglycaemia. The authors also
produced a measure called the blood glucose index (BG index). A detailed
explanation of the BG index can be found in the paper, but essentially it reflects the
relative number and extent of low blood glucose readings. The authors found that by
including the BG index and the standard deviation of blood glucose readings for the
subjects in their cohort in a regression model then 43.5% of the variance in severe
hypoglycaemia episodes could be accounted for (Cox et al. 1994).
8
Table. 1.1.1. Risk factors for the development of severe hypoglycaemia
FACTOR STUDY
Male DCCT 1997
Type 1 diabetes of long duration DCCT 1997; Bottet al. 1997
Lower glycated haemoglobin DCCT 1997; Bott et al. 1997; Pramming
et al. 1990
Lower stimulated C-peptide DCCT 1997; Bottetal. 1997
Higher insulin dose DCCT 1997; Bott et al. 1997; p
Previous severe hypoglycaemia DCCT 1997; Bottetal. 1997
Low blood glucose index Cox et al. 1994
Greater standard deviation in daily blood
glucose readings
Cox et al. 1994
Hypoglycaemia unawareness Gold et al. 1994; Clarke et al. 1995;
MacLeod et al. 1994
Impaired hypoglycaemia hormonal
counterregulation
White et al. 1983; Bolli et al. 1984
Sleep e.g. Lermann et al. 1988; Bendtson et al.
1988 and 1991; Pramming et al. 1990;
Gold et al. 1994; DCCT 1997
Pregnancy Rosenn et al. 1995
Not carrying emergency carbohydrates Bott et al. 1997
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Symptoms of hypoglycaemia
It has been recognised since the introduction of insulin in the 1920s that 'a
characteristic train of symptoms' occurs when the blood glucose falls to beneath the
normal range. These symptoms were so typical of a low blood glucose that they
were termed the 'hypoglycaemic reaction' (Fletcher and Campbell, 1922). It was
also recognised that individuals did not always experience the same symptom
complex and that some diabetics could progress to severe hypoglycaemia without
experiencing any symptoms at all. Hypoglycaemia unawareness was recognised as
long ago as 1922 (Joslin et al. 1922). This issue was highlighted with the
introduction of human insulin in the 1980s. A group in Switzerland suggested that
the symptoms ofhypoglycaemia induced by human insulin may be different from
those induced by animal insulin (Teuscher and Berger, 1987; Berger and Althaus,
1987; Berger et al. 1989). A recent review of all the studies, clinical and
experimental, that went on to formally examine this issue concluded that there was
in fact no evidence to support this claim (Nellemann Jorgenson et al. 1994).
However, the controversy did highlight the need to measure symptoms with greater
accuracy and resulted in a considerable body of research into the aetiology and
classification of hypoglycaemia symptoms.
The symptoms of hypoglycaemia can essentially be subdivided into three groups;
autonomic, neuroglycopenic and malaise symptoms. Autonomic symptoms result
from the activation of the autonomic nervous system producing stimulation of the
sympatho-adrenal system (Cannon et al. 1924) via centres in the hypothalamus
(Benzo, 1983). Neuroglycopenic symptoms relate to the direct effect of glucose
deprivation on the central nervous system, in particular cortical function, and
malaise symptoms are those which prove difficult to allocate to either of the other
groups. Objective allocation of appropriate symptoms into these subgroups has come
from both experimental and prospective clinical studies. Principal components
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analysis (a statistical technique whereby a large number of variables can be reduced
to a number of groups where variables tend to associate with each other more
strongly) of symptoms reported during experimental hypoglycaemia by 55 subjects
with and without type 1 diabetes (Hepburn et al. 1991a) allocated with confidence 5
symptoms to an autonomic grouping and 6 symptoms to a neuroglycopenic
grouping. A subsequent retrospective study of 295 insulin-treated diabetic subjects
suggested that there might be 5 groups ofhypoglycaemic symptoms (autonomic,
neuroglycopenic, general malaise, motor and sensory dysfunction) (Hepburn et al.
1992). However, the authors of this study felt a three factor solution might be more
appropriate and they repeated the analysis of this original cohort prior to performing
confirmatory factor analysis in a second cohort of 303 insulin-treated subjects
(Deary et al. 1993b). Confirmatory factor analysis showed that the three-factor
model was the optimal model for explaining symptom covariance in each group
(Deary et al. 1993b). This classification is shown below:







There is considerable agreement between the findings from analysis of symptom
reports and from experimental studies. For instance, physiological tremor (shaking)
is recognised to increase during hypoglycaemia (Heller et al. 1987) and is similarly
increased by an infusion of adrenaline (Fellows et al. 1986). Tremor can be
suppressed during hypoglycaemia by adrenergic and panautonomic blockade
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(Towler et al. 1993) indicating a role both for adrenaline released from the adrenal
medulla into the circulation, and for noradrenaline released from sympathetic
postganglionic nerve terminals in relevant target organs. These findings are
consistent with patient self-reports, which clearly identify tremor as an autonomic
symptom. Sweating is mediated by cholinergic sympathetic nerve fibres and
increases dramatically during experimental hypoglycaemia (Corrall et al. 1983;
Hepburn et al. 1991a). The sweating response is absent in tetraplegic
(sympathectomized) individuals (Frier et al. 1981) but present in those who have had
an adrenalectomy (Altorfer et al. 1981). Sweating is also unaffected by beta
blockade (Kerr et al. 1990), or by combined alpha- and beta-blockade (Towler et al.
1993), but can be blocked by atropine (Towler et al. 1993). The hypoglycaemia-
induced sweating response is therefore sympathetic cholinergic nerve fibre
stimulated and can be allocated to the autonomic symptom subgroup on the basis of
clinical and experimental studies. Similarly, panautonomic blockade during
experimental hypoglycaemia reduces the intensity of classical autonomic symptoms
but has little effect, or even increases awareness, ofneuroglycopenic symptoms such
as drowsiness and confusion (Towler et al. 1993). This again is consistent with
patient self-reports, which identify these symptoms as neuroglycopenic.
However, differences do exist between the symptoms reported during
experimentally induced hypoglycaemia and hypoglycaemia experienced in the
community. This is, in many ways, not surprising given the nature of hypoglycaemia
in the two different environments (one taking place in a controlled laboratory
environment, the other in every day life with a multitude of other influences).
Probably the most detailed analysis of experimental hypoglycaemia to date is that of
Towler et al. (1993) who examined 10 non-diabetic subjects using a one-step
hyperinsulinaemic glucose clamp. All subjects underwent 4 study sessions
(euglycaemia vs. hypoglycaemia vs. hypoglycaemia plus adrenergic blockade vs.
hypoglycaemia plus panautonomic blockade). The authors were able to show a clear
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physiological basis for the generation of autonomic symptoms (e.g. tremor
principally adrenergic; sweating principally cholinergic) and that neuroglycopenic
symptoms were unaffected by panautonomic blockade. The authors found that
symptoms of hypoglycaemia-associated malaise (nausea and headache) did not
change significantly during hypoglycaemia. The particular symptoms of
neuroglycopenia that were found to increase in this study also differed from the
Edinburgh studies (Hepburn et al. 1991a; Hepburn et al. 1992; Deary et al. 1993b) in
that warmness and weakness were found to be neuroglycopenic symptoms (i.e. not
affected by pan-autonomic blockade) rather than either autonomic or non-specific. In
fact, in the later analysis by Deary et al. (1993) both warmness and weakness were
excluded from the Edinburgh Hypoglycaemia Scale because they showed poor
discrimination. The classification proposed by Towler et al. (1993) for experimental
insulin-induced hypoglycaemia is shown below.
Table. 1.1.3. Symptoms of acute insulin-induced hypoglycaemia under experimental













Most obviously severe hypoglycaemia, and the reduced conscious level that results
from significant neuroglycopenia, is associated with the risk of trauma and injury to
an individual or to others as a result of their activities. Fractures of long bones, joint
dislocations, soft tissue injuries, head injuries and burns have been described in
association with acute hypoglycaemia (Hepburn et al. 1989) and hypoglycaemia
while driving can cause road-traffic accidents (Frier, 1992). Various forms of
trauma are associated with hypoglycaemia-induced convulsions, which affect about
7% of all insulin-treated patients (MacLeod et al. 1993). However, more widespread
effects of hypoglycaemia have also been reported and these will discussed in the
following section.
Cardiovascular system
Acute hypoglycaemia in diabetic patients has been associated with various major
vascular events such as stroke and myocardial ischaemia/infarction although much
of the evidence is anecdotal. The cardiovascular morbidity of hypoglycaemia may
be secondary to profound sympatho-adrenal stimulation or as a consequence of the
concurrent haemodynamic and rheological changes.
Anecdotal reports have been described of hypoglycaemia-induced myocardial
ischaemia or infarction (Fish et al. 1986; Gilbert and Goldzieher, 1946). One
possible reason for the limited documentation is the difficulty in identifying that an
acute vascular event, such as a myocardial infarction, has been precipitated by acute
hypoglycaemia. The sympatho-adrenal response resulting from acute hypoglycaemia
per se plus the stress of the acute vascular event may provoke a rise in blood glucose
and so mask antecedent hypoglycaemia. The development ofhypoglycaemia
preceding and provoking an acute vascular event may often be unrecognised and
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underestimated. However, hypoglycaemia promotes a major increase in myocardial
contractility, heart rate and cardiac output, plus a widening of pulse pressure (Odeh
et al. 1990), and this may compromise the coronary circulation in a patient who has
coronary heart disease. Hypoglycaemia can also provoke cardiac arrhythmias.
Table. 1.1.4
PROARRHYTHMIC EFFECTS OF HYPOGLYCAEMIA




The possible mechanisms promoting cardiac arrhythmias are indicated in Table
1.1.4. Increased ectopic activity of atrial, nodal and ventricular origin in type 1
diabetic (Fisher and Frier, 1993), and non-diabetic (Leak and Starr, 1962)
individuals, with (Leak and Starr, 1962), and without (Fisher and Frier, 1993)
evidence of coronary heart disease, has been documented. Spontaneous reversion to
sinus rhythm is usual following correction of hypoglycaemia.
Hypoglycaemia is associated with specific ECG changes which include flattening or
inversion of the T wave (Lloyd-Mostyn and Oram, 1975), QT prolongation (Egali
and Berkmen, 1960) and ST segment depression (Lloyd-Mostyn and Oram, 1975),
although the latter effect may reflect co-existing myocardial ischaemia. The T wave
changes can be reversed by simultaneous infusion ofpotassium (Egali and Berkmen,
1960), and are absent during concurrent beta-blockade (Lloyd-Mostyn and Oram,
1975). Hypoglycaemia-induced cardiac arrhythmia has been proposed to be a
precipitant of the 'Dead in Bed' syndrome, a phenomenon describing the sudden
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death of healthy young type 1 diabetic patients during sleep (Tattersall and Gill,
1991).
Renal system
Renal haemodynamics are affected by hypoglycaemia with a fall in glomerular
filtration rate and total renal blood flow (Patrick et al. 1989), and the changes are
more pronounced in subjects with type 1 diabetes (Patrick et al. 1992). Secretion of
plasma catecholamines and activation of the renin-angiotensin system are thought to
be implicated. In diabetic patients who have established nephropathy, these changes
in glomerular haemodynamics and rate of filtration plus other attendant effects of
hypoglycaemia might promote further deterioration in renal function, but this is
purely speculative.
Gastro-intestinal system
Hypoglycaemia causes transient mild hepatic dysfunction with subtle changes in
some liver enzymes that are probably of no clinical significance (Howie et al. 1989).
Hypoglycaemia does not appear to influence glucose absorption from the gut in
healthy non-diabetic subjects (Moller et al. 1992) but controversy surrounds the
effect on gastric emptying during hypoglycaemia. Gastric emptying has been shown
to be accelerated in patients with type I diabetes (Schvarcz et al. 1993) but
hypoglycaemia did not effect pyloric activity in non-diabetic humans (Fraser et al.
1991). It is not clear whether these changes have clinical importance in diabetic
patients and contribute to the morbidity of this state. Patients with autonomic
neuropathy may develop hypoglycaemia as a result of gastric stasis delaying
subsequent absorption of glucose from the small bowel.
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The Eye
Acute hypoglycaemia causes a sudden fall in intraocular pressure (Frier et al. 1987).
The acute changes in intra-ocular pressure will increase perfusion pressure and
capillary flow in retinal vessels and it has been postulated that such acute
haemodynamic changes may precipitate capillary closure, or even the rupture of
fragile new vessels causing haemorrhage (Frier and Hilsted, 1985). It was also
suggested that the acute effects on haemostasis and haemorrheology induced by
hypoglycaemia, coupled with haemodynamic changes in various vascular beds, may
effect blood flow in the microvasculature of diabetic patients who have established
microangiopathy (Frier and Hilsted, 1985). The changes in capillary blood flow and
the increased blood coagulability could promote capillary closure, with the
exacerbation of established background retinopathy and progression of diabetic
microangiopathy in other tissues. Circumstantial evidence to support this hypothesis
is provided by the Kroc, Steno and Oslo studies (Lauritzen et al. 1983; Dahl-
Jorgenson et al. 1985; Hanssen et al. 1986), which showed an initial deterioration in
diabetic retinopathy with the establishment of strict glycaemic control. A similar
phenomenon was observed in the DCCT in type 1 diabetic patients' exposed to strict
glycaemic control (The Diabetes Control and Complications Trial Research Group,
1993). Hypoglycaemia does not cause microangiopathy, but the pathophysiological
changes that it promotes may have deleterious effects on a diseased
microvasculature.
Central Nervous System
The clinical manifestations of hypoglycaemia are protean. Variable losses of
sensory and/or motor functions and convulsions have been reported. Features of
decortication or decerebration (Seibert, 1985) may occur, and focal abnormalities are
well described such as hemiplegia (Foster and Hart, 1987; Lala et al. 1989),
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choreoathetosis (Newman and Kindel, 1984), ataxia (Ingram et al. 1967), and severe
amnesia (Chalmers et al. 1991). In individual case reports structural abnormalities
have been observed by nuclear magnetic resonance imaging following
hypoglycaemia although CT scanning was normal (Chalmers et al. 1991; Perros et
al. 1994). A recent case was reported of a type 1 diabetic patient who became
hypoglycaemic during a contrast enhanced CT scan. The CT scan revealed a non-
enhancing low density area in the left internal capsule that disappeared after
treatment with glucose (Koppel and Daras, 1993). Intermittent hypoglycaemia may
not be diagnosed in elderly diabetic patients who are often assumed to be suffering
from transient ischaemic attacks. In general many of these episodes of neurological
dysfunction are reversed by the administration of glucose and permanent
neurological abnormalities are rare.
The pathophysiology ofmany transient episodes of neurological dysfunction
remains unclear. It is not unusual to find localised premature cerebrovascular
atherosclerosis in diabetic patients which might contribute to transient neurological
dysfunction or cerebrovascular infarction induced by hypoglycaemia. However, this
explanation is unlikely in children, or in adults who experience transient paralysis on
alternating sides (Foster and Hart, 1987). An acute change in regional cerebral
blood flow (CBF) causing local ischaemia is a more likely cause of this transient
neurological dysfunction.
Convulsions are a well-recognised sequel of acute hypoglycaemia, occurring often in
type 1 diabetic children. Idiopathic epilepsy is over-diagnosed in adult type 1
diabetic patients with convulsions and the prevalence of epilepsy is considered to be
similar to that of the non-diabetic population. One diagnostic problem is the
difficulty in interpreting the electroencephalogram (EEG) following a
hypoglycaemic convulsion because abnormalities may occur with hypoglycaemia
per se and can persist for up to several days. In addition a significant proportion of
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diabetic patients who have experienced severe recurrent hypoglycaemia develop
permanent EEG abnormalities (Gold et al. 1993).
Physiology of hypoglycaemia
Hypoglycaemia rarely occurs in a non-diabetic population. In non-diabetic humans
the ambient blood glucose concentration is tightly controlled by homeostatic
mechanisms. Because of the vital importance of glucose to the brain,
normoglycaemia is maintained by several counterregulatory systems, without which
an individual would become progressively hypoglycaemic even in the absence of
hyperinsulinaemia. The counterregulatory hormones have been shown to have
differing abilities to promote recovery from hypoglycaemia, with the most potent
being glucagon and adrenaline. Some hormones such as adrenaline and vasopressin,
which are released in response to hypoglycaemia, have significant haemodynamic
effects that influence vascular flow and perfusion of tissues, and promote
haemostatic changes effecting intravascular coagulability. In the following section I
will review our current understanding of the physiology of glucose counterregulation
during insulin-induced hypoglycaemia.
Hormonal counterregulation
The kinetics of glucose recovery from insulin-induced hypoglycaemia is such that
factors other than simple insulin dissipation must be involved. Acute glucose
production is predominantly secondary to hepatic glycogenolysis although
gluconeogenesis is initiated very early on during hypoglycaemia (Garber et al.
1976). The onset of glucose recovery is also marked by a considerable reduction in
peripheral glucose utilisation (Garber et al. 1976). As this occurs in the presence of
plasma insulin levels that are considerably higher (100-fold in Garber et al. 1976)
than baseline levels then additional factors must be involved in glucose
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counterregulation. Glucose counterregulation has now been extensively investigated
and we are beginning to understand its physiology. The important glucose
counterregulatory factors include hormones, neurotransmitters and metabolic
substrates/intermediates.
The most important counterregulatory hormone is glucagon, which is secreted by the
pancreatic islet a cells. It stimulates hepatic glucose production, raising blood
glucose levels within minutes, through glycogenolysis and gluconeogenesis (Cryer,
1993b). Adrenaline, released from the medullary region of the adrenal gland, is the
second most important counterregulatory hormone, and like glucagon, has a very
rapid effect on blood glucose levels (Cryer, 1993b). Its action is more complex, but
essentially stimulates hepatic glucose production and limits peripheral glucose
utilisation. Because adrenaline stimulates hepatic gluconeogenesis through
mobilisation of peripheral precursors (lactate, alanine) to the liver (Frizzell et al.
1988), and stimulation of lipolysis and ketogenesis (Fanelli et al. 1993), its
hyperglycaemic effect is more sustained. Adrenocorticotrophin (ACTH) and growth
hormone (GH) are also important glucose counterregulatory hormones, but their
effects only become apparent after several hours. GH and Cortisol (ACTH-
stimulated) predominantly limit glucose utilisation but also stimulate lipolysis
(Rizza et al. 1982b; Rizza et al. 1982a).
The two main neurotransmitters that have been shown to effect glucose production
during hypoglycaemia are noradrenaline and acetylcholine. Noradrenaline has a
similar action to adrenaline (Clutter et al. 1988), whereas acetylcholine inhibits
hepatic glucose production (Boyle et al. 1988a). It was previously felt that the
concomitant secretion of glucagon, which has the opposite effect, masked the
inhibitory effect of acetylcholine on hepatic glucose production. Should a defect in
glucagon secretion then develop in a type 1 diabetic subject the acetylcholine action
might render them more susceptible to hypoglycaemia. In fact, rates of glucose
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production and utilisation are unaltered during insulin-induced hypoglycaemia in
glucagon deficient type 1 diabetic subjects who have been given a muscarinic
antagonist (Hvidberg et al. 1996), which would suggest the acetyl-choline effect is
of no great significance in glucose counterregulation.
Other metabolic fuels are also thought to contribute to the hypoglycaemic response.
Plasma lactate levels rise during hypoglycaemia and reflect increased muscle
glycogenolysis (Davis et al. 1997). This is thought to be a reflection of adrenaline
action on muscle glycogenolysis, although more recent data suggest noradrenaline
may be as important (Maggs et al. 1997). Lactate is a substantive precursor for
gluconeogenesis and can potentially be used acutely by the brain (Veneman et al.
1994) [the use of alternative fuels for brain metabolism will be discussed later].
Lipolysis is also an important part of the metabolic response to hypoglycaemia
(Frizzell et al. 1988; Davis et al. 1997). Glycerol is a substrate for gluconeogenesis
and increased non-esterified fatty acids (NEFA) in the periphery limit glucose
utilisation owing to substrate competition. Furthermore, the liver converts NEFA to
ketone bodies, which could be used by the brain as an alternative fuel (Davis et al.
1993a). The effects of hypoglycaemia on peripheral metabolism were originally
thought to reflect adrenaline release from the adrenal medulla. This is because of the
known effects of adrenaline on peripheral metabolism and because during
hypoglycaemia adrenaline comprises about 85% of the catecholamine response
(Maggs et al. 1997). However, a recent study that examined adrenaline,
noradrenaline and metabolic substrates in the ECF using microdialysis catheters has
suggested that noradrenaline, released locally from the neuroeffector junction,
comprises about 35% of the catecholamines in adipose tissue and 50% in skeletal
muscle i.e. local noradrenaline release was as important in determining the
peripheral response to hypoglycaemia (Maggs et al. 1997). This study also shed
some light on local metabolic changes during hypoglycaemia. While it was
confirmed that peripheral tissues (especially muscle) released potentially important
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gluconeogenic precursors, it was shown that ECF glucose actually showed a greater
relative fall during hypoglycaemia implying an increased efficiency of glucose
extraction during hypoglycaemia in skeletal muscle and adipose tissue i.e. local
glucose transport has adapted acutely to hypoglycaemia.
It is currently believed that there is a redundancy amongst the glucose
counterregulatory factors and a hierarchy in their relative importance (Cryer et al.
1994; Cryer, 1993b). This subject has been reviewed extensively (e.g. Cryer et al.
1994; Cryer, 1993b), and will be briefly summarised here.
Hypoglycaemia induces the release ofmany different counterregulatory hormones,
neurotransmitters and metabolic substrates. However, only a few of these appear to
have physiological relevance to hypoglycaemia recovery. In a series of studies over
the last 20 years it has been shown that glucagon plays a primary role in glucose
counterregulation, that adrenaline is not normally crucial but becomes so in the
absence of glucagon, that growth hormone and Cortisol are important in continued
but not acute glucose counterregulation, and that other hormones, neurotransmitters,
and metabolic substrates probably do not play an essential role in the acute response
to hypoglycaemia (Cryer, 1993b). This was demonstrated most clearly in the work
by Gerich et al. (1979), where glucose recovery to insulin-induced hypoglycaemia
did not occur in somatostatin infused (blocking glucagon release), bilaterally
adrenalectomized human subjects.
The threshold for release of the glucose counterregulatory hormones during insulin-
induced hypoglycaemia has also been extensively studied. The definitive study was
probably that ofMitrakou et al. (1991), who used a stepped hyperinsulinaemic
glucose clamp technique with measures of arterialised venous blood and established
the threshold for glucagon and adrenaline release to be 3.0 mmol/1. More recent
studies (see later) have indicated that the threshold is in fact a very plastic
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phenomenon and many factors can influence its absolute value.
Impaired hormonal counterregulation
The developments in our understanding of the physiology of glucose
counterregulation have provided essential information to explain the occurrence of
hypoglycaemia in the insulin-treated population and to explain the particular
propensity of some individuals to hypoglycaemia. Whilst it is clear that insulin, if
present in sufficient quantities, will always overcome the body's natural defence -
mechanisms it is recognised that some individuals are particularly prone to
hypoglycaemia.
A deficient glucagon response to insulin-induced hypoglycaemia is common in type
1 diabetic individuals and develops as an acquired defect within the first few years
after diagnosis (Bolli et al. 1983). It is a selective defect in that glucagon responses
to other stimuli remains intact. The cause is unknown but its relationship to absolute
insulin deficiency suggests an influence of P-cell loss. Similarly, many patients with
relatively long-standing type 1 diabetes (>10 years) also have a deficiency in the
adrenaline secretory response to insulin-induced hypoglycaemia (Bolli et al. 1983).
As with the glucagon abnormality the deficiency is selective, and of unknown
mechanism.
Patients with combined deficiencies in glucagon and adrenaline responses to
hypoglycaemia have the syndrome of defective glucose counterregulation (Cryer,
1993b). Such patients, when compared to type 1 diabetic subjects who have an intact
adrenaline response to hypoglycaemia, have a 25-fold increased risk of severe
hypoglycaemia (White et al. 1983; Bolli et al. 1984).
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Otherfactors effecting the counterregulatory hormonal response to hypoglycaemia
Single or repeated episodes of antecedent hypoglycaemia cause elevated glycaemic
thresholds (lower plasma glucose concentrations) for several counterregulatory
responses (particularly adrenaline) to subsequent hypoglycaemia. This finding has
been confirmed in insulinoma patients (Mitrakou et al. 1993), in healthy non-
diabetic individuals (Heller and Cryer, 1991; Davis and Shamoon, 1991; Widom and
Simonson, 1992; Veneman et al. 1993; Davis and Shamoon, 1991) and type 1
diabetic subjects (Davis et al. 1992; Dagogo-Jack and Cryer, 1993; Kedes and Field,
1964; Lingenfelser et al. 1993b; George et al. 1997). Most studies have been either
of rather short duration (24hrs) or ofmuch longer duration so that it is difficult to
say how long this defect persists. George et al. (1995) demonstrated in non-diabetic
individuals that an impaired counterregulatory hormone response to subsequent
hypoglycaemia could be detected 5 days after the initial episode of experimental
hypoglycaemia, whilst others (Robinson et al. 1995) have found that the
counterregulatory defect persisted for more than 6 days but less than 28 days.
However, when George et al. 1997 studied type 1 diabetic individuals (using the
same protocol as in their previous study) the counterregulatory defect was found to
have returned to baseline between 1 and 2 days from the initial episode of
experimental hypoglycaemia. It is possible that the competing influences of
alternating hypo- and hyperglycaemia in some way compensate for each other, and
the effect of antecedent hypoglycaemia on subsequent hypoglycaemia may be less
sustained in the type 1 diabetic population.
Different degrees of antecedent hypoglycaemia have been shown to have a
differential effect on subsequent hypoglycaemia. A recent study (Davis et al. 1997)
examined the effect of 4 differing glycaemic states on a standardised day 2
hypoglycaemic stimulus. Mild day 1 hypoglycaemia (3.9 mmol/1) was found to
significantly blunt subsequent adrenaline (-40%) and glucagon (-40%) responses
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compared with day 1 euglycaemia. A slightly more pronounced day 1
hypoglycaemia (3.3 mmol/1) had the same effect on adrenaline and glucagon as mild
day 1 hypoglycaemia but also effected changes in growth hormone, noradrenaline
and pancreatic polypeptide. Finally, there was no further effect of day 1 moderate
hypoglycaemia (2.9 mmol/1) on subsequent responses to that noted when day 1
hypoglycaemia was 3.3 mmol/1. This study showed that, up to a maximum of ~3.3
mmol/1, the more intense the hypoglycaemic episode the greater its suppressive
effect on the counterregulatory response to subsequent hypoglycaemia.
Some explanation for the effects of antecedent hypoglycaemia on subsequent
hypoglycaemia can be gleaned from two elegant experiments reported by Davis et
al. (1994, 1997). In the first of these experiments it was shown that in normal
humans a physiological increase in Cortisol, mimicking the levels that can be found
following acute hypoglycaemia, could produce a similar counterregulatory hormonal
deficiency during subsequent hypoglycaemia as could an episode of antecedent
hypoglycaemia (Davis et al. 1994). Subsequently, it was shown that ifCortisol was
maintained at physiological levels (this was done by using a continuous
subcutaneous infusion of hydrocortisone) in a group of patients with Addison's
disease, then the effects of a single episode ofhypoglycaemia on hypoglycaemia
induced the following morning were ameliorated (Davis et al. 1997). Both these
experiments would suggest that the increase in Cortisol following an episode of
hypoglycaemia is responsible for the impaired counterregulatory response to
subsequent hypoglycaemia.
It has been argued that if antecedent hypoglycaemia causes a defect in the
counterregulatory responses to subsequent hypoglycaemia then it follows that
strictly avoiding hypoglycaemia could restore the thresholds for stimulation of the
counterregulatory response to normal. This, it is argued, should not entail a change
in overall glycaemic control. Certainly there are a few small studies that have
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suggested that strict avoidance of hypoglycaemia does indeed reverse the
counterregulatory hormonal defect (Fanelli et al. 1993; Fanelli et al. 1994; Cranston
et al. 1994).
The first evidence that the counterregulatory defect associated with antecedent
hypoglycaemia could be reversed came from a study in an insulinoma patient
(Maran et al. 1992). By studying this subject using a stepped glucose clamp the
authors were able to show that post-operatively, the magnitude of the
counterregulatory response to experimental hypoglycaemia increased significantly
and that the threshold for the adrenaline response to hypoglycaemia increased from a
plasma glucose of 1.9 mmol/ to 2.7 mmol/1 (Maran et al. 1992) (N.B. this was not
'normalised'). A similar finding was reported by Vea et al. (1992) in another
insulinoma patient. Finally, Mitrakou et al. (1993) performed stepped
hypoglycaemic clamps in 6 insulinoma patients preoperatively and 6 months post¬
operatively. This group found, in comparison with 14 normal subjects examined at
the same time points, that pre-operatively the insulinoma patients had an impaired
symptomatic and counterregulatory responses to hypoglycaemia, but that post¬
operatively there were no significant differences between groups (i.e. surgery had
reversed the abnormalities, although it is notable that the thresholds for autonomic
and neuroglycopenic symptoms and for each of the counterregulatory hormones
were higher than those of the non-diabetic individuals in all cases). An insulinoma
patient probably experiences what is effectively chronic hypoglycaemia and
therefore the interpretability of these findings to type 1 diabetic patients, who
experience alternating hyper- and hypoglycaemia, is in some doubt.
Fanelli et al. (1993) reported that the meticulous prevention of hypoglycaemia over a
3 month period in intensively treated type 1 diabetic subjects of short duration of
disease improved, though did not normalise, the magnitude and glycaemic
thresholds of the counterregulatory hormonal, symptom and cognitive response to
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experimental hypoglycaemia. Similarly, Cranston et al. (1994) performed stepped
hypoglycaemic clamps on 6 type 1 diabetic subjects with near-normal glycaemic
control (mean HbAlc=6.5%) and 6 type 1 diabetic subjects with moderate
glycaemic control (mean HbAlc=8.2%), who had experienced frequent
hypoglycaemia before and after 3 weeks of strict absence of hypoglycaemia. This
group found that avoidance of hypoglycaemia lead to a significant improvement in
the magnitude of the counterregulatory response to hypoglycaemia and lowered the
thresholds at which the hormonal and symptom responses were stimulated.
However, although reported as not significant, HbAlc did increase in both study
groups (by ~0.5%) and it is therefore possible that prevailing glycaemic control has
influenced the outcome measures and that a type II statistical error is being reported.
In a further study of this nature (n=6 type 1 diabetic subjects with normal awareness;
n= 6 type 1 diabetic subjects with unawareness; n=6 non-diabetic controls) it has
been reported that strict avoidance of hypoglycaemia over 3 months lead to an
improvement in the threshold for symptomatic awareness of hypoglycaemia but had
no effect on the thresholds for the hormonal response to hypoglycaemia (Fanelli et
al. 1994). Finally, Liu et al. (1996) reported that following 3 months of less strict
glycaemic control (mean HbAlc rising from 6.9 to 8.0%) there was a general
improvement in the thresholds for the hormonal and symptomatic responses to
hypoglycaemia in 7 type 1 diabetic subjects with strict glycaemic control and
unawareness.
All of these studies were very labour intensive and unlikely to influence routine
clinical practice at this stage. It is clear that hypoglycaemiaper se can disrupt the
counterregulatory and symptomatic response to subsequent hypoglycaemia, and that
this effect probably persists for between 24 and 48 hrs in type 1 diabetic subjects.
For those subjects prone to recurrent hypoglycaemia or with hypoglycaemia
unawareness, a short period of hypoglycaemia avoidance with some relaxation of
glycaemic control may partially restore some of these defects.
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The role of insulin in modulating the counterregulatory response to hypoglycaemia
is debated. Diamond et al. (1991) showed that raising insulin levels 10-fold
suppressed the magnitude of the counterregulatory response to hypoglycaemia. Kerr
et al. (1991) found that increasing insulin levels 3-fold also suppressed some of the
components of the counterregulatory response to hypoglycaemia (growth hormone
but not adrenaline). In neither of these studies did the threshold for triggering the
response change significantly. Davis et al. (1992), similarly studied the effect of
insulin on counterregulation, but found that when insulin concentrations were
increased 6- to 8- fold there was an increase in the adrenaline, noradrenaline and
Cortisol responses to hypoglycaemia. This finding was shown in animal studies
initially (Davis et al. 1992), and then replicated in normal volunteers (Davis et al.
1993a), but was not confirmed in type 1 diabetic subjects (Davis et al. 1993b). The
pharmacological doses of insulin used and the small numbers in each study group to
a certain degree compounded all of these studies. In a much larger study
Lingenfelser et al. (1996) assessed the counterregulatory, neurophysiological and
symptomatic responses to equivalent hypoglycaemia under two different but more
physiological hyperinsulinaemic glucose clamp experiments in 27 type 1 diabetic
subjects. This group showed that a higher degree of physiological hyperinsulinaemia
caused an enhanced counterregulatory (adrenaline, noradrenaline, growth hormone,
Cortisol), symptomatic (autonomic and neuroglycopenic) and neurophysiological
(auditory evoked potentials) to an equivalent degree of hypoglycaemia. All these
studies seem to suggest that insulin can modulate the physiological responses to
hypoglycaemia, but how this happens is unknown.
Other factors that have been shown to influence the magnitude and threshold of the
counterregulatory response to hypoglycaemia include age (Meneilly et al. 1995;
Amiel et al. 1987a) and sex (Draelos et al. 1995). The effect of autonomic
dysfunction is debated but in general has not been shown to influence responses to
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hypoglycaemia (Hepburn et al. 1990).
The influence ofalternativefuels on glucose counterregulation.
It is recognised that there are alternative substrates in the brain that it could
potentially oxidize, and which might therefore have a physiological action in
limiting the degree ofbrain dysfunction during hypoglycaemia. Amiel et al. (1991)
argued that the rebound increase in ketones which occurs during hypoglycaemia
could provide an alternative substrate for the brain. During prolonged fasting the
brain is able to use ketones as a fuel substrate (Owen et al. 1967). However, during
acute insulin-induced hypoglycaemia the issue is more debated. Ketone infusion has
either been found to have no effect on hormonal counterregulation in response to
acute insulin-induced hypoglycaemia (Frolund et al. 1980), or there has been
evidence of brain utilisation of ketones during acute hypoglycaemia (Amiel et al.
1991a; Veneman et al. 1994). In the later two studies (Amiel et al. 1991a; Veneman
et al. 1994) p-hydroxybutyrate was infused prior to the induction of hypoglycaemia,
however, if the rise in ketones following hypoglycaemia is prevented no effects on
brain function can be detected (Fanelli et al. 1993). Altogether, this suggests that
although the brain does appear to be able to utilise ketones as a fuel in the normal
day-to-day context of acute hypoglycaemia this is unlikely to have a significant
impact on hormonal counterregulation to hypoglycaemia.
Similarly, it has been postulated that lactate could serve as an alternative fuel
substrate. Animal studies have indicated an increased uptake of lactate by the brain
during hypoglycaemia (Avogaro et al. 1990). Furthermore, during strenuous exercise
in humans (where plasma lactate can rise as much as 10-fold), plasma glucose levels
can decrease to <3.0 mmol/1 without any apparent symptoms of hypoglycaemia
(Felig et al. 1998). In a small group of 10 non-diabetic subjects the infusion of
lactate just prior to the onset ofhypoglycaemia raised the threshold for the
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counterregulatory response to hypoglycaemia and reduced the magnitude of the
response (by as much as 73% in the case of adrenaline) (Veneman et al. 1994).
Furthermore, the post-hypoglycaemia infusion of lactate reduces the development of
symptoms acutely, reduces counterregulatory responses and prevents further
deterioration of cognitive function to continuing hypoglycaemia (Maran et al. 1996).
However, in these studies pharmacological concentrations of lactate have been used.
The recognised increase in lactate during hypoglycaemia is substantially less and
although an important aspect of the metabolic response to acute hypoglycaemia
(preventing prolonged hypoglycaemia) its role in effecting thresholds for hormone
release is unclear.
Localisation ofthe 'glucosensor'
In order for a physiological response to hypoglycaemia to be generated, the body
needs to be able to detect a low blood glucose and co-ordinate a response designed
to protect it from hypoglycaemia. A role for both CNS and extra-cerebral glucose
'sensors' has been proposed (Biggers et al. 1989; Donovan et al. 1991). Although a
role for glucose counterregulation in the liver (Donovan et al. 1991) has been
proposed, the bulk of evidence points to the CNS as the dominant centre for the
sensing and integration of hypoglycaemia signals. A bilateral infusion of glucose
into both carotid and vertebral arteries, designed to maintain cerebral euglycaemia in
the face of systemic hypoglycaemia, nearly abolishes hormone release during
hypoglycaemia (Biggers et al. 1989; Frizzel et al. 1993). Whilst these studies
provide evidence of the key role played by the brain in hormonal counterregulation
they do not localise the putative 'glucosensor' to any specific part of the brain.
More recently, information has emerged that the ventromedial hypothalamus (VMH)
is essential for hypoglycaemic counterregulation. The glucagon and catecholamine
responses to hypoglycaemia are markedly attenuated in rats with bilateral VMH
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lesions, compared with rats with lesions in other parts of the brain (Borg et al. 1994).
It has also been shown that if localised glucopenia is established in the VMH there is
a prompt increase in counterregulatory hormones (Borg et al. 1995). Borg et al.
(1997) recently showed in chronically catheterised rats that perfusion of the VMH
with either L-glucose (a non-metabolizable form of glucose) or an iso-osmotic
solution lacking glucose resulted in prompt and marked increases in the
concentrations of glucagon and catecholamines. In contrast, in the face of systemic
hypoglycaemia, the local perfusion into the VMH ofD-glucose inhibited the
counterregulatory response. Moreover, the counterregulatory response was only
partially attenuated by infusing 15 mmol D-glucose, but 85% suppressed when 100
mmol D-glucose was infused. This suggests that the VMH contains gluco-receptors
that sense fluctuations in glucose concentrations and modulate the counterregulatory
response to hypoglycaemia, perhaps through the release of neurotransmitters.
In support of this hypothesis, it has been reported that insulin-induced
hypoglycaemia stimulates noradrenaline release in the VMH (Shimizu and Bray,
1990). Furthermore, alterations to KATP channels have been shown to affect a change
in y-aminobutyric acid (GABA) release (During et al. 1995). In a previous study by
During et al. (1995) microdialysis probes were placed in the substantia nigra of the
rat, a region of the brain rich in KATP channels. Perfusion with lOmM glucose
increased GABA release two-fold, as did perfusion with the sulphonylurea,
Glipizide. Perfusion with the specific KATP channel activator, lemalkalim, or 2-
deoxyglucose with oligomycin, inhibited GABA release. When systemic
hypoglycaemia was induced nigral dialysate GABA concentrations decreased by
50% as well. This would indicate that glucose might modulate GABA release
through an effect on KATP channels in a manner similar to the pancreatic beta-call.
The cellular mechanisms used by the VMH to sense and transduce the glucose signal
are unknown. It is possible that the VMH may share common mechanisms for
glucose-sensing with the pancreatic beta cell, which is the only glucose-sensing cell
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that has been well characterised. In keeping with this possibility, cells within the
medial hypothalamus have been shown to express the gene for glucokinase as well
as GLUT-2 (Jetton et al. 1997). Moreover, VMH neurones contain KATP channels,
which are important in signal transduction (Zini et al. 1991). Taken together, these
data suggest that the VMH is integral to hypoglycaemia counterregulation, and that
cells within the VMH may have the ability to 'sense' prevailing glucose levels, thus
affecting a change in local neurotransmission.
Other relevantphysiological changes that occur during acute hypoglycaemia
(i) Cerebral bloodflow
It is recognised that the brain is normally reliant on a continuous supply of glucose
from the peripheral circulation. Glucose extraction from the cerebral circulation is
directly related to the surface area, as well as blood flow, and to the activity and
quantity of glucose transporters. It would seem logical that cerebral blood flow
(CBF) should increase before the blood glucose threshold for cognitive impairment
is reached. Most studies in humans do suggest that acute hypoglycaemia causes an
increase in cerebral blood flow (Tallroth et al. 1992; Tallroth et al. 1993), although
some controversy remains (Powers et al. 1993). However, the increase in CBF has
only been documented at very low blood glucose levels (<2.0 mmol/1), well below
the threshold for cognitive dysfunction (Tallroth et al. 1993). It is possible that CBF
is increased as consequence of capillary recruitment, rather than through an increase
in linear flow, which would substantially increase the area for glucose transport.
Recently there has been speculation that this may be responsible for the increased
glucose extraction that follows prolonged hypoglycaemia (Boyle et al. 1994).
Alternatively, there may simply be an increase in the number and activity of glucose
transporters, although this seems to be an effect of chronic as opposed to acute
changes in blood glucose (McCall et al. 1986; Kumagai et al. 1995). A recent study
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(Thomas et al. 1997) demonstrated that increasing CBF by about 30% during acute
hypoglycaemia (using a bolus of acetazolamide) attenuated the hormonal response
to, and perception of hypoglycaemia without altering the normal cognitive responses
to acute blood glucose lowering. This indicates that the brain may be differentially
sensitive to increased substrate delivery. Further support for this has recently been
demonstrated when it was shown in 4 non-diabetic subjects that despite an increase
in regional CBF (somatosensory cortex) during hypoglycaemia the regional cerebral
metabolic rate (measured during performance on a vibrio-tactile task) did not
proportionally increase (Powers et al. 1996) i.e. the matched increase in regional
CBF and regional cerebral metabolic rate that is seen during such task performance
in non-diabetic subjects during normoglycaemia did not occur. It has also been
shown that a caffeine-induced reduction in CBF enhances both the symptomatic and
hormonal responses to acute hypoglycaemia (Debrah et al. 1996).
Abnormal CBF and cerebro-vascular reactivity outwith experimental hypoglycaemia
is recognised in type 1 diabetes. Studies in animal models have demonstrated that
CBF is decreased in poorly controlled diabetic rats (Kikano et al. 1989), while in
diabetic humans diminished CBF may be related to increasing duration of disease
(McCall, 1992). Cerebro-vascular reactivity, with respect both to vasodilatation and
vasoconstriction, is abnormal in some diabetic patients (Croughwell et al. 1990), and
abnormalities may be related to duration of disease (Auer and Siesjo, 1993). These
observations suggest that while CBF may increase with hypoglycaemia,
abnormalities in CBF and cerebrovascular reactivity in diabetic patients may
attenuate the increment in CBF, rendering the brain more vulnerable to
neuroglycopenia. In diabetic patients who have been exposed previously to
recurrent severe hypoglycaemia, regional CBF is increased in specific areas of the
brain, including the frontal lobes (MacLeod et al. 1994). It has been postulated that
these permanent changes may represent an adaptive mechanism to protect these
regions from recurrent severe hypoglycaemia causing cumulative cerebral damage.
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(ii) Haemodynamic changes
The haemodynamic responses to insulin-induced hypoglycaemia are secondary to
activation of the autonomic nervous system and the release of hormones such as
adrenaline. Significant effects can be found in blood flow within various organs
including a pronounced increase in heart rate, cardiac output and myocardial
contractility. Blood flow through the skin is diminished, is increased through
skeletal muscle, and declines acutely in the kidney. While this is identical to the
"fight or flight" response to any form of acute stress, the changes in regional blood
flow may contribute directly to glucose counterregulation. Glycogenolysis in muscle
provides lactate and proteolysis yields alanine. The increased blood flow through
skeletal muscle promotes their transport into the circulation. Splanchnic blood flow
also rises during hypoglycaemia so increasing hepatic blood flow and delivering
greater quantities of these 3-carbon substrates to the liver for gluconeogenesis.
(Hi) Neurochemical changes
Because of the unique dependence of the brain on glucose as the principal energy
source, it is particularly vulnerable to the effects ofhypoglycaemia.
Neuroglycopenic damage can occur despite maintenance of cerebral blood flow and
cardiac output. During hypoglycaemia there is an excessive release of various
neuropeptides and aminoacids combined with a failure of energy-dependent re¬
uptake mechanisms, and a disruption in calcium ion homeostasis. This produces an
accumulation of excitatory aminoacids (principally aspartate or glutamate) which
cause cellular damage via specific receptors, especially the N-methyl-D-aspartate
receptor (McCall, 1992). This 'excitotoxic' process differs from cerebral ischaemia
or anoxia in that acidosis does not develop (McCall, 1992).
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The central nervous system is more vulnerable to neuroglycopenia in a rostro-caudal
direction, with the cerebral cortex (especially the frontal lobes), caudate nucleus and
hippocampus being most affected, while the brainstem is much more resistant to
hypoglycaemia. Selective neuronal necrosis occurs following prolonged





HYPOGLYCAEMIA AND COGNITIVE FUNCTION
Acute hypoglycaemia and cognitive function
Modalities ofCognitive Function effected by acute hypoglycaemia
Hypoglycaemia is a general metabolic stress that has been shown to effect different
aspects of cognitive function. In one of the first studies of the effect of
hypoglycaemia on a cognitive modality Flender and Lifshitz (1976) demonstrated
that hypoglycaemia led to impaired fine motor co-ordination in a group of
adolescent type 1 diabetic subjects. A series of influential studies in the 1980's by
Holmes et al. (1983, 1984, 1986 and 1987) followed, where the hyperinsulinaemic
glucose clamp technique was used to examine the effect of hypoglycaemia on
different modalities of cognitive function. This group examined tasks of short-term
memory, general attention, visuospatial, memory, psychomotor and academic ability
tasks. During hypoglycaemia visual reaction time was slower and fewer
mathematical tasks could be performed in a limited period of time, although
accuracy was maintained indicating that subjects had adopted a more cautious
approach. Holmes and Colleagues (1984) also reported that verbal processing was
impaired during hypoglycaemia, and that the more cognitive visual and auditory
reaction time tasks showed significant slowing during hypoglycaemia, whereas the
simple motor finger-tapping task did not (Holmes et al. 1987; Holmes et al. 1986).
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Holmes and colleagues (1984) suggested that immediate (short-term) memory may
not be affected during hypoglycaemia, but this is not consistent with most other
studies that have since followed (e.g. Pramming et al. 1986; Hoffman et al. 1989;
Widom and Simonson, 1990; Mitrakou et al. 1991).
Following on from these studies a series of other investigators have examined
different aspects of brain function during hypoglycaemia (see Table. 1.2.1). In the
ensuing section I will attempt to summarise the effects of hypoglycaemia on
different cognitive modalities in the light of the currently available literature.
Verbal Functions: Holmes et al. (1984) have provided the most detailed examination
of the effect of hypoglycaemia on verbal functions. This group examined different
aspects of verbal skills in a group of type 1 diabetic individuals during
hypoglycaemia. Verbal skills, specifically verbal fluency skills (Verbal Associative
Fluency Test and Word Naming from the Stroop Word task), were slowed during
hypoglycaemia. In the Verbal Associative Fluency test subjects are required to say
as many words as they can think of beginning with a particular letter (usually the
letters used are F, A and S). The subject is timed for 1 minute and a total score of
acceptable responses recorded. The final score in this test is the sum of three
separate trials with three different letters. Verbal fluency tasks are thought to be
sensitive to general brain dysfunction, and poor scores are particularly associated
with frontal lobe damage (Lezak, 1995). They provide a means of assessing how
well a subject is able to organise his thinking and develop strategies of his own.
Verbal fluency was also shown to be impaired by other groups at plasma glucose
values ranging from 2.4-3.1 mmol/1 (Pramming et al. 1986; Mitrakou et al. 1991;
Fanelli et al. 1993; Fanelli et al. 1994; Mokan et al. 1994; Veneman and Van
Haeften, 1994).
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Table. 1.2.1. The psychometric study of hypoglycaemia: Effects ofmild to moderate
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*N=non-diabetic. T1DM= type 1 diabetic DSS= Digit Symbol Substitution test. CFF = Critical
Flicker Fusion Threshold. AVLT = Auditory Verbal Learning Test. MFFT = Matching Familiar
Figures Test. BVRT = Benton Visual Retention Test. NDRT = Nelson Denny Reading Test. TM-A &
B = Trail Making test A and B. RVIP = Rapid Visual Information Processing. PASAT = Paced
Auditory Serial Addition Test. CRT = Choice Reaction Time test. SRT = Simple Reaction Time test.
AN = autonomic neuropathy, a = arterialised blood glucose.
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Memoryfunctions: Most studies that have looked at memory during hypoglycaemia
have examined short-term memory functions. The immediate recall ofmaterial, and
the span of that recall (i.e. the amount ofmaterial that can be grasped or encoded for
learning), has been the principal focus for research. One of the most commonly used
tests is the Digit Span subtest of the Wechsler Memory Scale. The Digit Span test
comprises two different sub-tests, Digits Forward and Digits Backward, both of
which consist of seven pairs of random number sequences that the examiner reads
aloud at a rate of one per second. With Digit Forward the subject's task is to repeat
each sequence exactly as it is given and with Digit Backward the subject's task is to
say them in reverse order. In each trial the number of digits in the sequence is
increased as the subject responds correctly until the subject fails or repeats a nine-
digit sequence correctly. Digit Span Forward is primarily a test of attention and can
be affected by age and head injury (Lezak, 1995). Digit Span backward, which
requires the brief storage ofmaterial and then some mental juggling of that material,
is more of a memory test in that it is examining working memory. It is much more
sensitive to diffuse brain damage such as dementia than is the Digit Forward task
(Lezak, 1995). Ability on the Digit Span Forward task during hypoglycaemia has
been shown to deteriorate in some (Pramming et al. 1986; Draelos et al. 1995;
Wirsen et al. 1992), but not in all (Holmes et al. 1983; Widom and Simonson, 1990;
Mitrakou et al. 1991) studies. Digit Span Backward was significantly impaired at a
plasma glucose of 2.4 mmol/1 in the work by Mitrakou. et al. (1991). Both the
Forward and Backward tests have also been included in the cognitive test batteries of
other studies (Mokan et al. 1994; Fanelli et al. 1993; Fanelli et al. 1994; Veneman
and Van Haeften, 1994). However, because z-scores were reported in these studies,
it is not possible to assess the effect of hypoglycaemia on these specific tests,
although z-scores in all these studies decreased significantly. Other investigators
have included different memory tasks of immediate and delayed recall as part of
their cognitive test battery. In general, it can be concluded from this data that the
more complex the test the more likely it is to be disturbed by hypoglycaemia [e.g.
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word recognition vs. verbal fluency (Holmes et al. 1984)].
Attention, Concentration and Tracking: Although these three constructs can be
differentiated theoretically, in practice, it is very difficult to do so. For instance,
conceptual tracking can be prevented or interrupted by a diminished ability to
maintain a focused attention or concentration while solving problems. Most of the
currently employed cognitive tests can be said to require sustained attention. Of the
available tasks, vigilance tasks are thought to examine sustained attention in itself
(Lezak 1995). Draelos et al. (1995) in a large study of 42 type 1 diabetic subjects
showed a significant impairment on the Digit Vigilance task at a plasma glucose of
2.2. mmol/1. Digit vigilance has also been included in the test batteries used by
others (Mitrakou et al. 1991; Mokan et al. 1994; Fanelli et al. 1993; Fanelli et al.
1994; Veneman and Van Haeften, 1994) where overall z-scores have deteriorated
during moderate hypoglycaemia (plasma glucose 2.4 - 3.0 mmol/1). Other studies
have also consistently shown a deterioration in sustained attention during
hypoglycaemia (Widom and Simonson, 1990; Pramming et al. 1986) using different
vigilance tests (e.g. letter cancellation).
The PASAT (Paced Auditory Serial Addition Test; a cognitive task that requires the
subject to listen to an audiotape and perform mental additions) is another measure of
attention and concentration. It is very sensitive to brain dysfunction. It is well
recognised, for instance, that post-concussion patients perform well below group
control averages immediately after injury but return to normal within 30-60 days.
Some investigators have used the PASAT to assess cognitive function during
hypoglycaemia and have shown that performance during moderate hypoglycaemia
(plasma glucose 2.5 mmol/1) is significantly impaired in non-diabetic (Gold et al.
1995a) and type 1 diabetic (Gold et al. 1995b) subjects. The Digit Symbol
Substitution task, and Trail Making tasks both require visuomotor tracking, attention
and concentration. Both are very reliable indicators ofmoderate hypoglycaemia.
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Because of this they are employed in many test batteries as a means of confirming
the presence of cognitive dysfunction.
Executive Functions: These can be conceptualised as having four components: (1)
goal formulation; (2) planning; (3) carrying out goal-directed plans; and (4) effective
performance (Lezak, 1995). There are few formal tests of these abilities although
most complex cognitive tasks require intact executive function and hence
abnormalities in performing these tasks could reflect the disruptive action of
hypoglycaemia on higher brain functions. The Stroop test is probably the most
recognised test that is purported to examine executive functions. It measures the ease
with which a person can change their perceptual set to changing demands (Lezak,
1995). The Stroop, or aspects of the Stroop, have been used to examine subjects
during hypoglycaemia, and in general performance has deteriorated (Holmes et al.
1984; Mitrakou et al. 1991; Mokan et al. 1994; Fanelli et al. 1993; Fanelli et al.
1994; Veneman and Van Haeften, 1994). Driving performance, which clearly
involves complex decision making, is disrupted by moderate hypoglycaemia (Cox et
al. 1993) and will be discussed later.
Motor functions: In most studies, simple motor function like the Finger-Tapping
task (principally a motor task which requires the subject to press a telegraph-type
key as rapidly as possible), is not significantly effected by hypoglycaemia (Holmes
et al. 1986; Stevens et al. 1989; Pramming et al. 1986; Cox et al. 1993). More
complex motor tests that require a greater degree of 'executive' input, such as the
Grooved Pegboard test, are disrupted by moderate hypoglycaemia (Kerr et al.
1991b). In the Grooved Pegboard test a subject is presented with a small board
containing a 5x5 set of slotted holes, which are angled in different directions. The
subject has to insert pegs, each ofwhich has a ridge along one side requiring it to be
rotated into position for correct insertion, into the relevant slots. Time to completion
of the task is scored.
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Conclusions: Some key points can be unravelled from this loose, but extensive,
body of research. Firstly, cognitive tasks appear more likely to be disrupted at a
given level ofneuroglycopenia than are simple motor tasks. Pramming and
colleagues (1986) found that moderate hypoglycaemia (2.0 mmol/1) had no effect on
a simple motor task, but did disrupt more complex cognitive tasks. Similarly, in a
comparative study of performance on the PASAT and on the Finger Tapping test
Cox et al (1993) demonstrated that only the cognitive task was significantly
disrupted during controlled moderate hypoglycaemia.
Secondly, cognitive tasks themselves also appear to show a 'hierarchy of
impairment' with the more complex tasks showing abnormalities before the simpler
cognitive tasks. During mild or moderate hypoglycaemia the ability to perform
complex tasks that require decision making, sustained attention, and planning
capacity is disrupted (Holmes et al. 1986; Stevens et al. 1989; Hoffman et al. 1989;
Mitrakou et al. 1991), whereas performance of simple cognitive tasks such as digit
span and simple reaction times is preserved (Stevens et al. 1989; Holmes et al. 1986;
Hoffman et al. 1989; Wirsen et al. 1992). It had been shown earlier that mild
hypoglycaemia did not effect the simple perceptual and cognitive task ofword
recognition, while complex associative word skills did show disruption (Holmes et
al. 1984). Driesen and Colleagues (1991) found that only choice reaction times were
prolonged during moderate hypoglycaemia (plasma glucose 2.8-3.3 mmol/1) in type
1 diabetic patients, while at lower plasma glucose concentrations (2.1 mmol/1) both
simple and choice reaction times were impaired.
Finally, it has been shown repeatedly that there is considerable variability in the
blood glucose level at which individuals begin to show dysfunction on any particular
cognitive task. This will be discussed in more detail in a later section.
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Driving requires complex decision-making and sustained attention. Its importance
in everyday life makes it an ideal task to examine. Hoffman et al. (1989) did not
show any significant abnormalities in driving performance in a small group of type 1
diabetic subjects at a venous blood glucose of2.7 mmol/1. However, the type of
simulator involved was thought unlikely to provide a good comparison with actual
driving conditions. More recently, Cox et al. (1993) did demonstrate significant
impairment of driving skills during controlled hypoglycaemia (arterialised blood
glucose 2.6 mmol/1) using a more sophisticated driving simulator. Subjects showed
deficiencies in steering ability, increased swerving and spinning, and poor road
positioning. Another notable observation was that many patients themselves did not
reliably recognise that their driving ability was affected by this moderate degree of
hypoglycaemia and stated that they would continue to drive under these
circumstances.
Neurophysiologies changes during acute hypoglycaemia
It is now established that cognitive dysfunction occurs during acute hypoglycaemia.
However, many psychometric tests require the performance ofmany distinct
cognitive functions in concert. For example, the reaction time is the end-result of the
time consumed by several cognitive processes such as selective attention and motor-
related processes, even when the simple reaction time procedure is used. Because of
this some investigators have suggested that neurophysiological tests provide a more
'objective' assessment of cognitive function.
The most commonly applied electrophysiological tests are evoked (EP) and event-
related potentials (ERP). An evoked potential represents the neuronal response to a
given stimulus (e.g. the Visual Evoked Potential (YEP) is a visual evoked response
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to an external stimulus such as a shift or reversal of a checkerboard pattern; this is
also known as the PI00 wave) and is measured using recordings from small
electrodes placed around the scalp. The placement of these electrodes has been
standardised. An event-related potential is the neuronal response to an external
stimulus or event, but occurs only when the subject is selectively attentive to that
stimulus, and is required to distinguish one stimulus (the target) from a group of
other stimuli (the nontargets). This means that the event-related stimulus is
dependent on the setting of the target, and not its physical characteristics, whereas
the evoked potential is very dependent on the physical characteristics of the stimulus
and independent ofwhether the subject is attentive or interested in the stimulus.
The simplest experimental design incorporating these two potentials is the auditory
'odd-ball' task . Here a subject is presented a sequence of two distinguishable
stimuli, one ofwhich occurs frequently and the other infrequently (odd-ball). The
subject is required to count mentally or otherwise respond to one of the two stimuli,
and during this procedure cerebral responses to the frequent and odd-ball stimuli are
recorded and averaged separately. The response to the frequent stimuli consists of a
series ofwaves (stimulus-related components) that relates in the most part to the
sensory modality studied (in this case auditory). For auditory stimuli this has been
divided into three sequential periods; the early-, mid-, and long-related responses.
The early related response (also known as the Brain Stem Auditory Evoked
Potential; BAEP) reflects activity in peripheral and brain-stem auditory structures.
The BAEP is divided into components I-V. Waves I, III, V primarily represent
electrical activity for the acoustic nerve, pons, and brain stem respectively, and the
latencies between them indirectly reflect neuronal conduction in the corresponding
segments of the central auditory pathway. Abnormal prolongation of these latencies
usually reflects a disturbance of central auditory conduction. The electrical response
to the odd-ball stimulus is termed the P300 brain potential. It is a more easily
identifiable wave form and, as noted, is not affected by the physical characteristics
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of the stimulus. The P3, because of its sensitivity to attentional processes, is related
to aspects of cognitive function. Thus, the P300 can be used to provide an index of
cognitive function and the BAEP provides an index of brain-stem function.
Electroencephalographic (EEG) recordings taken during hypoglycaemia have
consistently shown changes such as a slowing of alpha activity, and an increased
occurrence of theta and delta waves, particularly in the frontal areas of the brain
(Harrad et al. 1985; Pramming et al. 1988; Tamburrano et al. 1988; Tallroth et al.
1990; Bendtson et al. 1991). The plasma glucose levels at which these changes have
been demonstrated vary from 1.5 to 2.5 mmol/1. Evoked Potentials have also been
recorded during experimental hypoglycaemia (Kern et al. 1994; Tamburrano et al.
1988; Harrad et al. 1985; Ziegler et al. 1991; Jones et al. 1990). Ziegler et al (1991)
observed increases in the inter-peak latencies I-III, II-IV and I-V as well as an
increase in the amplitude ofwaves III and IV of the BAEP in a group of type 1
diabetic subjects at a mean blood glucose of 1.7 mmol/1 (insulin-infusion technique)
which paralleled changes in the neuroendocrine and symptomatic response to
hypoglycaemia. Using a hyperinsulinaemic stepped glucose clamp, Jones et al.
(1990) estimated the threshold for change in the BAEP of 8 non-diabetic subjects
was 3.0 mmol/1. This was the same as the threshold for the symptomatic response to
hypoglycaemia, although a higher threshold than that needed to stimulate the
neuroendocrine response (3.4 mmol/) (Jones et al. 1990). In both of these studies the
'central' waves III-IV of the BAEP seem to have been most effected by
hypoglycaemia in comparison to the peripheral waveform (reflecting neural
transmission in the auditory nerve). This could suggest that different neural
pathways may display a variable sensitivity to hypoglycaemia. Some supportive
evidence for their findings comes from studies in animals using microelectrodes
placed in the inferior colliculus and which show it to be highly susceptible to
hypoglycaemia (Jacob et al. 1995b; Jacob et al. 1995a; Weber et al. 1994). The
neural activity in the inferior colliculus is thought to be represented by wave V of
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the BAEP (Weber et al. 1994).
Hypoglycaemia has generally been found to increase the latency and decrease the
amplitude of the P300 wave (Blackman et al. 1990; Blackman et al. 1992; Tallroth et
al. 1990; De Feo et al. 1988; Jones et al. 1990). Blackman et al. (1990) noted that
both auditory and visual P300 waves to odd-ball stimuli were significantly affected
at an arterialised plasma glucose of 2.6 mmol/1, showing that hypoglycaemia was
disrupting different sensory systems to a similar degree. Blackman et al. (1990) also
noted in this experiment, and in a further experiment in type 1 diabetic subjects
(Blackman et al. 1992), that there was a lag time of up to 75 minutes before the P300
returned to baseline after the restoration of euglycaemia indicating a delayed
recovery in optimal brain functioning in the immediate period following a
hypoglycaemic episode.
Whilst neurophysiological techniques for measuring brain functions are not as
dependent on patient co-operation as psychometric testing, they are limited by
difficulties of interpretation. The evoked potential is, for instance, very susceptible
to factors such as differences in subject group and differences in electrode
placement, all ofwhich make interpretation of data difficult. The amplitude of the
BAEP recorded from scalp electrodes is only 1/100th of the amplitude of the
ongoing EEG activity and therefore must be extracted from this and other noise
using computer averaging which, again, is susceptible to error. Furthermore, in
interpreting the P300 wave it has to be accepted as axiomatic that cognitive
processes are caused exclusively by physical activity in the nervous system (i.e. we
assume a direct, predictable relationship between cognitive and neural processes)
(Rugg and Coles, 1995). It is also assumed that a different level of activation in an
event-related potential signifies a different degree or intensity of engagement of a
common cognitive process. Whilst this may be a reasonable assumption it remains at
present no more than an assumption. It is possible, for instance, that a change in
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amplitude is the result of an effect of hypoglycaemia on the overall
electrophysiological state of the brain, and may not mean that the performance of
cognitive processes carried out in that state are affected. Furthermore, the P300
deflection is actually the summation of a number of smaller deflections, which are
sensitive to distinct experimental factors (Rugg and Coles, 1995).
Recently, it has been reported that developments in neurophysiological research
have provided methods for assessing the timing of two important cognitive
processes in the brain: stimulus selection and response selection (Smid et al. 1997).
Smid et al. (1997) examined 24 non-diabetic subjects during euglycaemia and
hypoglycaemia (blood glucose 2.6 mmol/1), and on recovery from hypoglycaemia.
Visual event-related potentials to a series of tasks utilising colour letters were
measured. Hypoglycaemia was found to have a clear effect on the stimulus-selection
process and an additional effect on response-selection. A differential effect was
noted in the recovery period with stimulus selection returning to normal and the
response-selection process remaining delayed with a continuing increase in error
frequencies. The authors concluded that hypoglycaemia appeared to be exerting its
main effect on executive processes (e.g. stimulus selection, stimulus-response
coupling). This conclusion is perhaps a little presumptive in that the study did not
actually examine more basic sensory processing and therefore could not really
exclude additional effects in this aspect of information processing. Furthermore,
subjects in this study were not studied twice, rather they were divided into two
groups; one group undergoing the euglycaemia-placebo-euglycaemia arm the other
the euglycaemia-hypoglycaemia-euglycaemia arm, and hence the study was not
properly powered. It does though confirm the problems inherent in interpreting
reaction time data where motor, stimulus selection and response selection processes
are involved.
In conclusion, acute hypoglycaemia does lead to changes in some
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neurophysiologies measures and the P300 wave in particular, appears to be a
sensitive index of cognitive function. However, interpretation of the
neurophysiologies data (especially evoked potentiSs) is limited by the many
variables that can effect outcome measures. Also, the functions implications of an
altered P300 response are unknown.
49
The following table details the main studies in this field, the methods used in those
studies to induce hypoglycaemia and the blood glucose at which as significant
change in the electrical activity of the brain was noted.
Table. 1.2.2. The Neurophysiological Study ofHypoglycaemia.
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Studies combining cognitive function and neurophysiological tests
Blackman and colleagues (1990) studied P300 evoked potentials and reaction times
simultaneously during experimental hypoglycaemia. They found that changes in
P300 evoked potentials and reaction times occurred in parallel but that the PI40
wave (which measures sensory processing) was not altered by hypoglycaemia. An
interesting observation from this study was that the changes in the P300 wave and
reaction time occurred in parallel suggesting that some component common to both
may be affected by hypoglycaemia. As the P300 wave is not a measure ofmotor
activity this would suggest that hypoglycaemia is affecting some other component of
the reaction time task such as the central integration of information within the brain
(also note Smid et al. (1997); see above). Lindgren et al. (1996) found that moderate
hypoglycaemia (plasma glucose 2.6 mmol/1) in 10 non-diabetic subjects affected
P300 amplitudes during a relatively demanding visual search task, but not during a
relatively easy task. This finding supports psychometric studies that have shown that
the more complex a cognitive task the more likely it is to be disrupted by
hypoglycemia.
Studies combining P300 and reaction time measures have shown consistently that,
despite the blood glucose being restored to normal, a lag phase of at least 40 minutes
has been observed before performance on these tasks returns to normal (Herold et al.
1985; Blackman et al. 1990; Blackman et al. 1992; Wirsen et al. 1992; Jones et al.
1990; Lindgren et al. 1996). The clinical relevance of this finding is that type 1
diabetic patients should allow sufficient time for recovery of cognitive function after
an acute episode of hypoglycaemia before attempting to resume tasks such as
driving or operating machinery which involve decision-making and cognitive skills.
Only a few investigators have compared type 1 diabetic subjects and matched non-
diabetic controls within the same study protocol (Tallroth et al. 1990; Jones et al.
1990). In both studies basal measures ofP300 latencies were significantly longer in
type 1 diabetic patients, but these were not prolonged further during hypoglycaemia.
However, a highly significant reduction in wave amplitude was demonstrated during
hypoglycaemia in both studies. The differences between subjects with and without
type 1 diabetes may have occurred because of the influence ofprevailing glycaemic
control. Ziegler et al (1992), reported that the threshold for changes in the latency of
the P300 wave was higher for patients with strict glycaemic control (mean HbAlc
6%) than for poorly controlled patients (mean HbAlc 9%) (see section on effect of
glycaemic control on cognitive function).
Blood glucose thresholds for cognitive dysfunction
It is well known that the thresholds for activation of counterregulatory hormones and
symptom realisation are very plastic phenomena (Cryer, 1993a; Kimura, 1993) that
can vary in the individual over relatively short time periods. They are directly
influenced by such factors as antecedent hypoglycaemia (Heller and Cryer, 1991;
Davis et al. 1992; Widom and Simonson, 1992; Veneman et al. 1993), or strict
avoidance of hypoglycaemia (Fanelli et al. 1993; Fanelli et al. 1994; Cranston et al.
1994; Lingenfelser et al. 1995), and level of glycaemic control (Widom and
Simonson, 1990; Lingenfelser et al. 1995). This subject has been extensively
reviewed recently (Cryer, 1993a; Cryer, 1994).
The search for a universal threshold for cognitive dysfunction has been equally
unrewarding. Variable results have been obtained which probably reflect the
differing techniques used to induce hypoglycaemia, the different psychometric tests
employed, and variability in individual performance. Neurophysiological studies
which were thought to offer an objective means of identifying cognitive dysfunction
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have similarly produced very different results (Bendtson, 1993). Holmes et al.
(1983, 1984), first noted changes in cognitive function in type 1 diabetic patients at a
plasma glucose of 3.3 mmol/1 (using a hyperinsulinaemic glucose clamp), while
Pramming et al. (1986) found changes only occurred when the venous blood glucose
was less than 3.0 mmol/1 (using a continuous insulin infusion). Blackman et al.
(1990) and Jones et al. (1990) observed changes in p300 waves at arterialised blood
glucose concentrations of 3.0 and 2.6 mmol/1 respectively. More recently, using a
comprehensive battery of cognitive function tests and a 'stepped' clamp technique,
Mitrakou et al. (1991) observed that the initial changes in cognitive function
occurred at an arterialised blood glucose concentration of 2.7 mmol/1.
While it is highly unlikely that a universal threshold for cognitive dysfunction exists,
there is more controversy as to whether thresholds for an individual patient are
constant. Gonder-Frederick et al. (1994) showed in a sub-group of their main study
that individual performance differences were steady across time (3 months)
indicating stable and characteristic responses to hypoglycaemia at least in the short-
term. This result is consistent with that of Cranston et al. (1994) who noted that 3
weeks strict avoidance of hypoglycaemia altered the thresholds for counterregulatory
hormone and symptom response to hypoglycaemia in a small group of patients with
hypoglycaemia unawareness, but did not alter the threshold for cognitive
dysfunction, although his study involved only a small number of subjects and
employed only one test of cognitive function. Conflicting results are reported by
Fanelli et al. (1993, 1994) who did find a change in the threshold for cognitive
dysfunction following strict avoidance of hypoglycaemia, and by Boyle et al. (1994)
who found that the threshold for cognitive dysfunction was altered by 56 hr
interprandial hypoglycaemia. The threshold for cognitive dysfunction within an
individual does not appear to be as variable as that for the neuroendocrine response
to hypoglycaemia when subjected to a modifying influence such as antecedent
hypoglycaemia.
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Cerebral Adaptation to acute hypoglycaemia
There are a number of studies that have shown cerebral blood flow to increase
during acute hypoglycaemia .It has also been demonstrated in animals that there is
an increase in uptake of glucose by the brain and an increase in brain glucose
transport activity during hypoglycaemia (McCall et al. 1986; Pelligrino et al. 1990;
Kumagai et al. 1995). Moreover, the possibility exists that alternative fuels (e.g.
lactate, aminoacids and free fatty acids) are important in brain metabolism during
hypoglycaemia, although clinical studies in human subjects have not been
convincing. Ketone bodies when infused prior to an episode of controlled
hypoglycaemia have been shown to ameliorate the threshold and magnitude of the
counterregulatory hormone response to hypoglycaemia (Amiel et al. 1991b), but not
when infused concomitantly with hypoglycaemia (Fanelli et al. 1993). These effects
have lead some authors to suggest that the brain may be able to adapt acutely to
hypoglycaemia.
In a recent study in non-diabetic human subjects Boyle et al (1994) documented an
increase in basal cerebral blood flow and a preservation of normal brain glucose
uptake following prolonged (56 hr) interprandial hypoglycaemia. In this study
cognitive function (measured by the Stroop test, Finger Tapping and Verbal
Memory) initially deteriorated at an arterialised blood glucose level of 3.6 mmol/1,
but following 56 hours of hypoglycaemia it did not deteriorate until 2.5 mmol/1.
Although this study provides strong evidence for cerebral adaptation to
hypoglycaemia over a relatively prolonged period, it cannot be inferred from this
that the brain is able to adapt acutely to hypoglycaemia over the space of 60-90
minutes.
Kerr and colleagues (1989) examined 7 non-diabetic subjects during euglycaemia
(blood glucose 4.5 mmol/1) and hypoglycaemia (blood glucose 3.5 & 3.0 mmol/1)
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using the hyperinsulinaemic glucose clamp technique. Subjects were studied in a
randomised single-blind manner in two experimental sessions. At the beginning and
end of each glycaemic plateau the subjects performed a simple reaction time (SRT)
task. The investigators found that hypoglycaemia led to a significant impairment in
the SRT, but that performance returned to baseline when repeated 20 minutes later at
the same blood glucose level. This, the authors suggested, indicated that cerebral
adaptation to acute hypoglycaemia had occurred. In a similar study of 6 type 1
diabetic subjects, Kerr and colleagues (1991a) noted that SRT improved after 40
minutes of hypoglycaemia (blood glucose 2.8 mmol/1), in comparison to
euglycaemia, and that subjects became less symptomatically aware of being
hypoglycaemic. Both of these studies are limited by the small number of subjects
examined, by the use of a single cognitive test (and not one that has been shown to
be reliably sensitive to hypoglycaemia), and the failure to fully account for practice
effects. In a larger study, designed to account for practice effects, Gold and
colleagues (1995a) employed a detailed battery of cognitive function tests to
examine 24 non-diabetic subjects and demonstrated that there was no evidence of
improved cognitive function after 40 minutes ofhypoglycaemia (plasma glucose 2.5
mmol/1).
The conclusion from the few studies that have examined this issue is that there is no
good evidence to indicate that the brain is able to adapt acutely (at least within 40
minutes) in terms of brain functioning, although it does appear that a degree of
adaptation occurs after 56 hours of hypoglycaemia.
Effect ofglycaemic control on the threshold ofcognitive dysfunction
The effect of preceding glycaemic control on the blood glucose at which cognitive
dysfunction becomes evident in any individual is an area of some controversy. The
question as to whether divergent changes in glycaemic thresholds for
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counterregulatory responses in well controlled, intensively treated and in poorly
controlled, conventionally treated type 1 diabetic subjects are mirrored by similarly
directed changes in brain function is important because it is a key issue in current
concepts regarding the development of hypoglycaemia unawareness, and the
management strategies that have evolved to treat this condition.
There is some evidence from animal studies to suggest that the prevailing blood
glucose concentration may be important in determining the threshold for a
deterioration in brain functioning. In studies of diabetic and non-diabetic rats chronic
hyperglycaemia and chronic hypoglycaemia, respectively, decrease and increase the
efficiency of glucose extraction by the brain (McCall et al. 1982; McCall et al. 1986;
Pelligrino et al. 1990). Furthermore, chronically hyperglycaemic diabetic BB rats are
more susceptible, whilst chronically hypoglycaemic diabetic BB rats are more
resistant to the adverse effects of hypoglycaemia on brain stem function (Jacob et al.
1995b; Jacob et al. 1995a).
In normal human subjects rendered mildly hypoglycaemic for several days and in
well controlled type 1 diabetic subjects (Boyle et al. 1995), brain glucose uptake is
more effectively preserved during hypoglycaemia (Boyle et al. 1994; Boyle et al.
1995). The results of neurophysiological and neuropsychological studies in human
subjects have been less consistent. In the largest study to date, 42 type 1 diabetic
subjects completed a detailed cognitive test battery during controlled hypoglycaemia
(plasma glucose 2.2 mmol/1), euglycaemia (plasma glucose 5.5 mmol/1) or
hyperglycaemia (plasma glucose 8.9, 14.4 and 21.1 mmol/1) (Draelos et al. 1995).
All aspects ofneuropsychological function were found to be diminished during
hypoglycaemia, with some variability between tests, but no correlation was found
between glycaemic control and the degree of cognitive dysfunction demonstrated.
However, this study used a degree of hypoglycaemia that is considerably below the
level conventionally thought to represent the threshold for cognitive dysfunction
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(~2.8 - 3.2 mmol/1), and therefore, because all the tests might have been expected to
change at this level, the authors were in reality comparing performance between
individuals on the test themselves. This can be affected by age, sex, IQ, glycaemic
control, antecedent hypoglycaemia, practice etc. With so many independent
variables not accounted for, the likelihood of establishing a relationship between
glycaemic control and cognitive function is small. Finally, it is not possible to
calculate a threshold for cognitive change using a one-step clamp and therefore this
study did not answer the question as to whether glycaemic control could alter
thresholds for cognitive function
Maran and colleagues (1995) used a stepped hypoglycaemic clamp and the Four-
Choice Reaction Time test to examine 8 intensively treated type 1 diabetic subjects
(HbAl 7.7±0.3%), 10 conventionally treated type 1 diabetic subjects (HbAl
10.1±0.2%), and 8 non-diabetic subjects. They found that hormonal responses and
subjective awareness of hypoglycaemia occurred at lower glucose levels in the
intensively treated group, but that the threshold for a change in the reaction time test
was not significantly different between groups, i.e. there was an altered hierarchy of
responses to hypoglycaemia in the intensively treated group. However, in a more
recent, and larger study Pampanelli and colleagues (1996) examined three groups of
type 1 diabetic subjects (Group I HbAlc <5.5%, Group II HbAlc 6.1-7.0%, Group
III HbAlc >7.5%) all ofwhom were on intensive insulin therapy. 18 non-diabetic
subjects were used as controls. All subjects underwent a stepped hypoglycaemic
clamp and testing using a detailed cognitive test battery. The authors found that
cognitive function as expressed by the sum of z-scores, deteriorated in all groups at
the lowest plasma glucose (2.3 mmol/1) but that this deterioration only reached
significance in group II, group III and the non diabetic subjects. The deterioration
was greater in group III as compared to group II and non-diabetics. Similar findings
were noted in counterregulatory hormone and symptom responses to hypoglycaemia.
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Jones et al (1997) used a multi-step glucose clamp to establish thresholds for change
in the P300 wave of cortical evoked potentials in 8 intensively treated (HbAl
8.3±0.2%)and 11 conventionally treated (HbAl 14.6±1.3%) type 1 diabetic subjects,
and 10 healthy controls. This study showed that a greater reduction in plasma
glucose was required to alter P300 event related potentials in the intensively treated
type 1 diabetic compared to the conventionally type 1 diabetic and non-diabetic
groups. Similar results were found for counterregulatory hormone and symptom
responses. These findings are supported by an earlier study by Ziegler et al (1992)
who also used the P300 evoked potential but achieved hypoglycaemia by using an
insulin-infusion which lowers blood glucose more rapidly. Neither of these studies
adequately excluded hypoglycaemia in the few days leading up to the study days
which may have influenced the outcome of their trials, and although both
demonstrated a change in P300 the significance of this in terms of the actual
cognitive performance of an individual remains unclear i.e. this may be having
relatively little impact on brain functioning. Finally, in an earlier study using EEG
changes to establish thresholds for cognitive function in a mixed group of
intensively treated type 1 diabetic subjects and insulinoma patients in comparison
with conventionally treated and non-diabetic controls, the exact opposite finding was
reported (Amiel et al. 1991b). In this study EEG changes compatible with
hypoglycaemia were evident at a blood glucose of 1.9 mmol/1 in all intensively
treated/insulinoma patients but in only two of the conventionally treated non-
diabetic control group despite a downward shift in the blood glucose required to
initiate the counterregulatory response in the intensively treated group (Amiel et al.
1991b).
It has been suggested that if thresholds for cognitive dysfunction are affected by
glycaemic control then they are unlikely to be as much affected as the thresholds for
other factors of the hypoglycaemic response (e.g. counterregulatory hormones). In
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fact, the evidence to date does not bear this out. In those trials that have documented
a change in threshold in intensively treated type 1 diabetic subjects (Jones et al.
1997; Ziegler et al. 1992; Pampanelli et al. 1996) the differences between the
thresholds for cognitive and counterregulatory hormone changes have been very
similar. In conclusion, it is likely that glycaemic control does have an impact on the
threshold for cognitive dysfunction, however, the characteristic feature of type 1
diabetes is fluctuating glucose levels between hyper- and hypoglycaemia, and this
probably diminishes the overall influence of glycaemic control on the threshold for
cognitive dysfunction.
Effect ofantecedent hypoglycaemia on the thresholdfor cognitive dysfunction
It has now been established that a short period ofhypoglycaemia will impair the
physiological counterregulatory hormone response to hypoglycaemia induced on the
following day. The issue ofwhether antecedent hypoglycaemia has a similar effect
on cognitive function is less clearly resolved. Veneman et al. (1993) found elevated
thresholds for cognitive dysfunction after an episode of induced nocturnal
hypoglycaemia in non-diabetic individuals, but Dagogo-Jack et al. (1993) found no
effect of hypoglycaemia the previous afternoon on the threshold, despite
demonstrated effects on the thresholds for autonomic responses and for both
neuroglycopenic and autonomic symptoms, in people with type 1 diabetes.
Similarly, George et al. (1997) found no effect of a single 2 hour episode of
hypoglycaemia on the threshold for cognitive dysfunction during hypoglycaemia
induced two days later in type 1 diabetic subjects, and Robinson et al. (1995) found
no effect on day 2 and day 8 in non-diabetic subjects.
It is relevant, when asking this question, to look at the data from studies involving
type 1 diabetic subjects on intensive therapy. This is because therapy that actively
lowers blood glucose levels carries such a clearly increased risk of hypoglycaemia
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(e.g. (Pampanelli et al. 1996)) that it is often used as a surrogate for antecedent
hypoglycaemia. Elevated thresholds for counterregulatory hormone responses
(Amiel et al. 1987b; Amiel et al. 1988; Amiel et al. 1991b; Clarke et al. 1991; Jones
et al. 1997; Maran et al. 1995; Kinsley et al. 1995) and the symptomatic response to
hypoglycaemia (Amiel et al. 1987b; Amiel et al. 1988; Amiel et al. 1991b; Clarke et
al. 1991; Maran et al. 1995; Kinsley et al. 1995) have been found consistently in
intensively-treated type 1 diabetic patients. If one considers the neuroglycopenic
symptom response as indicative of cognitive function (i.e. that cognitive dysfunction
is likely to be present if an individual is experiencing neuroglycopenic symptoms)
then some (Clarke et al. 1991; Maran et al. 1995), but not all (Widom and Simonson,
1990) studies have shown elevated thresholds with intensive therapy in type 1
diabetes. However, in the study by Widom et al. (1990) a one-step hypoglycaemic
clamp was used which, whilst able to show that there were statistical differences
between conventionally and intensively-treated type 1 diabetic subjects in terms of
their autonomic symptom and counterregulatory hormone responses to
hypoglycaemia, is really unable to exclude a difference in threshold for cognitive
function between the two groups. Similar discrepancies are found in the trials which
have examined cognitive function using neurophysiological techniques with some
(Jones et al. 1997; Ziegler et al. 1992), but not all (Amiel et al. 1988) showing an
effect of tight glycaemic control on threshold for cognitive function.
Two recent studies have addressed the question more specifically (Mellman et al.
1994; Hvidberg et al. 1996). Mellman et al. (1994) studied 9 healthy volunteers
using a stepped hypoglycaemic clamp technique and two cognitive tests (Logical
Memory from the Wechsler Memory Scale and the Digit Symbol Substitution test
from the Wechsler Intelligence Scale - Revised). Subjects underwent a 2-hour
hypoglycaemic or euglycaemic clamp followed 90 minutes later by a stepped
hypoglycaemic clamp. They found that antecedent hypoglycaemia had the effect of
preserving ability on the Logical Memory test during ensuing hypoglycaemia (i.e.
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adaptation had occurred). However, this study is unusual in that thresholds for
counterregulatory hormones decreased following antecedent hypoglycaemia, which
is in contradiction to all other studies in this field, and they only had cognitive data
on 6 patients. Furthermore, a period of only 90 minutes separated both
hypoglycaemic studies which is of very questionable relevance to the practical issues
of diabetes management. In a more comprehensive study, again of non-diabetic
subjects, Hvidberg et al. (1996) examined 16 young healthy volunteers using a
similar study design except that the stepped hypoglycaemic clamp was performed
the following morning and a more detailed cognitive test battery was used. No
significant overall effect of afternoon hypoglycaemia on cognitive function during
hypoglycaemia the following morning was found, although the threshold for change
showed a non-significant increase on two of the tasks (Serial Addition and Delayed
Non-Match to Sample tasks). The expected changes in thresholds for neuroendocrine
responses to hypoglycaemia were seen.
Recently three publications have addressed the more practical issue ofwhether it is
possible, by avoiding hypoglycaemia to normalise the threshold for the
neuroendocrine response to hypoglycaemia (Fanelli et al. 1993; Fanelli et al. 1994;
Cranston et al. 1994). Each study also included a cognitive test battery. Fanelli et al.
(1994) found that strict avoidance of hypoglycaemia over 6 months in type 1
diabetic subjects with hypoglycaemia unawareness reduced thresholds for
hypoglycaemic cognitive dysfunction (as well as those for neuroendocrine responses
and symptoms), whereas, Cranston et al. (1994) reported no change for deterioration
of one cognitive function test (Four-Choice Reaction Time test). It is worth noting
though that in all three studies the mean HbAlc increased following avoidance of
hypoglycaemia which, although reported as statistically non-significant, may have
been important given the small numbers in each study. Finally, a reduction of the
glycaemic threshold for cognitive function has been noted following the surgical
treatment of insulinoma which effectively cured antecedent hypoglycaemia in that
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study group, although this is in reality a state of chronic hypoglycaemia.
In summary, it has not been shown convincingly that antecedent hypoglycaemia
significantly alters the threshold for cognitive dysfunction during hypoglycaemia.
The evidence that chronic hypoglycaemia in animal, non-diabetic human, type 1
diabetic and insulinoma subjects does alter thresholds for cognitive dysfunction is
clearer, but reflects an unusual physiological state. Studies of the effect of a single
episode of antecedent hypoglycaemia in type 1 diabetic subjects are difficult to
interpret in view of the frequent coexistence of antecedent hypoglycaemia and tight
glycaemic control. It is conceivable that some cognitive processes are more
sensitive that others.
Symptom change, counterregulatory hormone response, and cognitive function
during acute hypoglycaemia
An area of great interest concerns the question of how the glycaemic threshold for
cognitive dysfunction is related to the onset of hypoglycaemic symptoms and of
counterregulatory hormonal responses. A logical answer to this question would be
to suggest that as the counterregulatory response is designed to mobilise glucose
stores and preferentially divert glucose to the brain, and because symptoms are a
means of alerting the insulin-treated patient to hypoglycaemia, then the threshold for
the counterregulatory response and onset of hypoglycaemic symptoms should be
lower (a higher blood glucose) than that for cognitive dysfunction. This is borne out
in those studies which have shown a rise in plasma counterregulatory hormones
before any demonstrable changes in cognitive function in non-diabetic subjects (Ipp
and Forster, 1987; Stevens et al. 1989; Kerr et al. 1989; Mitrakou et al. 1991;
Schwartz et al. 1987). Mitrakou et al (1991) tested non-diabetic subjects and
reported that elevations in plasma catecholamines and glucagon were manifest at a
blood glucose concentration of 3.7 mmol/1, while autonomic symptoms occurred at
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3.3 mmol/1, neuroglycopenic symptoms were experienced at 3.0 mmol/1, and
significant cognitive dysfunction was not apparent until 2.4 mmol/1.
The question is more complicated when we consider the relationship between these
three variables in the type 1 diabetic population. Several factors such as the quality
of glycaemic control (Amiel et al. 1987b; Amiel et al. 1988; Widom and Simonson,
1990; Mokan et al. 1994; Boyle et al. 1988b; Clarke et al. 1991), antecedent
hypoglycaemia (Heller and Cryer, 1991; Widom and Simonson, 1992; Davis et al.
1992), strict avoidance of hypoglycaemia (Cranston et al. 1994; Fanelli et al. 1994)
the frequency ofprevious exposure to hypoglycaemia (Hepburn et al. 1991b; Mokan
et al. 1994) duration of diabetes (Bolli et al. 1983; Mokan et al. 1994; White et al.
1983) influence the putative glycaemic thresholds for perception of symptoms and
counterregulatory hormonal responses. For instance, strict avoidance of
hypoglycaemia reversed the counterregulatory hormone and symptom abnormalities
in type 1 diabetic patients with hypoglycaemia unawareness and long duration of
disease (>10 years), but showed no effect on the threshold for cognitive dysfunction
(Cranston et al. 1994). However, in unaware type 1 diabetic patients with a much
shorter duration of disease (mean 5.0 years) strict avoidance of hypoglycaemia did
lead to a change in threshold for cognitive dysfunction that paralleled that of
counterregulatory and symptom responses to hypoglycaemia (Fanelli et al. 1994). In
type 1 diabetic patients with hypoglycaemia unawareness and long duration of
disease (>10 years) Dagogo-Jack et al (1994) recently reported that 3 months strict
avoidance of hypoglycaemia lead to a 'normalisation' of both autonomic and
neuroglycopenic symptom responses (judged by a reversal of unawareness), but no
improvement in the counterregulatory response to hypoglycaemia.
Pramming et al (1986) obtained an omnibus neuropsychology score during different
levels of blood glucose. A decline in overall performance was noted following the
reduction in the blood glucose from 6.0 mmol/1 to 3.0 mmol/1, but this did not
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achieve significance until the blood glucose was reduced further to 2.0 mmol/1.
Also, evidence of cognitive dysfunction was apparent in 75% of subjects prior to
their becoming symptomatic of hypoglycaemia, providing evidence that a
dissociation might exist between the symptomatic response to hypoglycaemia and
the cognitive dysfunction that occurs.
These studies highlight the complexity of one aspect of the response of the patient
with type 1 diabetes to acute hypoglycaemia. There is clearly some dissociation
between the neuroendocrine, neurobehavioral and neurophysiological response to
hypoglycaemia, which reflects the multiple influences that can affect each response.
These factors, and more that we are as yet unaware of, contribute to the individual
variability in cognitive dysfunction that is evident during hypoglycaemia.
Individual variability
Herold et al. (1985) found considerable variability in the reaction times of both type
1 diabetic and non-diabetic subjects during hypoglycaemia. Some subjects showed
marked prolongation of reaction times, others had small, but significant, increases,
while others showed an improvement in their reaction times. For about 50% of
subjects their longest reaction time occurred up to 60 minutes after their blood
glucose nadir was achieved, and for most subjects there was a delay in normalising
the reaction time following restoration of normoglycaemia. This indicates a problem
with sustained attention during prolonged hypoglycaemia and a delay in recovery of
cognitive function following hypoglycaemia.
It is clear from many studies (Herold et al. 1985; Hoffman et al. 1989; Holmes,
1987; Cox et al. 1993; Cox et al. 1993; Gonder-Frederick et al. 1994) that the change
in each individual's performance on standard cognitive performance tasks varies
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greatly during hypoglycaemia. This variation is seen in both type 1 diabetic and
non-diabetic subjects. Gonder-Frederick et al (1994) examined 26 type 1 diabetic
subjects and found that 19 % exhibited a clinically significant deterioration in
cognitive performance (which they defined as a deterioration in performance of
more than two standard deviations from the baseline mean) during mild
hypoglycaemia, while almost half showed little or no deterioration. When moderate
hypoglycaemia was established a greater number ofpatients showed cognitive
dysfunction (>50 %), but 15 % still showed no evidence of cognitive dysfunction on
the battery of tests used. The only correlate with poorer performance in this study
was a history ofprevious hypoglycaemia-related unconsciousness. This study also
showed that individual performance differences were stable across 3 months,
indicating stable and characteristic differences in responses to hypoglycaemia at
least in the short-term.
Draelos et al. (1995) found that men performed less well than women on standard
cognitive tasks at a blood glucose level of 2.2 mmol/1, and also suggested that those
subjects with a higher verbal IQ showed a relatively greater cognitive deterioration.
More recently it has been shown that subjects with a higher score on standard
measures of current intellectual ability show a significantly greater decrement in
cognitive performance during hypoglycaemia in some, but not all mental tasks (Gold
et al. 1995).
Type 1 diabetic patients with hypoglycaemia unawareness also appear to show a
significantly greater cognitive decline during hypoglycaemia in comparison with
those with retained awareness. Previously it had been shown that subjects who
tended to experience neuroglycopenic, rather than autonomic, symptoms during
hypoglycaemia showed a greater deterioration in reaction times (Herold et al. 1985;
Hepburn et al. 1991b). A recent publication involving a group of 10 type 1 diabetic
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patients with persistently impaired awareness of hypoglycaemia and a group of
matched type 1 diabetic controls of the same "general cognitive ability" (as assessed
by standard tests), showed a trend (p=0.08) towards an overall effect of awareness
on cognitive function (Gold et al. 1995b). Interestingly there was a specific and
significant difference between the two groups on the Rapid Visual Information
Processing (RVIP) task. This implied that subjects with impaired awareness were
less cautious in their responses during hypoglycaemia. During the recovery phase
from hypoglycaemia those with impaired awareness performed less well on the Trail
Making B task, were poorer at detecting rapid visual targets and were slower to
make responses. Performance on the Digit Symbol Substitution test, Trail Making
B, and the Paced Auditory Serial Addition test did not differ between the two groups
during hypoglycaemia, although all were significantly disrupted. This result could
suggest that impaired awareness leads to a specific, not a global, effect on cognitive
ability during hypoglycaemia. From a more practical standpoint it would also
suggest that type 1 diabetic patients with chronically impaired awareness show
slowed reaction times and less accurate performance during hypoglycaemia, and that
this effect can persist for up to 45 minutes, which has implications for those
performing skilled tasks such as driving.
The factors so far described account for only a small amount of the variance in
individual variability. (Table 1.2.3.). There is clearly a great deal more to learn
about the sources of individual variability in cognitive performance during
hypoglycaemia, and this information will be of great clinical relevance in educating










Glycaemic control Chronic persistent hyper- or hypo¬
glycaemia probably do alter thresholds for
cognitive dysfunction (shifted lower and
higher respectively)
Antecedent hypoglycaemia ? - this issue remains unclear
Age Elderly subjects show a relatively greater
cognitive decrement
Sex Females perform better than matched
males
IQ Higher IQ groups show relatively greater
cognitive decrement
Hypoglycaemia unawareness type 1 diabetic subjects with an impaired
symptomatic response to hypoglycaemia
show a relatively greater cognitive
decrement
Type 1 Diabetic vs. Non-diabetic ? - this is unclear and probably relates to
heterogeneity of the type 1 diabetic
population in terms of such things as
duration of disease, glycaemic control,
daily variation in blood glucose
67
I
Chronic hypoglycaemia and cognitive function
It has been assumed that moderate episodes of acute hypoglycaemia have no
permanent effect on cerebral function and that hypoglycaemia is therefore an
inevitable, acceptable and benign consequence of strict glycaemic control. Evidence
is accumulating however that recurrent severe hypoglycaemia may be deleterious,
causing a cumulative cognitive decline with significant intellectual and
psychopathological morbidity.
Studies in children
Ryan et al. (1985) used a large battery of cognitive tests to examine a group of 46
type 1 diabetic adolescents whose diabetes was diagnosed before the age of 5 years,
79 well-matched type 1 diabetic subjects who developed diabetes at an older age,
and 83 non-diabetic controls. Early onset diabetes was associated with a
significantly poorer performance in the following areas ofmental ability:
intelligence, visuospatial ability, learning and memory, attention and school
achievement, and mental and motor speed. These deficits were attributed by the
author to " multiple episodes of hypoglycaemia " (Ryan et al. 1985). Ack et al.
(1961) found that children who developed diabetes before the age of 5 years were,
on average, more than 10 IQ points lower than their siblings. Rovet et al.
(1987,1988) found that children with onset of diabetes before 4 years of age were
lower on performance IQ than sibling controls and children whose onset of diabetes
was later than 4 years of age. In each of these reports severe hypoglycaemia has
been identified as an important factor in the aetiology of the apparent cognitive
impairment (Deary, 1993).
Golden et al. (1989) followed up 23 children with type 1 diabetes diagnosed before
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the age of 5 years for a period of 6-78 months. Episodes of severe hypoglycaemia
and the frequency of self-monitoring blood glucose (SMBG) measurements <2.8
mmol/1 were recorded every 3 months for each individual. On completion of the trial
period the children were asked to complete the Stanford-Binet Intelligence Scale. No
correlation was found between any subscale of this test and the occurrence of severe
hypoglycaemia. However, the relative frequency of asymptomatic hypoglycaemia
(SMBG <2.8 mmol/1) correlated with scores on the abstract /visual reasoning scale
(r=-.39) (Golden et al 1989). More recently, in a cross-sectional study of 28 type 1
diabetic children (5 diagnosed at <5years of age who had experienced 1-4 episodes
of severe hypoglycaemia; 10 diagnosed >5 years of age who had experienced 1 -4
episodes of severe hypoglycaemia; and 13 who had experienced no severe
hypoglycaemia) and 28 non-diabetic children matched for age, sex and social
background, it was reported that those children with early onset diabetes who had
experienced multiple episodes of severe hypoglycaemia had significantly lower
scores on tests of psychomotor efficiency and attention. Those children who had
been diagnosed after 5 years of age did not differ significantly from the control
group. Looking at the tests employed in the neuropsychological test battery in this
study it is clear that most are indexing sustained attention which would suggest that
the differences between the early-onset diabetes group and the others reflect some
form of frontal lobe dysfunction.
Studies in adults
In studies with adult type 1 diabetic subjects there is also evidence that suggests
recurrent severe hypoglycaemia may lead to permanent cognitive dysfunction. Bale
(1973) tested 100 patients with type 1 diabetes and 100 matched non-diabetic
controls on a verbal learning test. Seventeen type 1 diabetic subjects, but no controls,
scored in the "brain damaged" range. Further analysis of this data showed that 10 out
of 33 patients with a history of at least one admission to hospital with severe
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hypoglycaemia had "brain damaged" scores, whereas only one of 23 subjects with
no history of severe hypoglycaemia had a score in this range. In reviewing the
published data from this study (Bale, 1973), Deary (1993) noted that there was a
verbal-performance IQ deficit of about 5 points in those 17 subjects with a history of
severe hypoglycaemia. A substantial difference between verbal and performance IQ
is traditionally accepted as evidence of organic brain damage because verbal IQ is
relatively resistant to such damage whereas performance IQ is more sensitive.
Skenazy and Bigler (1984) found that performance on the Wechsler Adult
Intelligence Scale (WAIS) was lower in a group of diabetic subjects compared to
either healthy or chronically ill control subjects. The authors also found a 4.5 point
decrement in the performance IQ of the diabetic subjects compared with their verbal
IQ, but no difference in the two scores in the control groups. Furthermore, in the
diabetic group there was a correlation of -0.44 between performance IQ and the
number of "insulin-reactions" (p<0.04), but no correlation was observed between
verbal IQ and number of "insulin-reactions".
Wredling et al. (1990) in a well-controlled cross-sectional study compared type 1
diabetic patients with and without a history of recurrent severe hypoglycaemia, on a
battery of cognitive function tests. The recurrent severe hypoglycaemia group were
slower on two of five Finger Tapping tests, had more reversals on the Necker Cube
test, had reduced Forward Digit Span and were slower on the Digit Symbol
Substitution test. Langan et al. (1991) interviewed 100 type 1 diabetic subjects
diagnosed after 18 years of age to obtain histories of severe hypoglycaemia, and
calculated their IQ decrement from the difference between the subject's WAIS-R
performance IQ and estimated pre-morbid IQ from the National Adult Reading Test
(NART). A significant correlation (-0.33; p<0.001) was found between IQ
decrement and reported frequency of severe hypoglycaemia. No significant
relationship was found between severe hypoglycaemia and premorbid IQ, memory
or verbal fluency scores. Type 1 diabetic patients who had experienced 5 or more
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episodes of severe hypoglycaemia had lost 5.8 IQ points more than those with no
history of severe hypoglycaemia. Later reports on this cohort have replicated the
correlation between frequency of severe hypoglycaemia and IQ decrement (Deary et
al. 1992), and have shown that type 1 diabetic patients have lower verbal and
performance IQs than matched controls (Deary et al. 1993a). When compared to a
group of matched non-diabetic controls, it was evident that performance IQ
decrements were associated with recurrent severe hypoglycaemia, whilst a reduction
in verbal IQ was related to type 1 diabetesper se (Deary et al. 1993a). The major
results from the above study were supported by Lincoln et al. (1996) who also
investigated the relationship between cognitive impairment and recurrent severe
hypoglycaemia in 70 type 1 diabetic subjects aged 24-54 years, all ofwhom were
diagnosed after the age of 18 years. A significant correlation was found between the
estimated decline in intelligence score and the frequency of severe hypoglycaemic
attacks (r2 = - 0.30; p<0.01). Comparison of 11 patients who had experienced 5 or
more episodes of severe hypoglycaemia in their lifetime with 35 patients who
reported none showed significant differences at the 5% level on scores ofmemory
and information processing (Lincoln et al. 1996). Although the typical degree of
cognitive decrement demonstrated in these studies is modest, anecdotal reports have
indicated that the professional and social performance of individuals can be affected
significantly (Gold et al. 1994a).
Evidence against recurrent severe hypoglycaemia causing permanent cognitive
decrements comes from two prospective, large-scale trials of cognitive function in
type 1 diabetes. Neither the Diabetes Control and Complications Trial (DCCT) (The
Diabetes Control and Complications Trial Research Group, 1997), nor the
Stockholm Diabetes Intervention Study (SDIS) (Reichard et al. 1996) have
demonstrated any significant, severe hypoglycaemia-related deterioration in
cognitive function over time in their respective cohorts. However, the type of
patients included in the study must temper interpretation of the DCCT findings.
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Patients with a history of severe hypoglycaemia before recruitment were excluded ,
as were those patients who had experienced a severe hypoglycaemic episode without
symptomatic awareness in the two years before the study (i.e. had impaired
hypoglycaemia awareness). The follow-up period was short (mean 6.5 years), the
patients were highly motivated, of above average intelligence, young and had type 1
diabetes of short duration. Therefore the exposure to severe hypoglycaemia of
patients participating in the DCCT may have been significantly less than that
experienced by type 1 diabetic patients outside the setting of an interventional
prospective clinical trial. In the SDIS Trial (Reichard et al. 1996) it is possible that a
Type 2 statistical error may have occurred because the two groups were separated by
treatment type rather than by frequency of severe hypoglycaemia, and there was no
significant difference between the number of type 1 diabetic subjects who had
experienced severe hypoglycaemia in the intensively treated group (86% over 10
years) and the conventionally treated group (73%), although there was a difference
in the number of episodes experienced per patient per year (1.06 vs. 0.47 episodes
per subject per year). Furthermore, the cognitive test battery used in the SDIS was
inadequately sensitive (Deary, 1993).
The relationship between severe hypoglycaemia and cognitive impairment in type 1
diabetic subjects is, therefore, not clearly established. The majority of studies give
support to the hypothesis that recurrent severe hypoglycaemia causes a cumulative
cognitive decrement, especially in the domain of Performance IQ, and especially in
children diagnosed under the age of 5 years. The main concern that has been voiced
about the conclusions drawn from these studies is that they mostly reflect cross-
sectional data and should therefore be interpreted cautiously with respect to
causality. Whilst this may be true it would also be premature to dismiss the findings
as they all point in the same direction and indicate that properly designed
longitudinal studies in this area are needed.
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Neuroimaging and the cerebral effects ofsevere hypoglycaemia
In the search for more objective evidence of altered brain function in type 1 diabetes
following recurrent severe hypoglycaemia Single Photon Emission Topography
(SPET) has been used to examine regional cerebral blood flow. Persistent
abnormalities in regional cerebral blood flow, measured during euglycaemia, were
observed in type 1 diabetic subjects with a history of recurrent severe hypoglycaemia
(MacLeod et al. 1994). This was seen to particularly affect the frontal lobes where
basal regional cerebral blood flow was elevated (MacLeod et al. 1994). These
changes are also observed during acute hypoglycaemia in non-diabetic and type 1
diabetic subjects (MacLeod et al. 1996a). More recently Magnetic Resonance
Imaging (MRI) has been used to examine the brain of subjects with type 1 diabetes.
A high prevalence ofMRI-detected brain abnormalities in type 1 diabetic subjects
was noted (Perros et al. 1997). Two principal types of abnormality were
demonstrated; brain atrophy and leukoaraiosis. Leukoaraiosis is associated with
normal ageing and a variety ofmedical conditions such as hypertension,
demyelination and vascular dementia, and appears to be more prevalent in type 1
diabetic subjects, especially in those subjects with long duration of disease and
microvascular complications (Dejgaard et al. 1991). There was a high prevalence of
cortical atrophy in the type 1 diabetic subjects who had been exposed to recurrent
severe hypoglycaemia (Perros et al. 1997). Five of 11 patients (45%) with a history
of severe recurrent hypoglycaemia (mean age 45 years) had evidence of cortical
atrophy compared to none of a group of 11 matched type 1 diabetic patients without
a history of hypoglycaemia (p<0.05). The MRI findings suggest that cortical atrophy
in this relatively young cohort of type 1 diabetic subjects might have developed as a
consequence of recurrent severe hypoglycaemia.
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Non-cognitive aspects of psychological function during hypoglycaemia
Several early anecdotal accounts have described how hypoglycaemia might effect
behaviour and personality (Fischer and Dolger, 1946; Jones, 1947; Wilder, 1943;
Murphy and Purtell, 1943). However, it was not until the late 1980s that this area
was explored in more detail. Gonder-Frederick et al. (1989) in a study of 34 type 1
diabetic individuals demonstrated an idiosyncratic relationship between mood and
blood glucose concentration. Although no significant findings emerged, low blood
glucose levels tended to be associated with negative mood states such as
'nervousness'. In a more controlled laboratory setting, Hepburn et al. (1995)
measured mood, using the MacKay and Cox Mood Adjective Checklist, every 15
minutes during an insulin infusion which was designed to induce symptomatic
hypoglycaemia. Amongst 12 non-diabetic subjects and 15 type 1 diabetic patients
there was a significant increase in tense arousal (a measure of anxiety-calmness) and
a decline in energetic arousal (a measure of subjective energy), which suggested a
state of'tense-tiredness'.
The use of controlled hypoglycaemia as a biological tool for studying mood-state
was first reported by Gold et al. (1995c).This study improved on that by Hepburn et
al. (1995) in that it included a euglycaemic control limb and used a
hyperinsulinaemic glucose clamp technique to induce more controlled
hypoglycaemia. The UWIST Mood Adjective Check List (Matthews et al. 1990) was
administered to 24 non-diabetic subjects during hypoglycaemic and euglycaemic
steady states using a repeated measures design. In comparison with
normoglycaemia, hypoglycaemia was characterised by an increase in tense arousal, a
decrease in energetic arousal, and a decrease in hedonic tone (a measure of
happiness-sadness). This again suggests the state of'tense-tiredness'. Thayer (1989)
has previously postulated that mood might consist of two principal components,
tense arousal and energetic arousal, which would act in opposite directions to
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produce a state of tense tiredness. The state of tense-tiredness had been implicated in
the development of certain clinical states such as depression. Thayer (1989)
indicated that there was a need to develop methods of inducing this mood state to
validate the notion ofmultiple arousal systems underlying subjective reports of
mood, suggesting that "tension, energy, and the associated conditions of
physiological arousal might seem as variations of the same psychophysiological
condition, perhaps differentiated only in terms of subjective labelling" (p.54). The
study by Gold et al. (1995c) demonstrated that acute hypoglycaemia could evoke the
theoretically important mood state of tense-tiredness, and lent support to Thayer's
(1989) original hypothesis. Furthermore, support was also provided for the validity
of the three-dimensional structure ofmood proposed by Matthews et al. (1990).
It remains possible that the relationship between blood glucose levels and mood
share a common mechanism but that they are not causally related. For instance,
individuals who experience a more profound physiological stimulus during
hypoglycaemia may be more likely to show a change in mood-state (i.e. those
individuals who experience more intense autonomic symptoms [reflecting the
catecholamine response to hypoglycaemia] or neuroglycopenic symptoms [reflecting
low blood glucose to the brain] during hypoglycaemia may report a negative mood
because of the symptoms they are experiencing rather than because of the blood
glucose level per se). However, in neither of the aforementioned studies was a
relationship between symptom intensity and mood state reported. Also, a recent
study (Merbis et al. 1996) of type 1 diabetic subjects with unawareness of
hypoglycaemia found that subject's reported an overall tendency to a more negative
mood-state and to increased feelings of anger during hypoglycaemia despite an
impaired symptomatic response. This study was small and uncontrolled and so it is
not possible to state with certainty that the individual symptomatic response to
hypoglycaemia does not influence the mood-state experienced. There is also no
direct information on the association between counterregulatory hormone release
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during hypoglycaemia and mood-state. It is possible that the change in mood-state
results from an effect of these hormones on the brain, although the findings of
Merbis et al. (1996), would not be consistent with this. It is of note that a study of
adrenalectomized individuals suggested indirectly that adrenaline might be
important in the induction of tense arousal (Hepburn et al. 1996).
Recurrent hypoglycaemia and mood-state
There is very little information on the effects of repeated hypoglycaemic episodes on
mood-state. Type 1 diabetic patients with recurrent severe hypoglycaemia are
reported to score lower on measures ofhappiness and tend to be more anxious
(Wredling et al. 1992). Personality change (an increase in neuroticism and a decrease
in extraversion) has been reported in a small group of type 1 diabetic individuals
who had long duration of disease and a history of recurrent severe hypoglycaemia
(Gold et al. 1994a). Neuroticism has also been found to be higher in type 1 diabetic
individuals with self-reported impaired awareness ofhypoglycaemia (this is often
used as a surrogate measure for frequent hypoglycaemia) (Hepburn et al. 1994).
However, all of these studies are small, and cross-sectional, and therefore should be
interpreted with caution. Until prospective studies are reported the association






Mental (information) processing refers to the series of successive stages between the
appearance (detection) of a physical stimulus and an organism's response to it. One
model of this process sees it as a series of separate stages that take up a finite and
measurable period of time (Holzman, 1994). This model suggests that each stage can
be regarded as a specialised unit that has a specific role in processing of sensory
information. The serial nature of this process does not exclude the possibility that
simultaneous, parallel processing of information from several input sources may
occur. The advantage of this stage model of information processing is that it allows a
global process to be divided up into smaller units that may permit analysis.
Recent advances in experimental psychology and psychophysics have lead to the
development of psychophysical tests which allow a more specific and detailed
examination ofmental processing. The following section will briefly review the
theoretical background of these tests and the literature that has evolved around them.
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Inspection time
Inspection Time (IT) is a psychophysical measure which indexes the efficiency of
early visual information processing. The IT task is thought to measure the efficiency
with which information in iconic (sensory) memory is transferred to discrimination
processes in working memory (Deary et al. 1991). It is a measure of the presentation
time required for a subject to achieve a reliable level of accuracy in a simple two-
choice visual discrimination task. The stimulus is usually backward masked.
Vickers and colleagues (1972) described the theoretical basis of the IT. They
hypothesised that human visual perception functions through a series of quantal
'inspections' of the environment. Therefore, for a stimulus of a fixed magnitude
under controlled conditions, the amount of stimulus input time required to make a
given discrimination might represent a stable measure of an individuals perceptual
performance. The stimulus input time required by a subject to make an accurate
two-choice decision on a simple stimulus is called the 'inspection time' of that
individual for that particular stimulus (Vickers et al. 1972).
Deficits in early visual information processing have been found in pre-senile
Alzheimer's disease (Deary et al. 1991), multiple sclerosis (Kujala et al. 1994),
alcoholism (Wilson et al. 1988), head injury (Mattson et al. 1994), following
recovery from general anaesthesia (Chittelborough et al. 1992) and in major
behavioural disorders such as Schizophrenia and Mania (Green et al 1994). Various
pharmacological agents such as scopolamine (Brandeis et al. 1993), anti-epileptics
(Gillham et al. 1988), noradrenergics (Halliday et al. 1994), dopaminergics (Halliday
et al. 1987), and anaesthetic agents (Chittelborough et al. 1992) can also affect
mental processing speed. Inspection time is known to deteriorate with age
(Nettelbeck and Vernon, 1987), and ability on the Inspection Time task correlates
with psychometric intelligence (Nettelbeck and Vernon, 1987), and, perhaps more
specifically, with fluid-type intelligence tasks (Deary et al. 1991). This suggests that
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mental processing speed is an important aspect of general mental ability, and also
that it is sensitive to mild cognitive impairment.
Visual Change and Visual Movement Detection
These two psychophysical tasks are based on the work of Philips (1974). In an
elegant series of experiments Philips was able to relate a psychophysical model of
visual detection of appearances and disappearances directly to changes in the neural
activity of cells in the Lateral Geniculate Nucleus (LGN), the first post-retinal visual
centre. In the visual detection task an array of light points is displayed, turned off
for some time, and turned on again. The task is to detect and locate a point that was
in the first display but not the second (disappearance) or vice-versa (appearance). It
was shown, by taking intra- and extra-cellular recordings from relay cells of the cat's
lateral geniculate nucleus, that performance on this task could be predicted by a
model of lateral geniculate neural activity (Philips 1974). It was also observed that
some neurones of the LGN discharge when a point of light is turned on in the centre
of their receptive field (ON's), and others discharge when a point of light is turned
off in the centre of their receptive field (OFF's). Reciprocal cross inhibition occurs
whereby on-centre cells can inhibit off-centre cells and vice-versa, and this enhances
responses that partly take place already at the retinal level. With stimulus onset, the
ON's respond with a transient burst and gradually settle to a maintained level of
activity. Because of antagonistic inhibition the OFF's become hyperpolarised at
light onset. The resultant inhibition gradually decays, and after offset of the
stimulus the OFF's burst into activity that decays gradually, unless the activity is
suppressed by the onset of light again. If the onset of light occurs before the latent
period of the OFF's has expired, the cell may be hyperpolarised again and never fire
at all. Philips (1974) showed that conditions for appearance detection were different
from conditions for disappearance detection and that detection was not a function of
the comparison of successive 'icons' (i.e. was probably indexing 'pre-iconic'
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processing). This work was replicated in a series of experiments over the ensuing
years (Royer and Gilmore, 1984 and 1985; Di Lollo and Bourassa, 1983; Stelmach
et al. 1987; Wilson et al. 1987; Bourassa et al. 1987; Takakuwa and Callaway,
1990).
The visual change detection and visual movement detection tasks therefore relate to
the inspection time task in that both are providing a measure of the early stages of
visual information processing. Inspection time provides an index for this process for
a stimulus presented in fixed, predictable location whereas the change and
movement detection tasks index a wider, unpredictable visual field.
Test of Basic Auditory Capabilities
The Test of Basic Auditory Capabilities (TBAC) (Watson et al 1982) is a battery of
auditory discrimination tests which has been used extensively in auditory research,
especially that which has explored the relationships between auditory perception and
reading disabilities (Watson and Miller 1993). The TBAC was derived from the
examination of a large number of subjects with normal hearing (Watson et al 1982).
Analysis of 22 different tests suggested 8 subtests that best described the major
dimensions of auditory capability, and these 8 subtests were grouped into three
primary dimensions of auditory ability: simple auditory discrimination, auditory
temporal processing (non-verbal) and speech perception (Watson and Miller 1993,
Johnson et al 1987). The TBAC is also thought to provide an overall measure of the
speed and efficiency of auditory information processing (Watson and Miller 1993).
Performance on the TBAC is unaffected by mid- or high-frequency hearing loss
(Christopherson and Humews 1992). The psychometric properties of the TBAC and
its test-retest reliability in normal and in elderly hearing-impaired listeners have





Studies 1 and 2 - Information processing and acute hypoglycaemia
The effect of neuroglycopenia on different aspects of cognitive function has been
demonstrated and quantified in studies using a variety of neuropsychological and
neurophysiological tests (see chapter 2). In general, these studies have employed
measures of general cognitive performance to assess brain functioning during
hypoglycaemia. A problem with this approach lies in our limited knowledge of the
brain processes involved in most psychometric tests (Anastasi 1990). An example is
the Stroop test, which has been the subject ofmuch, detailed research and is used
extensively in hypoglycaemia studies and yet for which there is no agreed account of
the processes involved in its performance (Deary 1993). The fundamental
information processing functions affected by hypoglycaemia therefore remain
unknown, because most standard tests cannot be reduced reliably to a specific set of
psychological processes. In addition, it is not clear to what extent a significant
disruption in general cognitive performance tests provides a useful index of abilities
that are important in everyday cognitive functioning (Anastasi 1990). Thus, very
little detailed information is available on the effects of controlled hypoglycaemia
upon specific information processing abilities. This information is essential to aid
our understanding of the relative susceptibility, or importance, of different parts in
the sequence of a cognitive process; and to provide information ofmore direct
relevance to insulin-treated patients. Studies 1 and 2 were designed to examine the
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effect of acute hypoglycaemia on two fundamental aspects ofmental processing,
namely; visual and auditory information processing respectively. It was
hypothesised that acute hypoglycaemia would lead to a significant disruption in both
visual and auditory information processing.
Studies 3 and 4 - Non-cognitive aspects of psychological function during
hypoglycaemia
For both studies 3 and 4 it was hypothesised that hypoglycaemia, through its
induction of a negative mood state, would lead to an increased expression of
negative emotions in the participants. It has long been recognised that some
individuals show a marked increase in anger state during hypoglycaemia. However,
this has never been systematically studied. Study 3 was designed to examine the
effect of acute hypoglycaemia on anger-state using a well validated anger
questionnaire, and further to explore possible associations between an individual's
anger-trait, general mode of anger-expression, and change in anger-state. Similarly
study 4 was designed to extend previous work on acute hypoglycaemia on mood
state. It was hypothesised that acute hypoglycaemia through the induction of a state
of tense-tiredness would lead to a negative emotional state, which would cause
individuals to make more negative appraisals of a life event.
Study 5 - A comparison of the symptoms of hypoglycaemia induced using a
continuous insulin infusion or a one-step hyperinsulinaemic glucose clamp in
non-diabetic and IDDM subjects.
Previous studies have suggested that different techniques for inducing
hypoglycaemia may not evoke the same symptomatic response. It has also been
suggested that the Edinburgh Hypoglycaemia Scale, which has been derived from
type 1 diabetic subjects in the community, may not be applicable to experimental
hypoglycaemia. This study sought to answer these questions by analysing the
symptom reports of a large number of type 1 diabetic and non-diabetic subjects who
82
have participated in experimental hypoglycaemia research at the Royal Infirmary of
Edinburgh.
Study 6 - The symptoms of hypoglycaemia experienced by children with type 1
diabetes.
The application of statistical techniques such as Principal Components (Factor)
Analysis to examine symptoms ofhypoglycaemia in large groups of type 1 diabetic
adults lead to the development of the Edinburgh Hypoglycaemia Scale (Deary et al.
1993b). This measure ofhypoglycaemia symptoms provides a possible means by
which standardisation may be achieved across research centres. However, it is not
known whether the symptoms of hypoglycaemia in children with type 1 diabetes can
be classified in the same way. The literature would suggest that when they are
experiencing hypoglycaemia behavioural change is more apparent in type 1 diabetic
children. This study was designed to apply similar statistical techniques to the
analysis ofhypoglycaemia symptom reports from type 1 diabetic children in an
attempt to determine more accurately the nature of the symptoms of hypoglycaemia







The Lothian Health Board Ethics ofMedical Research Subcommittee for Medicine
and Clinical Oncology granted permission for each of the studies. Written consent
was obtained from all subjects following a detailed explanation of the nature of the
studies.
Subjects
The details of criteria for selection of subjects for each study are explained in the
individual study chapters.
Laboratory studies ofhypoglycaemia
The laboratory studies involving experimentally-induced hypoglycemia were
conducted in the Department ofPsychology, University ofEdinburgh, during the
period 1994-5.
The hyperinsulinaemic glucose clamp technique: In studies 1-4 hypoglycaemia was
induced and maintained using a modified manual hyperinsulinaemic glucose clamp
(DeFronzo et al. 1979). This method uses a fixed rate insulin infusion and a variable
rate 20% dextrose infusion to manipulate the blood glucose. Insulin is initially
infused at a rate of 150 mU/m2/min before being gradually ramped down, over a
period of 10 minutes, to a rate of 60 mU/m2/min, at which it is then maintained. This
loading dose saturates the insulin receptors to facilitate subsequent manipulation of
blood glucose. An infusion of 20% dextrose is commenced about 5 minutes after the
insulin infusion is started, initially at a rate of about 1 ml/kg/hour. The subsequent
rate of dextrose infusion is determined by the arterialised blood glucose
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concentrations measured by the bedside every 5 minutes. In all experiments a period
of stable euglycaemia is first established to enable baseline measurements to be
taken. To then induce hypoglycaemia the dextrose infusion is stopped for 5 minutes
then recommenced at half the rate that was required during stable euglycaemia. The
dextrose infusion is then adjusted as required to maintain the predetermined level of
hypoglycaemia. In the following experiments the blood glucose is initially stabilised
at euglycaemia (5.0 mmol/1) and then allowed to fall rapidly to a level of 2.6 mmol/1
(the predetermined level of hypoglycaemia). This is the one-step euglycaemic-
hypoglycaemic clamp and allows the investigator to provide a reproducible fixed
level of hypoglycaemia for a predetermined time and an identical stimulus with
which to compare subjects.
The hyperinsulinaemic glucose clamp produces plasma insulin levels that are
supraphysiological and this may have an influence on the outcome of experimental
studies employing this technique. The role of insulin in the counterregulatory and
cognitive responses to hypoglycaemia has been discussed in an earlier section of this
thesis. However, by including a hyperinsulinaemic euglycaemic control in each
study design it is hoped that this potential variable is controlled for. It is also a
criticism of this technique that, in the light of recent evidence of the variability of
individual responses to hypoglycaemia (Gonder-Frederick et al. 1994), it is not in
fact providing an identical stimulus to each individual (i.e. a fixed hypoglycaemic
stimulus of 2.6 mmol/1 may reflect different degrees of hypoglycaemia between
individuals in whom the thresholds for cognitive dysfunction vary). However, as
discussed in a previous section, the threshold for cognitive dysfunction is probably
less variable than that for the counterregulatory response to hypoglycaemia, and by
choosing a degree of hypoglycaemia that is sufficiently below the 'accepted'
threshold for cognitive dysfunction it is hoped that most individuals will show a
degree of cognitive change. Finally, it must be recognised that the technique
produces a stable period of hypoglycaemia that is not analogous to the 'real-life'
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experience of hypoglycaemia in type 1 diabetic individuals, and therefore the
interpretation of data from clamp experiments must be made with caution. Despite
these reservations, the hyperinsulinaemic glucose clamp is the only method available
for reliably maintaining the blood glucose at predetermined concentrations for
prolonged periods of time, sufficient to allow the administration of cognitive test
batteries.
Experimental procedure for clamp studies: Following a light breakfast at 0700 h
subjects were asked to attend the department at midday, and a Teflon cannula was
inserted into an antecubital vein in the non-dominant arm under local anaesthesia
(lignocaine 1%). This was used to infuse a fixed rate ofhuman soluble insulin
(Humulin S, Eli Lilly, Indianapolis, USA) and a variable infusion of 20% dextrose
as described above. Insulin was infused at a constant rate of 60 mU/m^/min using an
IMED Gemini PCI pump. Dextrose was infused using an IVAC Site Saver pump.
The rate of dextrose infusion was adjusted according to the arterialised blood
glucose concentration measured at the bedside (Yellow Springs Instrument 2300
Stat, Yellow Springs, Ohio, USA). A second cannula was inserted in a retrograde
direction into a vein on the back of the hand. The cannulae were flushed regularly
with heparinised 0.9% saline. The hand was placed in a heated Plexiglas box (60 °C)
to arterialise venous blood. Arterialised venous blood samples were initially
obtained at three-minute intervals, then at five-minute intervals once a stable blood
glucose concentration had been achieved. Warming the hand allows shunting of the
blood from the arterial to the venous system. This "arterialised" venous blood
glucose has been shown to approximate very closely with true arterial blood glucose
concentrations (Liu et al. 1992). This is necessary because venous blood glucose
concentrations are highly variable, particularly in combination with the glucose
clamp technique (Liu et al. 1992).
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The subjects were not informed of their blood glucose concentrations during the
experiments. The blood glucose was initially stabilised and maintained at 5.0 mmol/1
in all the clamp studies and then either allowed to fall to a hypoglycaemia plateau
(2.6 mmol/1) or continued on at euglycaemia (5.0 mmol/1).
Choice ofdegree ofhypoglycaemia: A level of hypoglycaemia was chosen that
would ensure the threshold for cognitive dysfunction had been reached in most
individuals, and which would be tolerated safely by the subjects, for the duration of
at least one hour. Based on a review of the literature (see Part I, pp.36-67), and
previous experiments conducted in our laboratory, it was decided to aim for a degree
of hypoglycaemia of approximately 2.5 -2.6 mmol/1.
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Mental (information) processing tests
(A) Visual information processing tests
Inspection Time.
The Inspection Time (IT) Test used in this study was a simple two-choice
discrimination task. IT is a measure of the speed of the early stages of visual
information processing (Vickers et al. 1972).
The object of the test is to determine the stimulus duration required by a subject in
order to reach a given level of correct responding in a very simple discrimination
task. In the IT task used here the subject is required to indicate which of two parallel
vertical lines, ofmarkedly different lengths, is the longer. During the test the
experimenter varies the stimulus duration, with briefer duration's being more
difficult. Only the correctness of responses at different stimulus durations is
examined. Response speed is not recorded and the subject is instructed and
encouraged to respond at leisure to achieve maximum accuracy. The IT stimuli and
backward masks have been described in detail by Deary et al. (1991). A mask is
designed to prevent the further processing of information from a briefly presented
stimulus. The stimulus presentation unit was a box that carried a 16x16 array of
circular red light-emitting diodes (LEDs). This display area (61 mm square) was
built up from four Siemens PD 1165 display modules, each ofwhich had an 8x8 grid
ofLEDs of 0.11 inch diameter on 0.15 inch centres. All stimuli were composed of
these LEDs. The cue, which preceded the IT stimulus, was an inverted U-shape,
16mm across by 14mm high, which shared the same crossbar as the IT stimulus. In
the IT stimulus the long line (29 mm) and short line (14 mm) were joined at the top
by a crossbar (16 mm). Thus the vertical lines were aligned at the top. The
backward mask was formed by lines 40 mm long and 10 mm wide (i.e. the masking
lines were wider and longer that the stimulus lines and completely covered them).
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The stimulus presentation unit was controlled by a BBC computer, which also
collated the response data.
Each subject carried out all the IT test sessions under the same lighting conditions
and in the same room, to ensure that stimulus contrast remained stable. A 300 msec
warning cue was presented at the start of each trial. One second after onset of the
cue, the IT stimulus was presented for the appropriate duration, which ranged from 1
to 400 msec. After IT stimulus offset the backward mask was presented
immediately to prevent further processing of the stimulus. The duration of the mask
was adjusted as stimulus duration varied so that stimulus plus mask duration
remained at 600msec. After the mask was turned off the subject was required to
respond by indicating which stimulus line was the longer. Responses were made on
two buttons linked to the stimulus presentation unit. There was no feedback as to
the correctness of the response. In this study a response from the subject initiated
the next trial (i.e. no reaction time was taken and the subject was continually
reminded that the emphasis was on accuracy rather than speed of response).
The IT test algorithm used measured the stimulus presentation time (in msec)
required by each subject to achieve 85% accuracy in responding (50% representing
chance responding). Stimulus presentation times were determined according to the
PEST adaptive staircase algorithm (Taylor and Creelman, 1967). Starting at a
presentation time of 200 msec with a minimum of five trials per step, the first step
size was 75 msec. The step size was halved with each reversal and the stopping step
size was 1 msec. Most subjects required about 90-130 trials to reach their IT. This
algorithm has the advantage of using reliability of response as its stopping criterion,
and provides a reliable index of visual information intake efficiency (Deary et al.
1991).
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Visual Change Detection (VCD).
This test is based on the work ofPhillips (1974) on change detection, as described
by Wilson et al. (1988). This test, like IT, assesses the speed of early visual
processing. However, in this task the subject must identify the locus of a discrete
change in a large array of homogeneous stimuli. Therefore, whereas IT measures
perceptual speed for detecting a difference in a stimulus occurring at a specific,
predictable location, the VCD task requires the subject to attend to a wider stimulus
field, so emphasising parallel processing. However, like IT, it is the timing (i.e.
speed) of the stimulus change that is manipulated, and in this task, as with IT, the
subject is allowed to respond without any pressure of time.
The stimulus display used for this test consisted of an array of 49 small rectangles on
a computer monitor screen to which, after a variable interval, a single (target)
rectangle was added. The subject's task was to identify this additional rectangle.
The experimenter can manipulate the time interval between the onset of the 49-
rectangle array and the target; shorter intervals are more difficult. The display was
generated by randomly lighting 49 of 100 potential rectangles in a regular 10x10
array upon a computer screen. The overall array size was 185 mm by 105 mm; each
rectangle measured 5mm vertically by 3mm horizontally and were non-contiguous.
The cue, which preceded the stimulus by a fixed interval, was a circle located in the
centre of the screen. The time intervals employed between the onset of the array and
the onset of the target were either: 14, 28, 42, 56, 70 or 86 msecs. A response was
made by touching the screen on the relevant rectangle, and the subject was given
feedback on each trial. In this test the subject initiated the next presentation, and, as
with IT, was reminded that accuracy ofresponding was being measured and not
reaction time. Each subject was tested on a random block of 60 presentations; 10
trials of each of the 6 different stimulus durations were presented at random. A total
score of accuracy of responding was obtained.
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Visual Movement Detection (VMD).
In this task a subject's efficiency of detecting the movement of a single stimulus in a
large array is assessed (Philips 1974, Wilson et al. 1988). The VMD resembles the
VCD task in all respects except one: the target rectangle, rather than appearing after
the rest of the array, appears with the array but, after a variable interval, moves to the
right or left by a distance identical to its width (i.e. 3 mm). As with the test of visual
change detection this test display was generated by randomly lighting 50 rectangles
in a potential 10x10 array. The array measured 185 mm by 105 mm, and each
rectangle measured 5mm vertically by 3 mm horizontally. After a variable interval
one (target) rectangle was deleted and re-displayed 3 mm away horizontally, thus
creating the subjective sensation of sudden movement. The subject's task was to
point to the rectangle that appeared to move. The cue was the same as that used for
the visual change detection task. The interval between the onset of the array and the
movement of the target rectangle ranged from 14-86 msec as for the VCD task. The
subject responded by touching the computer screen over the rectangle thought to be
the target. A random block of 60 presentations (10 trials of 6 different stimulus
durations) was also employed in this test, and the total number of correct responses
was obtained and used as the score.
(B) Auditory information processing tests
The tests used to examine different aspects of auditory information processing were
from the Boys Town Institute Test of Basic Auditory Capabilities [TBAC] (Watson
et al. 1982).
Each of the discrimination tests used in this battery is conducted using the same
psychophysical method, with six levels of the independent variable. The tests are
recorded on audiotape together with detailed instructions for the subjects. The
psychophysical method is a modified two-alternative forced choice procedure. A
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standard comparator stimulus precedes the two stimuli of the two-alternative, forced
choice presentation, yielding three stimuli in total for each item. The subject's task
is to identify which of the two stimuli following the standard was different from it.
This psychophysical procedure thus involves only two types of trials, SDS and SSD
(S = standard stimulus, and D = different stimulus). The subject's task is to identify
D. This method minimises demands on attention and memory, while providing a
valid test of auditory processing abilities (Watson et al. 1982). Trials are always
presented in a series of six steps of the independent variable, in ascending difficulty.
In the test battery employed in the present study a total of 72 trials was used for each
sub-test. The stimulus tones are all gated with 5-msec rise-decay times to minimise
onset and offset transients.
The studies were performed in a sound controlled listening room with an ambient
sound level of 30-32 dB. The TBAC was recorded on audiotape and played to the
subjects on a Levers-Rich Mastering Machine with a Sony Mixer. Subjects heard
the tests via Bayer Dynamic DT 100 headphones. The tasks were performed at a
sound level of 67 dB (mean of 10 recordings using a regularly calibrated Castle
Associates Sound Level Meter).
The TBAC contains eight sub-tests, ofwhich four sub-tests were used. These
examined two categories of auditory processing; simple auditory processing (pitch
discrimination, single-tone loudness, single-tone duration), and auditory temporal
processing (non-verbal; temporal order discrimination) (Watson and Miller, 1993;
Watson et al. 1982).
Pitch discrimination: The standard is a 1-kHz, 75-dB, 250-msec tone. The values of
the frequency differences range from 2 to 256 Hz.
Single-tone loudness: The standard is again a 1-kHz, 250-msec tone at 75-dB.
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Increments in level, expressed in decibels, range from 0.5 to 8.0 dB.
Single-tone duration: The standard is a 1-kHz, 75 dB, 100-msec tone. Increments in
duration range from 8 to 256 msec.
Temporal orderfor tones: The task is to discriminate the order in which two tones
are presented, one ofwhich is 550Hz, and the other 710 Hz. The duration of the two
tones is varied from 20 to 200 msec. The tones are presented without a gap between
them and are preceded and followed, without gaps, by a 'leader' and 'trailer',
consisting of 100-msec, 625 Hz tones.
Psychometric tests of general cognitive function
Two tests of general cognitive performance, known to be affected by moderate
hypoglycaemia (Deary, 1993), were included in the test battery. Both the Digit
Symbol and the Trail Making B test have a closer relationship to 'fluid' rather than to
'crystallised' (vocabulary-oriented) cognitive ability. These tests were included to
provide an indication of general brain functioning during controlled hypoglycaemia.
Digit Symbol (DSS). This is a performance sub-test of the Wechsler Adult
Intelligence Scale-Revised (Wechsler, 1981). Nine digits are represented by nine
different symbols, and subjects are required to write down the appropriate symbol
for each in a given array of numbers over a fixed time period. The score is the total
number of correct symbols drawn over this time period.
Trail Making Test B (TM-B). This is a divided attention task from the Halsted-
Reitan Neuropsychological Battery (Reitan et al. 1974). The subject has to connect
correctly an alternating series of numbers (1-13) and letters (A-L) in their respective
orders as quickly as possible. The score is the time taken to complete the task.
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Tests ofmental ability
Prior to enrolment for each of the experimental studies, the general level ofmental
ability was assessed in each individual. The Alice Heim 4 test (ATM; Heim, 1970)
and the National Adult Reading Test (NART, Nelson and Willison, 1992) were
used. The AH4 test is divided into two parts, the first part of the test provides an
assessment of verbal and numerical skills and the second an assessment of
visuospatial skills. The subject is asked to complete as many questions as possible in
ten minutes for each part. A choice of answers is provided for each question. The
test does not provide a measure of IQ, but does provide a good measure of global
cognitive ability. The maximum score is 65. The NART assesses premorbid IQ, that
is the peak level ofmental ability attained by a subject prior to any cognitive
deterioration. In this task the subject is asked to pronounce 50 irregular English
words (e.g. ache, depot) and the number pronounced correctly is the score obtained.
The NART has been validated against the Wechsler Adult Intelligence Scale and has
been shown to correlate closely with this test in subjects without reason for cognitive
decline (Crawford, 1992)
Assessment of symptoms of hypoglycaemia
A questionnaire was used to establish the symptoms ofhypoglycemia that the
subjects were experiencing. The questionnaire was given to the subjects at the
appropriate time-points described in each study. This questionnaire has been
developed from previous experimental and clinical studies (Hepburn et al. 1991a,
Hepburn et al. 1992, Deary et al. 1993b). Hypoglycaemia symptoms were classified
as autonomic (palpitations, sweating, shaking and hunger), neuroglycopenic
(confusion, drowsiness, odd behaviour, speech difficulty and inco-ordination) or
non-specific (nausea and headache) (Edinburgh Hypoglycaemia Scale, Deary et al.
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1993b). Each symptom was graded on a scale of 1 to 7 (1 = not present, 7 = very
intense). The total for each sub-group of hypoglycaemic symptoms was calculated.
Questionnaires used in studies on non-cognitive effects of hypoglycaemia
Measures ofanger state, trait and expression.
The State-Trait Anger Expression Inventory (STAXI) (Spielberger, 1991) is
designed to provide easily administered and objectively scored measures of anger
experience and expression. The STAXI has been used to examine the relationship
between anger expression and systolic blood pressure (Johnson et al. 1987a; Johnson
et al. 1987b), and to investigate the psychological functioning of patients with post¬
traumatic headache (Ham et al. 1994). The STAXI comprises three sub-scales;
anger-state, anger-trait and anger-expression, the scoring and interpretation ofwhich
have been explained in detail (Spielberger, 1991). Anger-state is a measure of the
degree of anger experienced by an individual at the time of questioning. A list of 10
questions is provided which includes questions such as: 'I am furious', 'I feel
irritated', and 'I feel angry'. Subjects are not under pressure of time to respond.
Scores for each question are graded from 1-4 (1= not felt at all, 4= very intense
feeling). The total score for each subject is then calculated. This questionnaire was
given to the subjects during the study conditions (euglycaemia and hypoglycaemia)
only, and not shown to them prior to this.
The anger-trait measure is based on a series of questions which ask the subject to
describe how they generally feel. Persons high in trait-anger frequently experience
angry feelings and often feel they are treated unfairly themselves. Measures of anger
expression are derived from a 24-stem questionnaire, which asks subjects to indicate
how they generally react or behave when they are angry or furious. Separate scores
are obtained for the degree to which subjects generally suppress angry feelings
(AX/In); express angry feelings as aggressive behaviour (AX/Out); and the degree of
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control they tend to exert over angry feelings (AX/Con). From these three individual
scores a measure of anger-expression is obtained (AX/EX).
UWISTMoodAdjective Check-list (UMACL (Matthews et al. 1990)).
The adjectives used to characterise the mood dimensions used in this questionnaire
were graded by intensity on a scale of 1 to 4 and were classified into three groups:
hedonic tone, tense arousal and energetic arousal. Higher scores indicated a high
happiness rating for hedonic tone, a high anxiety rating for tense arousal, and a high
energy rating for energetic arousal. The maximum score that could be obtained for
each of the three mood components was 32, and the minimum score was 8.
Appraisal ofLife Events Scale (ALE (Ferguson et al. 1997; Ferguson and Cox, 1993;
Ferguson et al. 1998)).
This questionnaire consists of 16 adjectives relating to the three appraisal
dimensions described previously: threat, challenge and loss. Questionnaire items
were graded by intensity on a scale of 1 to 4 (l=not very intense experience and
4=very intense feeling). A high challenge score means the subject is appraising a
situation as allowing for personal growth and development. A high threat score
indicates that a life problem is being appraised as potentially threatening, physically
harmful, and generating anxiety. A high loss score suggests the potential for
personal suffering. The ALE was completed by subjects during study conditions
(euglycaemic, hypoglycaemia) only, and not during either baseline.
Eysenck Personality Questionnaire-Revised, Short Form (EPQ-R (Eysenck et al.
1985)).
The EPQ-R short form consists of 48 questions, 12 relating to each of the three
major personality dimensions of neuroticism, psychoticism and extraversion, and a
further 12 questions making up a lie scale to assess the tendency to give desirable
answers. Participants answer yes or no to each question. The scores are then summed
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for each dimension. The EPQ-R was completed by subjects during study conditions
(euglycaemia, hypoglycaemia) only, and not at each baseline.
Visual acuity and contrast sensitivity tests
Vision acuity was examined by a series of standard clinical tests. An assessment of
static contrast sensitivity was also taken to provide evidence for any subtle changes
in peripheral vision.
VisualAcuity for each eye was assessed using a standard Snellen Chart positioned 6
m from the subject.
Visual near-point (binocular) and reading acuity (monocular) were assessed using a
Royal Air Force Meter (Clement Clarke International Ltd, Essex, England).
Stereoscopic Vision, a measure of the ability of subjects to judge the relative
distances of objects by means of binocular vision, was assessed using Stereo-test
Circles (Stereo-Optical Company Limited, Chicago, Illinois, USA).
Contrast Sensitivity (static) was measured using the Cambridge Low Contrast
Gratings (Clement Clarke International Ltd, Essex, England). In each item of this
test the subject views two adjacent pages of a booklet positioned at a distance of 6
m, only one page ofwhich contains horizontal lines (a grating). Each 'line' in the
grating is composed of small black dots on a white background separated from each
other by equal distances. Viewed from a distance the subjective impression is of
grey lines with white spaces between them. The opposite page of the booklet has the
same number of dots evenly dispersed (i.e. not as lines). Here the subjective
impression, when viewed from six metres, is of a blank page. The subject's task is to
identify the page that contains the lines (the grating). The task is very difficult when
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the lines are composed of few, widely spaced black dots, where the impression is of
very faint grey lines on the page. Therefore, by varying the number of dots, and the
distance between them, a series of gratings are produced with different levels of
contrast. The gratings have 11 levels ofdifficulty, all with the same spatial
frequency of 4 cycles/degree. In this study the subject was presented with a block of
50 presentations (10 trials of each of the five most difficult gratings (contrast %
0.37, 0.27, 0.19, 0.14, and <0.14)) in random order, and the total number correct was
used as the score. The lighting in the room was adjusted so that the luminance of the
non-grating plate in the demonstration pair (contrast = 13 %) was 100 cd/m^. This
was kept constant for all visual assessments.
Statistical methods
The individual tests employed are detailed in the relevant study chapters. All
statistical procedures were performed using an IBM computer with software package
SPSS-PC+.
Power analysis
The calculation of the sample size required to achieve a power of 80% in the studies
presented in this thesis is based on the following formula:
n>2[(z2a + Zjpja/S ]2
Specifying an a of 0.05 and a power of 80% and assuming that the critical interval
(8) is the same as the standard deviation (a) then it can be calculated that at least 16









Visual information processing during acute hypoglycaemia
That moderate hypoglycaemia can cause general cognitive dysfunction has now
been established using neuropsychological and neurophysiological tests. However,
as I have already indicated, our knowledge of the brain processes involved in most
psychometric tasks is limited (Anastasi, 1990). This is important because one cannot
infer from studies employing these tasks the actual functional impact of
hypoglycaemia on more fundamental brain processes. The speed and efficiency with
which the brain is able to process information received from the visual sensory
system is essential to normal brain functioning, and may provide an index ofmental
ability in general (see pp 78-79). Advances in psychophysics have lead to the
development of tests which provide a much more accurate index of visual
information processing. This study was designed to examine the impact ofmoderate
hypoglycaemia on visual information processing in non-diabetic individuals.
Acute controlled hypoglycaemia does have an effect upon the eye with documented
changes in intra-ocular pressure (Frier et al. 1987) and anterior chamber dimensions
(Hepburn et al. 1993), but it is not known whether these physical changes translate
into clinically relevant abnormalities of vision. Blurring of vision and diplopia are
recognised features of acute hypoglycaemia (Hepburn, 1993). When symptom
profiles reported during acute insulin-induced hypoglycaemia are analysed, blurring
of vision clusters together with the neuroglycopenic symptoms of hypoglycaemia
(Hepburn, 1993). Corrected visual acuity does not appear to deteriorate during
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insulin-induced hypoglycaemia (Harrad et al. 1985), nor is there evidence of a
significant change in colour vision (Hardy et al. 1995). These findings are
inconclusive and afford data of limited practical relevance because real-world visual
perception involves making decisions about transitory and low contrast stimuli. An
important example of such a task is driving, and deleterious effects of
hypoglycaemia on driving ability have been found using a driving simulator (Cox et
al. 1993).
Contrast sensitivity provides a more subtle measure of unspeeded visual function (Di
Leo et al. 1992) than standard acuity tasks, and is more relevant to everyday human
visual perception. Contrast sensitivity provides a measure of the amount of contrast
required to detect a visual target. Sub-clinical visual dysfunction is more likely to be
detected by degrading the stimulus (visual target) intensity using this more
demanding visual assessment (Di Leo et al. 1992).
The aim of the present study was therefore to examine two important aspects of
visual perception during controlled hypoglycaemia, viz. speed of iconic processing
and contrast sensitivity. Standard tests of general cognitive performance gave a
measure of the degree of general cognitive disruption during hypoglycaemia.
Simultaneous standard measurements of visual acuity were recorded.
Methods
Subjects
Twenty (18 male, 2 female) healthy non-diabetic human subjects were studied. All
subjects had a visual acuity (measured by a Snellen chart) of 6/6 or better. The
subjects were aged 26 (23-30) years (median (range)) and had a Body Mass Index of
23 (19-26) kg/m2. All of the subjects had above average intellectual ability as
assessed by the National Adult Reading Test and the Alice Heim 4 Test (standard
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tests of general intellectual ability). The subjects did not have a previous medical
history or a family history of diabetes, nor were they taking regular medication.
Subjects were recruited by advertisement, and were not paid for their participation in
this study. Each subject was informed that they would be required to attend the
department on three separate occasions. On two of these occasions they would
undergo the experimental procedure during which they would either be kept at
euglycaemia or rendered hypoglycaemic. Subjects were made aware that they would
undergo both study conditions but would not be informed as to which condition was
being performed on each study day. The local medical ethics advisory committee
approved the study, and written consent was obtained from all subjects.
Experimental Procedure
The subjects were studied on three separate occasions, each at least two weeks apart.
The initial visit was to familiarise the subjects with the tests that would be used
during the experimental condition. During familiarisation subjects completed all of
the psychometric tests, the order and duration ofwhich were the same as that of the
experimental condition. Familiarisation was used to help minimise any practice
effects that might occur. The results from this session for each individual subject
were discarded. In the two subsequent visits to the laboratory subjects underwent a
hyperinsulinaemic glucose clamp procedure (described on pages 86-88).
The study design is shown in Figure 3.1.1. Each subject underwent two laboratory
sessions. On each occasion the arterialised whole blood glucose concentration was
initially stabilised at 5.0 mmol/1 (baseline phase) for one hour. In one study session
hypoglycaemia (2.6 mmol/1) was then induced and maintained for one hour, and in
the other the blood glucose concentration was maintained throughout at 5.0 mmol/1
(euglycaemia). An interval of 20 minutes was interposed between baseline and the
hypoglycaemic or euglycaemic phases to allow achievement of the new glycaemic
level. Subjects were not informed of their blood glucose level at any time during the
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laboratory sessions. During each phase of the study (each baseline, euglycaemia and
hypoglycaemia) the subjects were asked to complete the test battery (see below).
During each study phase the blood glucose was stabilised for ten minutes at the
target glycaemic level before the assessment of information processing. The
subjects underwent the experimental conditions in a counterbalanced fashion (i.e.
half the subjects underwent hypoglycaemia first followed by the euglycaemic
control condition, and half the reverse).
Test battery
During each phase of the study (each baseline, euglycaemia and hypoglycaemia) the
subjects underwent tests of:
Visual Information Processing
1 - Inspection Time [IT] (Vickers et al. 1972).
2 - Visual Movement Detection [VMD] (Phillips, 1974).
3 - Visual Change Detection [VCD] (Phillips, 1974).
General Cognitive Function
4 - Digit Symbol Substitution test [DSS] (Wechsler, 1981).
5 - Trail Making Test B [TM-B] (Reitan and Davison, 1974).
Visual Acuity and Contrast Sensitivity
6 - Visual Acuity
7 - Visual Near Point
8 - Stereoscopic vision
9 - Contrast Sensitivity
Hypoglycaemia symptoms.
10 - Edinburgh Hypoglycaemia Scale (Deary et al. 1993b).
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The tests used in the battery are described in detail in Part II. Subjects completed the
tests in the same order during each study condition, and the battery took between 40-
45 minutes to complete.
Statistical analysis
The results were analysed independently for each measure of visual function, tests of
general cognitive function, and information processing tests. A mixed model
Analysis ofVariance (ANOVA) was used with order of session as a between
subjects factor with two levels (euglycaemia-hypoglycaemia or hypoglycaemia-
euglycaemia), and study type as a within subjects factor with two levels
(euglycaemia vs. hypoglycaemia). Test results at baseline were used as variable
covariates in each analysis.
Due to a computer fault on a single occasion one of the subjects was unable to




This diagram represents the study design. Each subject underwent both euglycaemic
and hypoglycaemic study conditions on separate days. Once stable glycaemic levels
had been achieved a period of stabilisation (S) followed prior to subjects completing








Overall mean ± S.D plasma glucose during the hypoglycaemic clamp was 2.60±0.1,
and 4.98±0.05 during the euglycaemic clamp (Fig.3.1.2).. The coefficient of
variation in blood glucose was 0.5% and 0.6% for the euglycaemic and
hypogycaemic clamps respectively.
The initial statistical analysis revealed that no significant order effects (asymmetrical
transfer effects) had occurred for any of the outcome variables in this study.
Symptoms
There was a significant increase in total autonomic symptom scores (F = 33.31, df
1,18, p < .001) and total neuroglycopenic symptom scores (F = 12.86, df 1,18, p <
.005) during the hypoglycaemia condition of the study (Table 3.1.1).
Hypoglycaemia-associated non-specific malaise symptom scores showed a tendency
to increase though this did not achieve a conventional level of significance (F = 4.25,
df 1,18, p = .055). Sub-group analysis is based upon symptoms from the Edinburgh
Hypoglycaemia Scale (Deary et al. 1993b).
General cognitive function
In the present study scores achieved on the DSS were significantly lower (F = 69.97,
df 1,18, p < .001), and times taken to complete the TM-B were significantly longer
(F = 4.66, df 1,18, p < .05) during hypoglycaemia when compared with euglycaemia
(Table 3.1.1). This confirms that these standard measures of general cognitive
dysfunction were significantly affected at a blood glucose of 2.6 mmol/1.
Visual acuity and contrast sensitivity
No significant changes were observed in visual acuity or visual near point during
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hypoglycaemia (Table.3.1.1). Visual acuity, for both eyes, tested separately, was not
significantly affected by hypoglycaemia (F = 2.22, df 1,18, p = ns, and F = 1.08, df
1,18, p = ns, respectively). Visual near point for binocular vision (F = 0.81, df 1,18,
p = ns), and reading point, for both eyes tested separately (F = 0.00, df 1,18, p — ns,
and F = 0.16, df 1,18, p = ns respectively), showed no significant changes during
hypoglycaemia. Stereoscopic vision was also unaffected (F = 0.00, df 1,18, p = ns).
Therefore, standard tests of visual acuity were unaffected during controlled
hypoglycaemia, indicating that no disruption in vision, as detectable by these tests,
had occurred despite a significant and concurrent deterioration in cognitive
performance.
Although visual acuity for highly contrasting symbols was unaffected during
moderate hypoglycaemia, a significant deterioration was observed in the ability of
the subjects to detect differences in contrast (F=13.70, df 1,18, p<.005) (Fig.3.1.3).
This implies that visual dysfunction is demonstrable when the visual system is
stressed by symbols of low visual contrast (i.e. by degradation of the stimulus).
Visual information processing
Acute insulin-induced hypoglycaemia caused a significant and marked deterioration
in visual information processing ability (Table 3.1.1). Visual inspection time (IT)
for the study group increased (i.e. the presentation times required to discriminate
between the two arms of the stimulus were longer) during moderate hypoglycaemia
(F=8.35, df 1,18, p<.05) (Fig. 3.1.4). Hypoglycaemia resulted in an impaired ability
to detect visual change (F=13.34, df 1,17, p<.005) (Fig.3.1.5), and an impaired
ability to detect visual movement (F=14.19, df 1,17, p<0.005) (Fig.3.1.6). These
results indicate that moderate hypoglycaemia significantly disturbs the early stages
of visual information processing both for focused stimuli and for stimuli presented
in a wider visual field.
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The group's mean (±SEM) total score achieved during euglycaemia and
hypoglycaemia for each stimulus duration on the VCD and VMD tasks (Fig. 3.1.7
and Fig. 3.1.8), and for each level of difficulty on the contrast sensitivity task
(Fig.3.1.9) demonstrate a shift in the response curve along the x-axis during
hypoglycaemia; the steepness of the curve was not affected. This finding indicates
that hypoglycaemia raises detection thresholds in each of the visual information
processing tasks (Wilkins et al. 1988). A change in subjects' criterion (their
willingness to report a weak sensation) or neural 'noise' would be expected to alter
the steepness of the curve.
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Table 3.1.1. Visual information processing, visual acuity, and general cognitive
performance during baseline and study conditions.
EUGLYCAEMIC STUDY HYPOGLYCAEMIC STUDY
Baseline Euglycaemia Baseline Hypoglycaemia
(meanlSD) (mean±SD) (meanlSD) (meanlSD)
Inspection Time (ms) 51.5± 10.5 51.5±10.4 47.618.7 58.3114.4 p<05
Change Detection
(score)
39.6±4.4 41.45±6.2 39.713.6 38.315.6 p<.005
Movement Detection
(score)
55.5±3.6 56.412.6 55.313.5 52.715.0 p<.005
Contrast Sensitivity
(score)
40.6±5.6 41.516.2 40.816.5 38.216.3 p<.005
Visual Acuity-right 6/5 6/6+2 6/6+2 6/6+2 p=ns
Visual Acuity-left 6/6+2 6/6+2 6/6+2 6/6+2 p=ns
Near Point (cm) 10.6±2.3 10.912.4 10.912.5 11.712.7 p=ns
Reading Acuity-right
(cm)
11.4±2.4 11.512.3 12.012.4 11.912.5 p=ns
Reading Acuity-left
(cm)
11.4±2.4 11.411.9 12.212.1 12.112.6 p=ns
Stereopsis (score) 8.6±1.4 8.711.0 8.611.2 8.711.4 p=ns
DSS (score) 45.4±7.0 50.117.9 46.214.2 42.415.3 p<.001










































































































































































































The present study has demonstrated that controlled hypoglycaemia provokes
significant changes in visual information processing in a homogeneous group of
non-diabetic human subjects. The disruption in visual information processing was
accompanied by general cognitive dysfunction. Despite these effects, no changes in
standard measures of visual acuity were found during moderate hypoglycaemia.
However, visual dysfunction was detected when subjects were required to
discriminate between images of low visual contrast.
The response curves for the VCD, VMD and contrast sensitivity tasks (shown in
Figures 3.1.7-9) provide additional information on the effect of hypoglycaemia on
each of these visual information-processing tasks. In any forced choice task it is
essential to separate the willingness of an observer to report weak sensations (his
criterion) from his ability to detect them (his sensitivity). Characteristically a
change in sensitivity affects the x-positions of a response curve and changes in
criterion the steepness of the response curve. Wilkins et al. (1988) has examined this
aspect of the contrast sensitivity task in some detail. Rather than 'criterion' change,
any flattening of the psychometric curves' steepness in this study could be
interpreted as increased noisiness in decision making. Hypoglycaemia has been
shown in this study to disrupt cognitive function. It is therefore important to show
that hypoglycaemia per se has not lead to a change in the subjects' criterion as this
would influence our interpretation of the effects of hypoglycaemia on visual
information processing. Examination of the graphs ofmean score at each level of
difficulty on the VCD, VMD and contrast sensitivity tasks at euglycaemia and
hypoglycaemia shows clearly that it is the position of the response curve on the x-
axis which has changed as a result ofhypoglycaemia and not its steepness. This
means that hypoglycaemia has caused a true change in the subjects' sensitivity
during each of these visual information-processing tasks.
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The interpretation of the information processing tasks used in this study has been
derived from experimental psychology and psychophysics. This allows a more
detailed parsing of the cognitive dysfunction in hypoglycaemia than would be
possible with standard neuropsychological tests. The Inspection time, VCD and
VMD tasks are thought to measure the efficiency with which information in iconic
(sensory) memory is transferred to discrimination processes in working memory
(Deary et al. 1991; Phillips, 1974). If the early information processing tasks
described do reflect the time taken to make a single observation from the sensory
input, then it also seems likely that this measure will function as a basic factor
limiting perceptual and cognitive performance in general (Vickers and Smith, 1986).
Consistent with this hypothesis is the correlation between mental processing speed
and general mental ability, and the sensitivity ofmental processing speed to general
cognitive stresses. The present study has clearly demonstrated abnormalities in this
important early stage of visual information processing in a homogeneous group of
human subjects when the brain is stressed by controlled hypoglycaemia.
Hypoglycaemia is also a general cerebral stress and therefore it is possible that the
abnormalities in early visual information processing may reflect a more general
disruption in information processing. The disruption in this fundamental aspect of
cognition may have profound effects on the functioning of the human subject in
everyday life who is exposed to hypoglycaemia.
In the present study the information processing tasks have assessed the ability of
each subject to discriminate between stimuli within either a narrow (IT) or a broad
(VCD and VMD) attentional field. Both types of test were significantly disrupted by
moderate hypoglycaemia. The IT task is a simple two-choice discrimination task
with stimuli presented at differing speeds in a fixed location with no distracters,
whereas the VCD and VMD tasks incorporate a changing or moving stimulus,
respectively, within a broad field of 49 similar images, whilst also changing the
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stimulus presentation speed. It could be argued therefore, that it is information
processing speed per se that is disrupted during moderate hypoglycaemia
irrespective of the specificity of the attentional demands, or the complexity, of the
task.
The present study has also demonstrated a significant deterioration in contrast
sensitivity during moderate hypoglycaemia, but no changes in standard measures of
visual acuity. These results indicate that low-contrast test targets (where the image
is degraded) reveal visual irregularities that are not shown by high-contrast test
targets. In Parkinson's disease (Regan and Maxner, 1987) and multiple sclerosis
(Regan et al. 1980) abnormalities in contrast sensitivity have also been documented.
The disruption in contrast sensitivity in these conditions was orientation selective
and, as orientation sensitive neurones are only found in the visual cortex, the authors
suggested that these abnormalities might be due to a functional abnormality in the
striate cortex as opposed to the retina. In the present study there was a general
increase in the total score achieved on the contrast sensitivity task on the
euglycaemic study day (Fig.3.1.3). This practice effect also suggests the
involvement of higher cognitive processing in the contrast sensitivity task. Whilst
there are methodological differences preventing direct comparison of the present
study with that ofRegan and colleagues (1987) it is possible that the contrast
sensitivity task may not distinguish between abnormalities at the retina or of higher
cognitive processing.
Our results indicate that visual discrimination for standard clinical acuity tests is
unaffected by hypoglycaemia despite a concurrent disruption in cognitive
performance tasks. This is consistent with a previous study (Harrad et al. 1985).
Harrad et al. (1985) did demonstrate abnormalities of colour discrimination (a more
sensitive index ofmacular vision) during hypoglycaemia in a small number of type 1
diabetic and non-diabetic subjects. However, the hypoglycaemia was induced by
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intravenous bolus injection of insulin and was uncontrolled and often quite
profound. Furthermore, the group of type 1 diabetic subjects all had diabetic
retinopathy of various degrees. By contrast, Hardy et al. (1995) examined 10
aretinopathic type 1 diabetic subjects during controlled hypoglycaemia (2.5 mmol/1)
and found no significant changes in colour discrimination. Hypoglycaemia is a
general metabolic stress and it is probable that physiological changes within the
retinawill influence changes in higher visual pathways and vice versa. In the light
of these studies it is therefore important that any assessment of information
processing is conducted using high-contrast stimuli to minimise any subtle changes
in visual function at the retinal level.
The results of the present study have important practical and theoretical
implications. These results imply that if an examination of visual information
processing employs images of high contrast that are produced in aperceptually
unspeeded manner then abnormalities of visual processing will not be found during
moderate hypoglycaemia. However, if the stimulus is degraded by lowering contrast
and /or shortening its duration then abnormalities of visual processing will be
revealed. The important practical implications relate primarily to the type 1 diabetic
patient for whom real life decisions are most often made on the basis of information
provided under conditions of low contrast and short perceptual duration.
Abnormalities in driving performance during moderate hypoglycaemia have been
demonstrated (Cox et al. 1993), and our findings would suggest that these may stem
partially from a more basic disruption in information processing. The present
findings may also have implications for the employment of type 1 diabetic subjects
in other occupations which rely heavily on decision-making based on visual
information (e.g. air-traffic control, or commercial pilots, or drivers) who may be
exposed to intermittent hypoglycaemia of varying severity.
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In summary
At a blood glucose level of 2.6 mmol/1 significant disruptions in the early stages of
visual information processing can be demonstrated in non-diabetic individuals. The
disruption in visual information processing is accompanied by evidence of general
cognitive dysfunction. However, no changes in standard measures of visual acuity
were found during moderate hypoglycaemia although visual dysfunction was





Auditory information processing during acute hypoglycaemia
The effect of hypoglycaemia on psychometric aspects of auditory information
processing is also largely unexplored. In studies using neurophysiological
techniques it has been shown that reversible abnormalities in brain-stem auditory
evoked potentials (BAEPs) occur in non-diabetic (Jones et al. 1990) and type 1
diabetic subjects (Lingenfelser et al. 1993a; Ziegler et al. 1991) during
hypoglycaemia. Several groups have also shown changes in the auditory P300 wave
in response to 'odd-ball' tasks during hypoglycaemia (Jones et al. 1990; Kern et al.
1990; Tallroth et al. 1990; Ziegler et al. 1991), though this has not been a consistent
finding (Lindgren et al. 1996).
The Test ofBasic Auditory Capabilities (TBAC) (Watson et al. 1982) is a battery of
auditory discrimination tests which has been used extensively in auditory research,
especially that which has explored the relationships between auditory perception and
reading disabilities (Watson and Miller, 1993; Watson, 1992). The TBAC was
derived from the examination of a large number of subjects with normal hearing
(Watson et al. 1982). Analysis of 22 different tests suggested 8 subtests that best
described the major dimensions of auditory capability, and these 8 subtests were
grouped into three primary dimensions of auditory ability: simple auditory
discrimination, auditory temporal processing (non-verbal) and speech perception
(Johnson et al. 1987; Watson and Miller, 1993). The TBAC is also thought to
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provide an overall measure of the speed and efficiency of auditory information
processing (Watson and Miller, 1993). Performance on the TBAC is unaffected by
mid- or high-frequency hearing loss (Christopherson and Humews, 1992). The
psychometric properties of the TBAC and its test-retest reliability in normal and in
elderly hearing-impaired listeners have been validated (Christopherson and
Humews, 1992). The aim of the present study was therefore to examine the effect of
controlled hypoglycaemia on basic, validated aspects ofauditory information
processing in a homogeneous group of non-diabetic subjects.
Methods
Subjects
Twenty (15 male, 5 female) healthy non-diabetic human subjects were studied, who
were aged 27 (21 - 42) years (median (range)) and had a Body Mass Index of 23
(19-26) kg/m2. All of the subjects had above average intellectual ability as assessed
by the National Adult Reading Test and the Alice Heim 4 Test (standard
psychometric tests of intellectual ability). None of the subjects had any previous
medical history or a family history of diabetes, nor were they taking any regular
medication. None of the subjects had a history of hearing difficulties. Subjects were
recruited by local advertisement, and were not paid for their participation in the
study. Each subject was informed that they would be required to attend the
department on three separate occasions. On two of these occasions they would
undergo the experimental procedure during which either euglycaemia would be
maintained or hypoglycaemia induced. Although subjects knew that they would
undergo both study conditions, they were not informed as to which condition was
being performed on each study day. The study was approved by the Healthy
Volunteer Studies Medical Research Ethics Sub-Committee of the Lothian Medicine
and Oncology Ethical Advisory Committee, and written consent was obtained from
all of the subjects.
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Experimental procedure
All subjects undertook three laboratory sessions, each at least two weeks apart. The
initial visit was to familiarise the subjects with the tests that would be used during
the experimental conditions. During the familiarisation, subjects completed all of
the psychometric tests, the order and duration ofwhich were the same as that of the
experimental conditions. Familiarisation was used to help minimise practice effects
during the experimental sessions. The results from this session for each individual
were discarded. In the two subsequent visits to the laboratory the subjects underwent
a hyperinsulinaemic glucose clamp as described in Part II (pp 85-8).
Arterialised whole blood glucose concentration was stabilised initially at 5.0 mmol/1
(baseline phase) on both study days. In one study, hypoglycaemia (2.6 mmol/1) was
then induced and maintained for one hour, and in the other study the blood glucose
concentration was maintained throughout at 5.0 mmol/1 (euglycaemia). An interval
of 20 minutes was interposed between baseline and the hypoglycaemic or
euglycaemic phases to allow achievement of the new glycaemic level. Subjects were
not informed of their blood glucose level at any time during the laboratory sessions.
During each phase of the study (each baseline, euglycaemia and hypoglycaemia) the
subjects were asked to complete the test battery (see below). During each study
phase the blood glucose was stabilised for ten minutes at the target glycaemic level
before the assessment of information processing. The subjects underwent the
experimental conditions in a counterbalanced fashion (i.e. half the subjects




During each phase of the study (each baseline, euglycaemia and hypoglycaemia) the
subjects underwent tests of:




4 Temporal order for tones
Psychometric tests of general cognitive function
5 Digit Symbol Substitution test [DSS] (Wechsler, 1981).
6 Trail Making B test [TM-B] (Reitan and Davison, 1974).
Hypoglycaemia Symptoms
7 Edinburgh Hypoglycaemia Scale (Deary et al. 1993b).
The tests used in the battery are described in detail in Part II. Subjects completed the
tests in the same order during each study condition, and the battery took between 40-
45 minutes to complete.
Statistical analysis
The results were analysed independently for each measure ofauditory information
processing, test of general cognitive function, and symptom score. A mixed model
Analysis ofVariance (ANOVA) was used with order of session as a between-
subjects factor, with two levels (euglycaemia - hypoglycaemia or hypoglycaemia -
euglycaemia), and study condition as a within-subjects factor with two levels (
euglycaemia vs. hypoglycaemia). Test results at baseline were used as variable co-




The mean ± S.D blood glucose during the hypoglycaemia clamp was 2.6 (±0.2)
mmol/1, and 5.0 (±0.4) mmol/1 during the euglycaemia clamp (Fig.3.2.1). The
coefficient of variation in blood glucose was 0.6% and 0.7% for the euglycaemic and
hypoglycaemic clamps respectively. The initial statistical analysis revealed that no
significant order effects (asymmetrical transfer effects) had occurred for any of the
outcome variables in this study.
Symptoms
Significant increments in total autonomic symptom scores (F = 34.4, df 1,18, p<
.001) and in total neuroglycopenic symptom scores (F = 7.6, df 1, 18, p <.05) were
recorded during the hypoglycaemia condition of the study (Table.3.2.1). No
significant change occurred in symptoms ofhypoglycaemia-associated malaise (F =
.25, df 1, 18, p = ns).
General cognitive function
In the present study scores achieved on the DSS were significantly lower (F = 31.0,
df 1, 18, p< .001), and times taken to complete the TM-B were significantly longer
(F = 9.8, df 1, 18, p< .01) during hypoglycaemia when compared with euglycaemia
(Table.3.2.1). This confirmed that these standard measures of general cognitive
function were significantly affected at a blood glucose of 2.6 mmol/1.
Auditory information processing
The TBAC is designed to yield overall percent-scores of 75-90% in young adults
with normal hearing (Christopherson and Humews, 1992). It is recognised that
within the TBAC there will be intra- and inter-individual variation in performance
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on the tests. This is consistent with the existence of independent dimensions of
auditory capability (Johnson et al. 1987). In the present study subjects' overall
percent-correct scores (achieved by adding total scores for each subtest to provide an
overall percentage score for the test battery for each individual) on each of the study
days at baseline were: 85% (76-94%) (euglycaemia study), and 85% (75-93%)
(hypoglycaemia study); Spearman correlation = .86 (p<0.01). Individual
performances therefore, were stable across time, and consistent with previous studies
(Christopherson and Humews, 1992; Johnson et al. 1987).
Acute insulin-induced hypoglycaemia caused a significant deterioration in auditory
temporal processing, and in one of the three simple auditory processing tasks
(Table.3.2.1, Fig.3.2.2-5). The ability of the subject group to discriminate the
temporal order of two tones was impaired during moderate hypoglycaemia (F =
9.91, df 1, 18, p< .01) (Fig.3.2.2). Hypoglycaemia also provoked an impairment in
ability to discriminate the loudness of a single tone (F = 6.1, df 1, 18, p<.05)
(Fig.3.2.3). No significant change was noted in the subjects' ability to detect the
duration (F = 1.7, df 1, 18, p=ns) or pitch (F = .64, df 1, 18, p=ns) of a single tone
(Fig.3.2.4 and Fig.3.2.5).
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Table3.2.1. Measures of auditory information processing, general cognitive
performance, and hypoglycaemia symptoms during each study condition.
EUGLYCAEMIC STUDY HYPOGLYCAEMIC STUDY
Baseline Euglycaemia Baseline Hypoglycaemia
Temporal Order (score) 55.4 (7.5) 56.7 (6.5) 54.8 (7.9) 52.1 (7.7) p<0.01
Pitch Discrimination (score) 63.5 (4.6) 63.7 (3.9) 61.9 (5.1) 61.3 (4.8) p=ns
Single-tone Loudness (score) 65.9 (3.9) 64.6 (4.5) 66.5 (4.4) 62.7 (5.5) p<05
Single-tone Duration (score) 59.9 (4.5) 59.3 (4.9) 61.1 (3.9) 57.3 (5.7) p=ns
Digit Symbol (score) 69.9 (14.0) 73.2(14.6) 68.9(14.8) 66.1 (12.5) p<001
Trail Making B (sees) 30.5(13.4) 28.2(14.4) 31.4(15.7) 35.6(16.2) P<.01
Autonomic symptoms
(max score; 28)
8.5 (2.6) 7.8 (2.0) 8.4 (3.6) 14.2 (6.5) Pc.001
Neuroglycopenic symptoms
(max score; 35)
8.2 (3.4) 8.0 (5.0) 8.1 (4.7) 10.6 (5.7) p<.05






































































































The present study has demonstrated that moderate hypoglycaemia results in a
deterioration in specific aspects of basic auditory information processing in a
homogeneous group of non-diabetic human subjects. Impairments in auditory
temporal processing (non-verbal; temporal order discrimination), and in one of three
tests of simple auditory processing (single-tone loudness) have been demonstrated.
The impairment in auditory information processing was accompanied by a general
cognitive dysfunction. This would suggest that the central nervous system effects of
moderate hypoglycaemia are not limited to higher cortical areas and complex
cognitive tasks, but extend to more basic information processing functions.
One prominent account of auditory information processing considers there to be two
different types of auditory (or echoic) sensory memory; (a) an unanalysed short
auditory storage, and (b) a separate, longer memory of auditory information (Cowan,
1984). Short auditory storage refers to the initial recognition of the auditory
stimulus, prior to further analysis and retention. The auditory stimulus is therefore
experienced as a sensation rather than a memory. Experiments in psychophysics
have determined that short auditory storage applies to stimuli ofup to 350msec in
duration (the TBAC uses tones of up to 250 msec). The TBAC is a measure of short
auditory storage and as such examines one specific aspect of basic auditory
information processing. The TBAC also utilises information processing tasks,
which by manipulating stimulus duration, arguably provide an index of the speed at
which individuals are able to process auditory input. The present study therefore
reveals two important findings: (i) significant disruptions in short auditory storage
during acute insulin-induced hypoglycaemia, and (ii) that hypoglycaemia might slow
the speed at which the brain is able to process information provided by hearing.
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The present study uses tasks that are arguably very similar in nature to those used in
the previous study on the effect of acute hypoglycaemia on visual information
processing. In both studies the tasks used are information processing tasks which
index the stimulus duration required to make a simple discrimination from the
sensory input. Neither study involved speeded responses; in all the tasks discussed
the stimulus durations were manipulated and the correctness of the subjects'
decisions noted. It is possible that these tasks may be accessing, in addition to any
modality-specific performance, a sensory speed or efficiency factor which limits
perceptual and cognitive performance in general. There is a considerable body of
research on the relationships between sensory processing measures and performance
on higher cognitive ability tests, such as IQ-type tests. Significant correlations have
been found between traditional psychometric tests of intelligence and measures of
visual inspection time, simple and choice reaction time, speed of scanning
information in short term memory, speed of retrieval on information from long-term
memory, and pitch discrimination (Deary, 1994a; Eysenck, 1988; Vernon, 1983).
Furthermore, correlation's between auditory information processing and mental
ability are also well recognised in the scientific literature (Deary, 1994a; Deary,
1994b; Deary, 1995; Raz et al. 1983; Raz et al. 1987), and have been demonstrated
for overall-percent scores on the TBAC (Watson, 1992). Deary (Deary et al. 1991)
conducted a longitudinal study that suggested that efficiency of lower level auditory
processing is causal to later high-level cognitive ability differences. In a study by
Watson (1992), scores achieved on each of the 4 sub-tests of the TBAC used in the
present study correlated significantly with scores achieved on the mathematical
section of the Scholastic Aptitude Test (SAT). The importance of this research for
the present study is that individual deficits in low-level cognitive processing may
have widespread effects on cognitive performance.
Hypoglycaemia may be exerting its primary effect on other regions of the auditory
pathway such as the cochlear or auditory nerve. However, as far as we are aware
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there are no studies which show an effect of hypoglycaemia on standard measures of
hearing and those studies that have assessed neurophysiological aspects of the
auditory pathway have tended to show abnormalities in 'central' processing. Ziegler
and colleagues (1991) found that there was an increase in the inter-peak latency of
waves III - V and latency ofwave V at a blood glucose level of 1.7 mmol/1. The
latency ofwave I was unaffected. The authors suggested that this provided evidence
that hypoglycaemia induces a conduction delay in the central segments of the brain
stem (superior olivary complex to inferior colliculus) without auditory nerve
impairment (Ziegler et al. 1991). Jones et al. (1990) supported this finding when
they reported a decrease in the amplitude ofwave V ofBAEP in a small group of
non-diabetic subjects during hypoglycaemia (arterialised blood glucose 3.0 mmol/1).
This group have also demonstrated in an elegant experiment, using microelectrodes
implanted in the rat brain, that the peak V wave of the BAEP reflects activation of
the Inferior Colliculus, and that the predominant effect of hypoglycaemia appears to
occur in or near the Inferior Colliculus in this animal model (Weber et al. 1994).
Abnormalities in the auditory P300 wave have also been demonstrated both in type 1
diabetic and non-diabetic subjects during hypoglycaemia (Jones et al. 1990; Kern et
al. 1990; Tallroth et al. 1990).
Individual differences in the waveforms of event-related potentials (P200) have been
shown to correlate with performance on visual and auditory inspection time, and
pitch discrimination tasks (Caryl et al. 1995). Caryl and Harper (1996)
demonstrated, in a group of 35 undergraduate students, that differences in thresholds
and accuracy of responding on a visual inspection and a pitch discrimination task
were reflected in differences in the waveforms of event-related potentials (latency
and amplitude of the p300 wave). These two groups of evidence (the effect of
hypoglycaemia on neurophysiological measures and the relationship between
psychometric measures of information processing and event-related potentials), and
the finding of the present study that hypoglycaemia has an effect on psychometric
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measures of information processing (i.e. that both psychometric tests and
neurophysiological measures point to the same sort of variance) indicate that both
techniques should be incorporated in future study design to more clearly describe the
effects ofhypoglycaemia on basic sensory processing.
In the present study hypoglycaemia led to a disruption in performance on only one
of the 'simple' auditory discrimination tasks [though there is a tendency towards a
poorer performance on the single-tone duration task during hypoglycaemia
(Fig.3.2.4)]. This finding may reflect differences in threshold amongst these
auditory performance tasks during hypoglycaemia. It is recognised that different
cognitive performance tasks often show different thresholds for disruption during
hypoglycaemia, though this finding has to date been limited to tasks which are non¬
specific in nature (Deary, 1993). It is possible that hypoglycaemia of a slightly
greater degree would have had a more widespread effect on of auditory information
processing.
The results of the present study have theoretical and practical implications. Further
evidence is provided about the importance of sensory processing speed to perceptual
and cognitive performance in general, and of its sensitivity to mild cerebral stresses.
The important practical implications relate primarily to the type 1 diabetic person
who is frequently exposed to hypoglycaemia of varying severity as a side-effect of
treatment. The demonstration of significant, though small changes in aspects of
auditory discrimination may have implications for those type 1 diabetic individuals




At a blood glucose level of 2.6 mmol/1 significant disruptions in some aspects of the
early stages of auditory information processing can be demonstrated in non-diabetic
individuals. This specific disruption in auditory information processing is




Anger-state during acute insulin-induced hypoglycaemia
The literature on the effects of hypoglycaemia on mood and other non-cognitive
aspects of behaviour in human subjects is sparse (Gold et al. 1997). This information
is of considerable practical as well as theoretical importance. Negative mood states
and behavioural change can have an adverse effect upon an individual's social and
work relationships, and may explain why the achievement of good glycaemic control
is so difficult in some individuals with type 1 diabetes.
The relationship between mood and blood glucose concentrations is idiosyncratic
(Gonder-Frederick et al. 1989). However, recent work has demonstrated that certain
characteristic mood changes occur during experimental hypoglycaemia in both the
non-diabetic (Gold et al. 1997; Gold et al. 1995c; Hepburn et al. 1995) and type 1
diabetic subjects (Weinger et al. 1995; Hepburn et al. 1995). Hypoglycaemia results,
in general, in the expression of negative mood states (Gold et al. 1997; Hepburn et
al. 1996; Hepburn et al. 1995; Gold et al. 1995c; Gonder-Frederick et al. 1989). The
negative mood-state anger, as an expression of hypoglycaemia, is recognised, but
equally poorly studied. There are reports of irrational and aggressive behaviour in
insulin-treated subjects during hypoglycaemia (Adlersberg and Dolger, 1938; Maher
and Frier, 1993). In the 1970's there was considerable interest in the relationship
between 'reactive hypoglycaemia' and aggression. It was proposed that certain
individuals responded to the sugar content in a meal by the overproduction of insulin
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to such an extent that several hours after a meal 'rebound hypoglycaemia' occurred.
Some investigators found that reactive hypoglycaemia occurred with a greater
frequency in subjects with a violent background (Bolton, 1973; Bolton, 1976;
Virkkunen, 1982; Virkkunen, 1986; Virkkunen and Huttenen, 1982). Benton and
colleagues (1982) gave a glucose tolerance test to a group ofmales with no past
history of violent and anti-social behaviour, and observed a relationship between the
tendency of the blood glucose to fall and scores on several questionnaire measures of
aggression. The relevance of these findings has been questioned because, as Benton
(1988) himselfhas pointed out, the glucose tolerance test is an unphysiological
technique which creates a model for hypoglycaemia that will rarely be encountered
by most normal individuals. Studies using the oral glucose tolerance test are also
complicated by the fact that individuals are subjected to different absolute levels of
blood glucose (a measure of the rate ofchange in blood glucose has been used in
most studies as a means to compare individuals rather than the nadir of blood
glucose), and the glucose concentration is estimated from capillary blood which does
not provide a true reflection of the blood glucose to which the brain is being
exposed. Furthermore, as no measures of the classical symptoms of hypoglycaemia
(Deary et al. 1993b) were taken, it is difficult to ascertain how many of the subjects
were actually 'experiencing' hypoglycaemia. In addition, in all of the studies, except
that by Benton and colleagues (1982), a relationship between glucose tolerance test
abnormalities and aprevious history of violent or antisocial behaviour was observed,
rather than with measures of aggression taken during the test itself. However,
Benton (1988) also argued that, as all of the studies had been very consistent in their
findings, they should not be dismissed prematurely, and that "studies should be
carried out in which the blood glucose is manipulated and aggression monitored".
That is what is done in the present study.
The aim of the present study was to examine the effect of insulin-induced
hypoglycaemia on anger-state in non-diabetic human subjects. Anger-state, -trait,
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and -expression were assessed using a well validated questionnaire for which
normative data are available for more than 9000 subjects (Spielberger, 1991).
Methods
Subjects
A total of 18 subjects were studied: 18 (14 male, 4 female) healthy non-diabetic
human subjects ofmean (SD) age 27 (8) years. Subjects were recruited by local
advertisement, and were not paid for their participation in the study. The study was
approved by the Healthy Volunteer Studies Medical Research Ethics Sub-
Committee of the Lothian Medicine and Oncology Ethical Advisory Committee.
Written consent was obtained from all of the subjects.
Study design
Subjects were asked to attend the laboratory three times, each at least two weeks
apart. During the initial visit subjects completed a questionnaire that assessed anger-
trait and anger expression (Part II; pp 96-97). In the two subsequent visits to the
laboratory the subjects underwent a modified hyperinsulinaemic glucose clamp
procedure (DeFronzo et al. 1979). In one condition, hypoglycaemia (2.6 mmol/1)
was induced and maintained for one hour, and in the other condition the blood
glucose concentration was maintained throughout at 5.0 mmol/1 (euglycaemia).
During the two study conditions (euglycaemia and hypoglycaemia) subjects
completed a questionnaire which assessed anger-state, and a questionnaire assessing
symptoms ofhypoglycaemia. Subjects were not informed of their blood glucose




The details of the hyperinsulinaemic glucose clamp technique are given in Part II (pp
85-88).
Test Battery:
(a) Measures taken prior to clamp studies:
Anger-Trait (Spielberger, 1991)
Anger-Expression (Spielberger, 1991)
(b) Measures taken during clamp studies:
Anger-State (Spielberger, 1991)
Hypoglycaemia Symptoms - Edinburgh Hypoglycaemia Scale (Deary et al. 1993b).
Statistical analysis
Results are expressed as median (range) or as mean (± S.D.), as appropriate. A non-
parametric Mann-Whitney U test was used initially to examine for order effects. No
order effects were noted for any of the variables in the study. The Wilcoxon
matched pairs test was used to compare state measures during each condition
(hypoglycaemia and euglycaemia). Correlation analyses were performed using
Pearson's Correlation or Kendall's tau-b as appropriate. Statistical analysis was




Stable blood glucose plateau's were achieved during each study. The mean (± S.D)
blood glucose during the hypoglycaemic clamp was 2.6 (±0.2) mmol/1, and 5.0
(±0.4) mmol/1 during the euglycaemic clamp.
Symptom scores for the subject group as a whole increased significantly as predicted
during hypoglycaemia. The mean (SD) autonomic symptom score during the
euglycaemic condition was 11 (4) and during the hypoglycaemic condition was 19
(10) (p <0.05). Similarly, the mean (SD) neuroglycopenic symptom score during the
euglycaemic condition was 14 (9) and during the hypoglycaemic condition was 20
(13) (p <0.05). (The lowest possible autonomic and neuroglycopenic symptom
scores were 4 and 5 respectively).
Group mean and standard deviation scores on each of the measures of anger-trait and
anger-expression (Table.3.3.1) fall within the expected normal range for this age
group (Spielberger, 1991).
Anger-state scores during euglycaemic and hypoglycaemic conditions are shown in
Table 3.3.1. There was an increase in reported anger-state from a median (range)
score of 10 (10-13) during euglycaemia to 11(10-27) during hypoglycaemia. This
increase in anger-state was significant: z = -2.9; p< 0.005.
To explore possible relationships underlying the observed effect of hypoglycaemia
on anger-state, a correlational analysis was performed between the residuals
obtained from regressing anger-state scores reported during hypoglycaemia against
those reported during euglycaemia and the separate measures of anger-trait and
anger-expression. Because of the number of tied ranks and relatively small n,
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Kendall's tau-b was chosen. No significant correlation's were found between the
residuals obtained and the measures of anger-trait and anger-expression.
A final correlational analysis was performed between an individual's change in
anger-state, and the change in autonomic and neuroglycopenic symptom scores
between the two study conditions. The correlation's between the change in anger-
state and change in autonomic symptoms and neuroglycopenic symptoms were: r =
0.13 (p=0.39) and r - 0.23 (p=0.12) respectively. However, the correlation between
autonomic and neuroglycopenic symptom change was highly significant: r = 0.77,
p<0.001. This implies that the change in anger-state showed no significant
association with an individual's symptomatic experience of hypoglycaemia.
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Reported measures of anger-state during study conditions, measures of anger-
expression and anger-trait taken during familiarisation session, and normative data
for the STAXI (normal male values are given because most of the subjects in this
study were male but they do not differ substantially from normal females). * =
p<0.05 hypoglycaemia vs. euglycaemia.
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Discussion
This is the first study to examine the effects of hypoglycaemia on anger-state under
controlled experimental conditions using a validated measure of anger-state.
Hypoglycaemia has been shown to induce an overall increase in anger-state in non-
diabetic individuals under stable laboratory conditions. The change in anger-state
could not be predicted from measures of anger-trait or anger-expression, nor did it
relate to the intensity of the symptomatic experience ofhypoglycaemia.
The findings of this study lend weight to the argument that the relationship between
hypoglycaemia and anger has been prematurely dismissed (Benton, 1988). The
problem that had been encountered in the interpretation of studies such as that by
Benton et al. (1982) is that the use of the glucose tolerance test can lead only to the
finding of a correlation between a non-physiological test and a questionnaire
measure of aggression. The intrinsic difficulties of interpreting a correlational
analysis are well known. Using the hyperinsulinaemic glucose clamp technique
enables one to manipulate the blood glucose in a controlled manner whilst at the
same time measuring individual responses in terms of anger experienced during this
altered physiological state. A small, but significant, increase in median anger-state
score during moderate hypoglycaemia was demonstrated. Although the increase in
anger-state was small it is important to note that the study was carried out in a non-
confrontational laboratory setting that would be unlikely to stimulate the expression
of anger in the form of aggressive behaviour. Despite this, a marked increase in
state-anger was observed in some individuals, and a slight increase in most others. It
is possible that the increase in anger shown by some individuals during
hypoglycaemia may lead to aggressive behaviour depending on provocation or other
aspects of the situation. The present studies findings may provide some explanation
for those rare circumstance where hypoglycaemia has occasionally resulted in very
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aggressive behaviour (Maher and Frier, 1993). The few subjects who had large rises
in anger during hypoglycaemia are ofparticular interest, and this type of individual
warrants further study.
It remains possible that the relationship between blood glucose levels and aggressive
behaviour share a common mechanism but that they are not causally related. For
instance, individuals who experience a more profound physiological stimulus during
hypoglycaemia may be more likely to show a change in anger-state (i.e. those
individuals who experience more intense autonomic symptoms [reflecting the
catecholamine response to hypoglycaemia] or neuroglycopenic symptoms [reflecting
low blood glucose to the brain] during hypoglycaemia may show aggression because
of the symptoms they are experiencing rather than because of the blood glucose level
per se). However, no association was found in the present study between either the
autonomic or the neuroglycopenic symptoms as experienced by the subjects and the
change in anger-state. On the other hand, the change in autonomic and
neuroglycopenic symptom scores between study conditions was highly correlated.
This suggests that the factors, which determine an individual's anger-state during
hypoglycaemia, are independent of those that result in symptom generation. Some
support for this come from a recent study by Merbis et al. (1996) of type 1 diabetic
subjects with unawareness of hypoglycaemia (i.e. loss of the classical autonomic
warning symptoms of hypoglycaemia) where an overall tendency to a more negative
mood-state and to increased feelings of anger were reported by subjects despite an
impaired symptomatic response to hypoglycaemia. The counterregulatory hormones
released during hypoglycaemia were not measured in the present study (e.g.
adrenaline, noradrenaline, and glucagon) and so an analysis for correlation's
between the hormonal response and anger-state was not possible. It is possible that
the change in anger-state results from an effect of these hormones on the brain,
although the symptom data from the present study, and the findings ofMerbis et al.
(1996), would not be consistent with this.
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It is also possible that high insulin levels may have modified the expression of anger
during hypoglycaemia. The model used to induce hypoglycaemia requires a
supraphysiological dose of insulin to overcome the body's natural defence
mechanisms against hypoglycaemia. By including a hyperinsulinaemic euglycaemic
control condition this effect is at least partially controlled for, but this does not
exclude a possible effect of insulin on mood that is specific to the hypoglycaemic
state.
The subjects in this study were predominantly male which may have affected the
reported findings. Normative data from the STAXI suggests that females generally
report a greater baseline anger-state score than males, although this is reversed in the
sub-group of subjects who were college students (Spielberger, 1991). The size of the
study group in this analysis is too small to permit any examination of sex differences
in response to hypoglycaemia.
In summary: -
The present study has shown a significant overall increase in anger-state during
hypoglycaemia in a group of non-diabetic human subjects, whose self-reported
measures of anger-trait and anger-expression fall well within the expected normal
distribution. Hypoglycaemia-associated anger may adversely effect an individual's
social and work relationships and may explain why some type 1 diabetic individuals
refuse to be aided in the treatment ofhypoglycaemia as it occurs. Future research





Mood, appraisal and personality during acute hypoglycaemia.
The use of controlled hypoglycaemia as a biological tool for studying mood-state
was first reported by Gold et al. (1995c). In their study the UWIST Mood Adjective
Check List (Matthews et al. 1990) was administered to 24 non-diabetic subjects
during hypoglycaemic and euglycaemic steady states using a repeated measures
design. In comparison with normoglycaemia, hypoglycaemia induced a mood-state
termed 'tense-tiredness', characterised by an increase in tense arousal (a measure of
anxiety-calmness), a decrease in energetic arousal (a measure of subjective energy),
and a decrease in hedonic tone (a measure of happiness-sadness). Other studies have
confirmed in a less controlled manner the association of hypoglycaemia with
negative mood states (Gonder-Frederick et al. 1989; Hepburn et al. 1995). Thayer
(1989) had previously postulated that mood might consist of two principal
components, tense arousal and energetic arousal, which could respond in opposite
directions to produce a state of tense tiredness. The state of tense-tiredness had been
implicated in the development of certain clinical states such as depression. Thayer
(1989) indicated that there was a need to develop methods of inducing this mood
state to validate the notion ofmultiple arousal systems underlying subjective reports
ofmood, suggesting that "tension, energy, and the associated conditions of
physiological arousal might seem as variations of the same psychophysiological
condition, perhaps differentiated only in terms of subjective labelling" (p.54). The
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study by Gold et al. (1995c) demonstrated that acute hypoglycaemia could evoke the
theoretically important mood state of tense-tiredness, and lent support to Thayer's
(1989) original hypothesis. Furthermore, support was also provided for the validity
of the non-orthogonal three-dimensional structure ofmood proposed by Matthews et
al. (1990).
The association between acute hypoglycaemia and negative mood states has now
been replicated using different models of experimental hypoglycaemia (Gold et al.
1995c, Hepburn et al. 1995). It is of value now to extend this research further by
examining the more cognitive aspects of the emotional changes, in particular
appraisal, during hypoglycaemia. An appraisal is a subjective or objective rating of a
life event, usually in terms of its degree of unpleasantness, changeability or control
(Lazarus and Folkman, 1984). In this context, a life event is a 'major' event that
impacts on an individual in either a positive or negative way (Holmes and Rahe,
1967). Lazarus and Folkman (1984) proposed that there are two principal types of
appraisal process: primary and secondary appraisals. Primary appraisals describe
how a person evaluates the nature and meaning of a particular event in relation to
their well-being, whilst secondary appraisals rely on an individual's knowledge in
determining how best to cope during a particular event (Lazarus and Smith, 1988).
During primary appraisal a situation's potential stressfulness is assessed either in
terms of emotional outcomes or as an evaluation of a situation (i.e. 'I was...' versus
'It was...'). This is called psychological and situational reasoning, respectively
(Locke and Pennington, 1982). Cox and Ferguson (1991) have proposed that
situational reasoning is a more theoretically sound method for the evaluation of
primary appraisals. More recently, Ferguson and colleagues (Ferguson et al. 1997;
Ferguson and Cox, 1993; Ferguson et al. 1998) have developed a psychometric
questionnaire of primary appraisal (the Appraisal ofLife Events scale [ALE]) from
current theories of appraisal and previous empirical work. The authors have
proposed a model ofprimary appraisal, which consists of three, non-orthogonal
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dimensions: 'threat', 'loss' and 'challenge'. Challenge in this context refers to the
degree to which the environment is perceived as allowing for personal growth and
development (e.g. 'stimulating', 'enjoyable '). Threat indicates the degree to which
the environment is appraised as being potentially threatening, physically harmful,
and generating anxiety (e.g. 'hostile', 'worrying'). Loss refers to the potential for
personal suffering. The ALE has been shown to good construct validity, internal
reliability and high test-retest reliability (Ferguson et al. 1997; Ferguson and Cox,
1993; Ferguson et al. 1998). Thayer (1989) has proposed that individuals should
show more negative appraisals and negative cognitions during tense tiredness. Our
hypothesis was that hypoglycaemia, through its induction of the negative mood state
tense-tiredness, would lead to participants' giving more negative appraisals of a life
event. Thus, the study was designed to examine the effects of a controlled
physiological change on the life difficulty appraisal process.
Methods
Subjects
Twenty (15 male, 5 female) healthy, non-diabetic human subjects aged 27 (21 - 42)
years (median [range]) were studied. The subjects did not have any significant
medical history or a family history of diabetes, nor were they taking any regular
medication other than the oral contraceptive pill. Subjects were recruited by local
advertisement, and were not paid for their participation in the study. The study was
approved by the Healthy Volunteer Studies Medical Research Ethics Sub-
Committee of the Lothian Medicine and Oncology Ethical Advisory Committee, and
written consent was obtained from all of the subjects.
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Procedure
All participants undertook two laboratory sessions, each at least two weeks apart, in
which experimental euglycaemia was either; (i) established and maintained or (ii)
hypoglycaemia then induced. Although subjects knew that they would undergo both
study conditions, they were not informed which condition was being performed on
each study day. A modified hyperinsulinaemic glucose clamp technique was used to
achieve the experimental conditions of hypo- and euglycaemia (DeFronzo et al.
1979).
In this study arterialised whole blood glucose concentration was stabilised initially at
5.0 mmol/1 for one hour for both conditions. In one condition, hypoglycaemia (2.6
mmol/1) was then induced and maintained for one hour, and in the other condition
the blood glucose concentration was maintained throughout at 5.0 mmol/1
(normoglycaemia). An interval of 30 minutes was interposed between baseline and
each study condition to allow for the time required to achieve hypoglycaemia.
Subjects were not informed of their blood glucose level at any time during the
laboratory sessions. The subjects underwent the experimental conditions in a
counterbalanced fashion (i.e. half the subjects underwent hypoglycaemia first
followed by the normoglycaemic control condition, and half the reverse).
As subjects were recruited by local advertisement our study cohort consisted entirely
of health professionals (17 doctors, 2 nurses, 1 dietician). All of our subjects were
post-graduates, but none had achieved their final career post. Health professionals
are in a highly competitive working environment at this stage in their careers,
because of the limited number of senior posts. This may also mean that a health
professional may have to move to different regions in the country in order to obtain a
more senior post, which disrupts working and personal relationships. Because of the
considerable stress involved in the progress of their career, we decided to ask
subjects to appraise their career prospects during each of the study conditions.
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Participants then completed the ALE questionnaire with respect to the challenge,
threat and loss induced by this subject.
Test Battery:
(A) Patients completed four self-report questionnaires:
1. Edinburgh Hypoglycaemia Scale (Deary et al. 1993b).
2. UWIST Mood Adjective Check-list [UMACL] (Matthews et al. 1990).
3. Appraisal of Life Events Scale [ALE] (Ferguson et al. 1997; Ferguson and
Cox, 1993; Ferguson et al. 1998)).
4. Eysenck Personality Questionnaire-Revised, Short Form [EPQ-R]
(Eysenck et al. 1985).
(B) Psychometric tests of general cognitive function
5. Digit Symbol (DSS) (Wechsler, 1981).
6. Trail Making Test B (TM-B) (Reitan and Davison, 1974)
The EHS and measures of cognitive function (DSS and TMB tests) were used to
establish that, at the predetermined level of hypoglycaemia (2.6 mmol/1), significant
symptomatic and cognitive change had occurred in our study cohort, i.e. significant
neuroglycopenia had been established. The UMACL was applied to compare mood-
state between study conditions and in an attempt to replicate previous findings (Gold
et al. 1995c). The EPQ-R was used to establish whether self-reports of the major
personality dimensions remained stable between the two physiological states
because of the recognised influences of personality on both appraisal and emotion
(Wells and Matthews, 1994). The expectation was that mood and appraisal would
alter negatively during the hypoglycaemic condition, but that subjects' self-reports
of long-standing personality levels would not.
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Statistical analysis
The results were analysed independently for each test of general cognitive function
and for each measure of symptom score, mood, personality and appraisal. For those
measures taken at baseline(s) and during study conditions (normoglycaemia and
hypoglycaemia) a mixed model Analysis of covariance (ANCOVA) was used with
order of session as a between-subjects factor, with two levels (normoglycaemia -
hypoglycaemia or hypoglycaemia - normoglycaemia), and study condition as a
within-subjects factor with two levels (normoglycaemia vs. hypoglycaemia). Test
results at baseline were used as variable covariates in each analysis. For those
measures taken during study conditions only, the Wilcoxon matched-pairs signed
ranks test was used to compare study conditions and a Mann-Whitney used to
examine for order effects. Correlation's between study conditions were performed
using the Spearman's Rank Order test. An alpha level of 0.05 was used for all
statistical tests.




The mean (± S.D) blood glucose during the hypoglycaemic clamp was 2.6 (±0.2)
mmol/1, and 5.0 (±0.4) mmol/1 during the euglycaemic clamp, showing that stable
glycaemic plateau's had been achieved.
Symptoms
Significant increments in total autonomic symptom scores (F = 34.4, df 1,18, p<
.001) and in total neuroglycopenic symptom scores (F = 7.6, df 1, 18, p <.05) were
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recorded during the hypoglycaemia condition of the study (Table.3.4.1). No
significant change occurred in symptoms of hypoglycaemia-associated malaise (F =
.25, df 1, 18, p = ns). The significant increases in neuroglycopenic and autonomic
symptom reports confirm that the subject group was symptomatically aware of
hypoglycaemia at the predetermined blood glucose level, and more specifically were
experiencing neuroglycopenia.
General cognitive function
In the present study, scores achieved on the DSS were significantly lower (F = 31.0,
df 1, 18, p< .001), and times taken to complete the TM-B were significantly longer
(F = 9.8, df 1, 18, p< .01) during hypoglycaemia when compared with
normoglycaemia (Table.4.3.1). This confirmed, as expected, that these standard
measures of general cognitive function were significantly affected at a blood glucose
of 2.6 mmol/1 indicating that neuroglycopenia sufficient to impair brain functioning
had been established.
Personality
Table 3.4.1. shows scores recorded on each of the personality dimensions during
each of the study conditions. Overall mean (S.D.) score for neuroticism during
normoglycaemia was 3.4 (3.0), and during hypoglycaemia was 3.4 (3.0), which were
not significantly different (z = - 0.52, p = 0.60). Overall mean (S.D.) score for
extraversion during normoglycaemia was 7.7 (3.5), and during hypoglycaemia was
7.7 (3.5); (z = - 0.09, p = 0.92). Mean (S.D.) score for psychoticism during
normoglycaemia was 2.6 (1.6), and during hypoglycaemia was 3.0 (1.9); (z = - 1.4, p
= 0.16). These results indicate that subjects' reports ofpersonality dimensions
remain stable between the two physiological states. A Spearman's Rank Order
Correlation was performed to assess whether this stability in personality dimensions
also held true for individual subjects (i.e. whether stability of group means obscured
considerable variability in individual responses to the hypoglycaemia condition).
157
Spearman's rs for extraversion, neuroticism and psychoticism personality traits were
0.76 (p <0.001), 0.58 (p <0.05), and 0.74 (p <0.001) respectively. These results
indicate that individual personality dimensions also remained reasonably constant
between study conditions.
Mood
The hypoglycaemic condition evoked a negative mood state and produced a clear
separation of the three dimensions ofmood (Table.3.4.1). Measures of hedonic tone
significantly decreased during the hypoglycaemic condition (F = 21.2, df 1,18,
p<0.01), whereas measures of tense arousal significantly increased (F = 41.2, df
1,18, p<0.01). Energetic arousal did not alter significantly during hypoglycaemia (F
= 1.4, df 1,18, p=0.25).
This result confirms the previous finding of the separation of each of the three mood
dimensions during hypoglycaemia, although the lack of a significant change in
energetic arousal was unexpected (Gold et al. 1995c). In this experiment
hypoglycaemia has induced a negative mood state characterised by increased tension
and decreased happiness, but has had no significant effect on subjective energy.
Appraisal
The results of the subjects' appraisal of their career under the two study conditions
are shown in Table 3.4.1. The mean (S.D.) score on the challenge sub-scale during
normoglycaemia was 20.2 (5.2), and during hypoglycaemia was 17.8 (6.0), which
were significantly different (z = - 2.05, p = 0.04). Mean (S.D.) score on the threat
sub-scale during normoglycaemia was 9.3 (5.3), and during hypoglycaemia was 12.1
(4.9); (z = - 2.73, p=0.006). Mean (S.D.) score on the loss sub-scale during
normoglycaemia was 3.0 (2.2), and during hypoglycaemia was 5.1 (3.7); (z = - 2.76,
p = 0.006). Spearman's rank order correlation was performed on individual scores
on each subset of the ALE between study conditions. Spearman's rs for Challenge,
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Threat and Loss were 0.53 (p <0.05), 0.74 (p <0.001), and 0.68 (p <0.005)
respectively.
These analyses indicate that, for this group of subjects, the physiological state of
hypoglycaemia, in comparison with normoglycaemia, has evoked significantly more
negative appraisals of a life problem. They also show that this group effect does not
obscure significant individual variation in response to the study condition.
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Table 3.4.1
Measures of general cognitive performance, hypoglycaemia symptoms, personality,
mood and appraisal. Values are shown as mean (standard deviation).
EUGLYCAEMIC STUDY HYPOGLYCAEMIC STUDY
Baseline Euglycaemia Baseline Hypoglycaemia
DSS (score) 69.9(14.0) 73.2(14.6) 68.9(14.8) 66.1(12.5) p<.05
TM-B (sees) 30.5(13.4) 28.2(14.4) 31.35(15.7
)
35.6(16.2) p<.05
Autonomic 8.5(2.6) 7.8(2.0) 8.4(3.6) 14.2(6.5) p<.05
Neuroglycope
nic
8.2(3.4) 8.0(5.0) 8.1(4.7) 10.6(5.7) p<.05
Neuroticism 3.4(3.0) 3.4(3.0) p=ns
Extraversion 7.7(3.5) 7.7(3.5) p=ns
Psychoticism 2.6(1.6) 3.0(1.9) p=ns
Tense Arousal 13.7(4.5) 13.6(4.7) 15.5(5.2) 22.6(4.4) p<.05
Hedonic Tone 25.8(3.6) 26.8(2.7) 26.2(4.4) 22.8(4.3) p<.05
Energetic
Arousal
17.4(5.2) 16.8(4.6) 16.8(5.1) 18.2(4.4) p=ns
Challenge 20.2(5.2) 17.8(6.0) p<.05
Threat 9.3(5.3) 12.1(4.9) p<.05
Loss 3.0(2.1) 5.1(3.7) p<.05
160
Discussion
The present study has demonstrated that, during controlled hypoglycaemia, a
specific life problem may be viewed significantly more negatively. The professional
careers of this group of health care workers were subjectively appraised as less
challenging, as potentially more likely to generate anxiety and threat, and more
likely to entail personal loss while the subjects were in a state of hypoglycaemia.
The present study also lends support to the hypothesis that hypoglycaemia, through
its evocation of a negative mood state, would lead to more negative appraisals of a
life event. Furthermore, it has been demonstrated that personality trait levels are
preserved during experimental hypoglycaemia, and are not altered by the induction
of a negative mood and appraisal state.
The direction of change observed in each of the ALE sub-scales during
hypoglycaemia provides useful information to the debate concerning the nature of
the relationship between mood and emotion. Some authors have suggested that
feelings of stress should be positively correlated to appraisal of threat, loss and
challenge (Lazarus and Folkman, 1984), whereas others have suggested that feelings
of stress should only be related to threat and loss appraisals (Dienstbier, 1989).
Ferguson et al. (1997) have examined the relationship between mood and situational
appraisal in a study of 71 blood donors. The Stress-Arousal Checklist (SACL) (Cox
and Mackay, 1985) and the ALE were applied to the subjects who were asked about
their perceptions and feelings about blood donation. The SACL assesses mood along
two orthogonal dimensions: stress and arousal. A high score on the stress dimension
indicates feelings of unpleasantness and high scores on the arousal scale indicate
feelings of being alert and awake. Ferguson, Matthews, and Cox (Ferguson et al.
1998) found that in blood donors stress was positively correlated with negative
appraisals (threat and loss) and not with challenge. Challenge was positively
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associated with arousal. The findings of the present study, and those of Ferguson,
Matthews, and Cox (1998), would tend to support the hypothesis ofDienstber
(1989) and suggest that stress can have both positive and negative aspects.
In the present study hypoglycaemia has produced a negative mood state
characterised by increased tension and decreased happiness. Unlike previous work
(Gold et al. 1995c) no change in the subjects' energetic arousal was seen. This
finding is surprising because one would intuitively expect neuroglycopenia, which is
ordinarily associated with drowsiness and low cortical arousal, to cause a decrease in
energetic arousal, and indeed this was the finding in previous work using the same
model (Gold et al. 1995c). It is recognised that there is considerable inter-individual
variability in cognitive (Gonder-Frederick et al. 1994) and mood (Gonder-Frederick
et al. 1989) changes during hypoglycaemia. Moreover, the thresholds (blood glucose
level) at which autonomic and neuroglycopenic symptoms develop, and cognitive
function deteriorates, during experimental hypoglycaemia also show inter-individual
variability (Gonder-Frederick et al. 1994). In this regard, it is interesting to note that
the group examined by Gold et al. (1995c) showed a much greater increase in
neuroglycopenic scores than the present study group during the same degree of
hypoglycaemia. The participants in this study completed the UMACL towards the
end of the 60 minute clamp period which would compare with the third time points
in the two hypoglycaemic conditions used in the study by Gold et al. (1995c). At this
time point Gold et al (1995c) reported a doubling in reported neuroglycopenia
symptoms from baseline (p<0.001), whereas an increase in neuroglycopenic
symptoms of= 25% only (p<0.05) was noted in the present study. Furthermore,
because mood and symptoms were assessed at multiple time points they were able to
show that energetic arousal fell progressively through the 60 minutes of the
hypoglycaemic clamp and that this was matched by a continuing rise in
neuroglycopenic symptoms. The authors suggested that the different time courses
shown by the three dimensions ofmood might indicate different biological factors
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were involved in their genesis. The present study could therefore been seen as
providing further evidence of the centrality of cortical arousal to the generation of
the mood state of energetic arousal, and of the existence of different arousal systems.
It is also clear that, during controlled hypoglycaemia, both the degree and duration
ofhypoglycaemia affect mood-states and this should be taken into consideration in
future research in this area.
The present study has provided further evidence of the usefulness of controlled
hypoglycaemia as a model for manipulating stress and emotion in human subjects.
Hypoglycaemia has been shown to produce negative mood states and associated
negative appraisals and this might allow for future study into the biological bases of
mood, and the effect of pharmacological interventions. Despite the absence of a
change in energetic arousal the present study still found more negative appraisals
during hypoglycaemia which suggests that changes in tense arousal and hedonic tone
might be more important influences on primary appraisal.
In summary: -
These findings add to the expanding literature on the non-cognitive psychological
effects of acute hypoglycaemia. It is now quite clear that acute hypoglycaemia can
evoke negative stresses and emotions in human subjects which may have an adverse
influence on an individuals social and work interactions. In particular, the present
findings show that, in non-diabetic subjects, acute hypoglycaemia induces a negative
mood state that leads to more negative appraisals of life events. Type 1 diabetic
subjects may not show such negative appraisals during hypoglycaemia because of
prior experience of the hypoglycaemic state or other factors related specifically to
the diabetes per se. However, type 1 diabetic subjects also show a tendency towards
negative mood states during acute hypoglycaemia (Gonder-Frederick et al. 1989)
and as such it appears likely that they might report similar negative appraisals.
Future studies should be directed at examining the interaction between negative
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stresses and emotions during acute hypoglycaemia in type 1 diabetic subjects and





A comparison of the symptoms of hypoglycaemia induced by the
one-step hyperinsulinaemic glucose clamp and the insulin-infusion
techniques in type 1 diabetic and non-diabetic subjects.
It has been recognised since the introduction of insulin in the 1920s that 'a
characteristic train of symptoms' occurs when the blood glucose falls to beneath the
normal range. These symptoms were so typical of a low blood sugar that they were
termed the 'hypoglycaemic reaction' (Fletcher and Campbell, 1922). It is now
recognised that distinct symptom sub-types represent the 'hypoglycaemia reaction'.
However, some controversy has arisen as to which symptoms most characterise an
individuals symptomatic response to hypoglycaemia.
Two retrospective analyses of large numbers of type 1 diabetic subjects lead to the
development of the Edinburgh Hypoglycaemia Scale (Hepburn et al. 1992; Deary et
al. 1993b). This has provided one means by which studies between centres can be
compared. However, differences do exist between the Edinburgh Hypoglycaemia
Scale, derived from the retrospective reports of individuals with type 1 diabetes, and
symptoms derived from experimental studies. Towler et al. (1993), using the one-
step hyperinsulinaemic glucose clamp to examine the symptomatic response to
hypoglycaemia, suggested that it could best be divided into two sub-groups, viz.
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autonomic [or neurogenic] and neuroglycopenic symptoms, both ofwhich have
distinct physiological bases. This compares with the Edinburgh Hypoglycaemia
Scale, which suggested three symptom subgroups; autonomic, neuroglycopenic and
hypoglycaemia-associated malaise symptoms (Deary et al. 1993b). Using the
insulin-infusion technique to induce hypoglycaemia in 30 type 1 diabetic and 25
non-diabetic subjects Hepburn et al. (1991a) also suggested that the hypoglycaemic
reaction could be represented by two distinct symptom sub-types; autonomic and
neuroglycopenic. However, this analysis differed from that of Towler et al. (1993) in
that Hepburn et al. (1991a) found the symptom warmness to be autonomic whereas
Towler et al. (1993) found it to be neuroglycopenic. Hepburn et al. (1991a) also
found the symptom weakness did not group clearly into either symptom sub-type
whereas Towler et al. (1993) suggested it was clearly a neuroglycopenic symptom.
Furthermore, Hepburn et al. (1991a), suggested that palpitation (pounding heart) was
not a good symptom ofhypoglycaemia and they did not include the symptom
tingling. The differences between these two studies may have arisen because of the
different techniques employed, and also because of the nature of the subjects studied
(non-diabetic vs. a mixed group of type 1 diabetic and non-diabetic subjects).
In order to clarify this area, the symptom reports from a large number of type 1
diabetic and non-diabetic subjects who have participated in hypoglycaemia research
in our centre over the last few years have been analysed. By combining these
studies, the power of our analysis to discover differences in the symptomatic
response to hypoglycaemia, if they are apparent, between the two methods of
inducing hypoglycaemia, and also between type 1 diabetic and non-diabetic subjects
is significantly increased.
Methods
The analysis in this study is based on the hypoglycaemia symptom reports of 154
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(78 type 1 diabetic; 76 non-diabetic) subjects who had participated in studies in our
centre over the last few years. None of the type 1 diabetic subjects included in this
analysis had reported a history of hypoglycaemia unawareness, or a change in
symptom pattern and intensity since commencing insulin therapy. All type 1
diabetic subjects were using human insulin for their insulin replacement regimen,
and type 1 diabetic subjects were excluded if they were taking any medication that
may have interfered with their symptomatic response to hypoglycaemia (e.g. beta-
adrenoreceptor blockers),or if they had any clinical evidence ofmicrovascular
disease. None of the type 1 diabetic subjects had clinical evidence of autonomic
neuropathy, as assessed by standard cardiovascular reflex tests (Ewing et al, 1982).
In those studies designed to compare different types of insulin only those subjects
given human insulin have been included. The non-diabetic subjects were all healthy
and on no regular medication other than the oral contraceptive pill. None had a
family history of diabetes, or a history of neurological or cardiovascular disease. The
age of our subject group ranged from 20-55 years.
The methods used to induce hypoglycaemia in two of the studies from which
hypoglycaemia symptom reports were taken for the present analysis have been
described in detail elsewhere (MacLeod et al. 1994, Gold et al. 1995).
Hypoglycaemia symptom reports were also taken from subjects participating in
those studies reported in this thesis (visual and auditory information processing
studies; pp 101-140) and from studies currently being conducted in the Department
ofDiabetes, Royal Infirmary of Edinburgh (Ewing et al. unpublished data). The
hyperinsulinaemic glucose clamp involves the continuous infusion of insulin at a
fixed rate (following a priming ramped infusion to saturate insulin receptors) and a
glucose infusion at a variable rate which is appropriately adjusted to maintain the
blood glucose at a desired level. In all of the studies included in this analysis
subjects have been maintained at euglycaemia (5.0 mmol/1) for a period of45-60
minutes prior to being dropped in a single step to hypoglycaemia (2.6 mmol/1) where
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they have been maintained for a further 45-60 minutes. With the insulin infusion
technique a continuous, unopposed infusion of insulin is delivered until there is
evidence of autonomic activation. At this point a dextrose infusion is often started to
aid in the restoration of euglycaemia. The time of autonomic activation is identified
by the rapid onset of sweating (measured by a hygrometer) and increase in heart rate
(measured by precordial leads) (Hepburn, 1993). In all of the studies included in this
analysis it is arterialised blood glucose recordings that are being reported, and all
have used human insulin to induce hypoglycaemia.
The hypoglycaemic questionnaire used in these studies was developed in Edinburgh
over the last few years (Hepburn et al. 1991a; Hepburn et al. 1992; Deary et al.
1993b). During hypoglycaemia subjects are asked to complete the questionnaire, and
to rate the presence or absence of the symptoms they are experiencing along a 7-
point Likert-like scale (where 1 = symptom not experienced at all, and 7 = symptom
experienced with maximum intensity). This questionnaire is given to subjects after
they have been stabilised for 15 minutes at a predetermined level of hypoglycaemia
in the hyperinsulinaemic glucose clamp studies, and when there is evidence of
autonomic activation in the continuous insulin infusion studies. Because this
questionnaire evolved over repeated studies the symptoms used are not identical in
each study. The symptom headache was only used in later studies. In the 69 subjects
who reported on this symptom during hypoglycaemia only 15 (22%) responded
positively, with a mean intensity of only 0.3. Inco-ordination and odd behaviour
were also only reported by a small number of subjects, and hence all three of these
symptoms were rejected from further analysis. The symptoms used in this analysis
were; hunger, inability to concentrate, weakness, warmness, drowsiness, trembling,
sweating, tired, confusion, blurred vision, palpitation, anxiety, nausea, tingling lips,
difficulty speaking and double vision.
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Statistical Analysis
Statistical analysis was performed on the Statistical Package for the Social Sciences
(SPSS/PC + 2.0), SPSS (Chicago, Illinois, U.S.A). Symptom frequency and
intensity were compared using Spearman's rank correlation for non-parametric data.
Principal components analysis (PCA), followed by an orthogonal varimax rotation
was used in an attempt to ascertain whether any latent structure could be identified
in the hypoglycaemia symptom-profiles of type 1 diabetic and non-diabetic subjects,
and during the insulin-infusion or hyperinsulinaemic glucose clamp studies. Finally,
PCA was applied to the group as a whole. PCA begins with a correlation matrix
where scores for every symptom are correlated with those for every other symptom.
Sub-groups of symptoms that intercorrelate relatively highly are revealed,
suggesting certain grouping with a common underlying cause. For each of the
following separate analyses the first unrotated principal component revealed that all
of the symptoms loaded moderately or highly confirming that they were all good
indicators ofhypoglycaemia. Factor analysis is then used to determine if, within the
main unrotated principal component, there is evidence of any sub-grouping of
variables (e.g. autonomic or neuroglycopenic symptoms). Each factor is given an
eigen value and these can be plotted graphically (Scree slope). In theory, it is
possible to produce an infinite number of factors from an analysis such as this.
Traditionally, factors with eigen values greater than 1 have been taken to be
significant, however, from the scree slope one is usually able to determine how
many factors best represent the latent structure of the variables in the analysis.
Where the slope of the curve flattens is usually the point at which each additional
factor adds little to the overall variance in the analysis.
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Results
In the following section results are presented separately for the two subject groups
(type 1 diabetic vs. non-diabetic subjects) and for the two experimental techniques
(hyperinsulinaemic glucose clamp studies vs. insulin infusion studies). A final
analysis of the pooled data from all subjects is then presented.
Symptom frequency and mean intensity
1. Type 1 diabetic patients (N=78) vs. non-diabetic subjects (N=76)
The symptoms reported with the greatest frequency by type 1 diabetic patients were
hunger (91%), inability to concentrate (81%), warmness (76%) and drowsiness
(73%), and those reported with the least frequency were nausea (25%), tingling lips
(19%), and difficulty speaking (15%). The non-diabetic subjects reported hunger
(92%), inability to concentrate (80%), tiredness (75%), and trembling (74%) with
the greatest frequency, and double vision (8%), tingling lips (11%), and difficulty
speaking (19%) the least (Table 3.5.1). The symptoms reported with the highest
mean intensity (maximum score 7; minimum score 1) by the type 1 diabetic subjects
were hunger (4), inability to concentrate (3), weakness (3) and warmness (3), and
those reported with the highest mean intensity by the non-diabetic subjects were
hunger (4), trembling (3), warmness (3) and sweating (3) (Table3.5.1).
There was very close agreement between type 1 diabetic and non-diabetic subjects
when frequency of reported symptoms were correlated (rho = 0.74; p<0.01).
Similarly type 1 diabetic and non-diabetic subjects showed close agreement when
mean (rho = 0.61; p<0.05) and standard deviation (rho = .45; p=0.14) of the intensity
of reported symptoms were compared. These results indicate that during
hypoglycaemia both type 1 diabetic and non-diabetic subjects are experiencing a
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similar symptomatic response in terms of the type of symptoms they report, the
intensity with which they report those symptoms and the variability of their
responses.
2. Hyperinsulinaemic glucose clamp studies (N = 88) vs. insulin infusion studies (N
= 66).
The symptoms reported with the greatest frequency during the hyperinsulinaemic
glucose clamp studies were hunger (83%), inability to concentrate (77%),
drowsiness (70%) and trembling (67%). Those reported with the least frequency
were tingling lips (20%), double vision (22%) and nausea (25%) (Table3.5.1).
Similarly the symptoms reported with the greatest frequency during the insulin
infusion studies were hunger (89%), inability to concentrate (85%), warmness (77%)
and trembling (71%). Those reported with the least frequency were tingling lips
(12%), nausea (24%) and double vision (26%) (Table3.5.1).
There was also close agreement between subjects during both techniques in terms of
the frequency (rho = 0.69; p<0.05), mean intensity (rho = 0.83); p<0.01) and
variability (rho = 0.63; p<0.05) of the symptom responses.
Factor analysis
Principal components analysis (PCA) was applied to the symptom scores of each
separate sub-group (type 1 diabetic, non-diabetic, clamp and infusion groups) and to
the study population as a whole in order to examine the latent structure of the
hypoglycaemic response. Only those symptoms which were reported by more than
25% of the study group were included in this analysis, as these were felt to be better
discriminators of the hypoglycaemic response (the symptoms 'tingling lips',
'nausea', 'difficulty speaking', and 'double vision' were rejected at this stage). For
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each analysis in this study, the resulting scree slopes are shown in Figure 3.5.1. It is
very clear from this that each analysis reveals one very significant factor that
accounts for between 43-48% of the shared variance. The significance of this factor
is such that any attempt to reduce the variables to a structure containing more than
one factor would not be reliable (despite some of the other factors having eigen
values greater than 1).
1. Principal components analysis of the symptoms reported by the type 1 diabetic
subjects during hypoglycaemia revealed only one factor which had an eigen value of
6.2 and accounted for 48.0 % of the variance in responses (Table 3.5.2). Similarly,
PCA of the non-diabetic subjects revealed only one factor with an eigen value of 5.6
accounting for 43.0 % of the variance (Table 3.5.2). PCA of the symptom reports
resulting from the hyperinsulinaemic glucose clamp experiments also revealed one
factor with an eigen value 6.0, and accounting for 46.0 % of the variance. PCA of
the symptom reports during the insulin-infusion technique also suggested that a
single factor would best account for the latent structure of the responses. This factor
accounted for 43.0 % (eigen value 5.6) of the shared variance (Table 3.5.2).
Finally, PCA was applied to all of the symptom reports (N=154). Once again all of
the symptoms reported loaded moderately or highly on the first unrotated principal
component confirming their usefulness in assessing hypoglycaemia (Table 3.5.2).
This analysis revealed that one factor alone best described the structure of the overall
symptom response, i.e. the subjects recognised that they were hypoglycaemic, but
did not differentiate between autonomic or neuroglycopenic symptoms.
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Table 3.5.1 Frequency and mean intensity of hypoglycaemia symptoms reported
during experimental hypoglycaemia (note; mean intensity scores have been adjusted
so that the minimum score is 0, the maximum 6). Only those symptoms, which were
then used in factor analysis, are included. The 5 most intensely experienced







F / F I F I F I
Hunger 91 3.0 92 3.3 83 3.2 89 3.0
Inability to
concentrate
81 1.8 80 1.9 77 1.8 85 2.0
Weakness 72 1.8 63 1.4 67 1.6 68 1.7
Warmness 76 1.8 67 2.0 67 1.8 77 1.8
Drowsiness 73 1.7 64 1.5 70 1.6 67 1.6
Trembling 64 1.6 74 2.0 67 1.8 71 1.9
Sweating 63 1.6 68 2.0 65 1.8 67 1.9
Tired 72 1.6 75 1.8 81 1.8 64 1.6
Confusion 60 1.3 49 1.0 47 1.0 65 1.4
Blurred vision 55 1.2 45 0.8 44 0.8 58 1.2
Palpitation 56 1.2 64 1.6 60 1.4 62 1.3
Anxiety 46 0.9 57 1.4 52 1.1 50 1.0
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Symptom Factor Factor Factor Factor Factor
Anxiety 0.66 0.63 0.68 0.62 0.64
Blurred Vision 0.75 0.59 0.67 0.68 0.68
Confusion 0.70 0.74 0.71 0.69 0.71
Difficulty
Speaking
0.67 0.75 0.73 0.69 0.70
Drowsiness 0.76 0.68 0.65 0.76 0.70
Hunger 0.57 0.42 0.48 0.50 0.50
Inability to
concentrate
0.75 0.75 0.79 0.67 0.74
Pounding heart 0.76 0.53 0.62 0.69 0.64
Sweating 0.47 0.60 0.61 0.40 0.53
Tiredness 0.62 0.70 0.66 0.64 0.65
Trembling 0.72 0.64 0.69 0.68 0.68
Warmness 0.64 0.56 0.60 0.54 0.59
Weakness 0.83 0.79 0.80 0.81 0.81
Eigen value 6.2 5.6 6.0 5.6 5.8
Percentage of
total variance
47.8 43.0 46.0 43.0 44.4
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Figure 3.5.1
This Scree Slope shows the eigen values plotted against factor
number for each rotation in the factor analysis for each of the
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Research into the symptomatic response to hypoglycaemia has essentially taken two
forms; retrospective analysis of symptoms reported by ambulant type 1 diabetic
subjects in the community and analysis of symptoms reported by subjects (type 1
diabetic and non-diabetic) during experimental hypoglycaemia. The Edinburgh
Hypoglycaemia Scale (Deary et al. 1993b), although originally derived from
experimental studies (Hepburn et al. 1991a), is mainly the product of the analysis of
large numbers of type 1 diabetic subjects in the community. This symptom
questionnaire has proven a robust measure of the symptomatic response to
hypoglycaemia as experienced by type 1 diabetic subjects in their day-to-day
activities (Deary et al. 1993b).
There is considerable agreement between the findings from analysis of symptom
reports and from experimental studies. For instance, physiological tremor (shaking)
is recognised to increase during hypoglycaemia (Heller et al. 1987) and is similarly
increased by an infusion of adrenaline (Fellows et al. 1986). However, differences
do exist between the symptoms reported during experimentally induced
hypoglycaemia and hypoglycaemia experienced in the community. In many ways
this is not surprising given the nature of hypoglycaemia in the two different
environments (one taking place in a controlled laboratory environment, the other in
every day life where a multitude of other influences can effect the symptomatic
response). Towler et al. (1993), for instance, found that symptoms of hypoglycaemia
associated malaise (nausea and headache) did not change significantly during
hypoglycaemia. Similarly, Hepburn et al. (1991a) suggested headache was a
neuroglycopenic symptom and nausea an autonomic symptom. Neither symptom
was reported with great frequency or intensity (Hepburn et al. 1991a). In this
analysis both headache and nausea were excluded because of the inffequency with
176
which they were reported, and their marginal increase in intensity when they were
experienced. This indicates that headache and nausea are not reliable discriminators
of experimental hypoglycaemia, and that neither type 1 diabetic, nor non-diabetic,
individuals are experiencing a specific hypoglycaemia-associated malaise during
experimental hypoglycaemia.
Earlier analysis of the symptomatic response to experimental hypoglycaemia had
also suggested that there may be differences between experimental techniques and
between type 1 diabetic and non-diabetic subjects (Towler et al. 1993; Hepburn et al.
1991a). The results from this analysis indicate that the symptomatic response to
hypoglycaemia induced by either technique, and between type 1 diabetic subjects
with intact hypoglycaemia awareness and non-diabetic subjects, is very similar.
Furthermore, during hypoglycaemia induced by either the continuous insulin
infusion or the hyperinsulinaemic glucose clamp technique, type 1 diabetic subjects
with intact hypoglycaemia awareness and non-diabetic subjects are unable to
differentiate between autonomic and neuroglycopenic symptoms.
In summary:-
Based on the data pooled from a large number of studies involving experimental
hypoglycaemia, the findings of this analysis would suggest the following symptoms
as being most discriminatory of the symptomatic response to hypoglycaemia;
hunger, inability to concentrate, weakness, warmness, drowsiness, trembling,
sweating, tired, confusion, blurred vision, palpitation and anxiety. Furthermore, type
1 diabetic and non-diabetic subjects appear to be unable to distinguish between
classical autonomic or neuroglycopenic symptoms if either a continuous insulin







Symptoms of hypoglycaemia in children with type 1 diabetes
mellitus
Hypoglycaemia engenders fear and apprehension in most diabetic patients treated
with insulin (Pramming et al. 1991), and is of particular concern to the parents of
children with type 1 diabetes. Hypoglycaemia in children may be difficult to
identify as the manifestations may be represented principally by behavioural change,
such as being irritable or naughty. A young child may be unable to describe
physiological changes which adults recognise as typical symptoms of
hypoglycaemia, and symptoms change with age.
Symptoms of hypoglycaemia in adults are idiosyncratic, and vary in intensity and
nature among individuals (Hepburn, 1993; Pennebaker et al. 1981; Hepburn et al.
1992). However, within the insulin-treated diabetic population, acute
hypoglycaemia presents as a characteristic symptom complex. The development of a
reliable and valid system for measurement of symptoms, essential for comparative
studies ofhypoglycaemia, has proved to be difficult. The application of statistical
techniques such as Principal Components (Factor) Analysis to examine symptoms of
hypoglycaemia in large groups of type 1 diabetic adults has permitted an objective
allocation of symptoms to specific subgroups (Hepburn et al. 1992; Hepburn et al.
1991a; Deary et al. 1993b). The Edinburgh Hypoglycaemia Scale has been devised
from these analyses and provides a possible means by which standardisation may be
achieved across research centres (Deary et al. 1993b). Hypoglycaemia symptoms in
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this scale are subdivided into those generated by activation of the autonomic nervous
system ('autonomic' or 'neurogenic' symptoms), those that occur through the direct
effect of glucose deprivation on the brain ('neuroglycopenic' symptoms), and those
that are less clearly defined and represent hypoglycaemia-associated malaise, (see
Part I, pp. 10-13, for detailed discussion). It is not known whether the symptoms of
hypoglycaemia in children with type 1 diabetes can be classified this way.
In addition to the scientific value of an objective examination of the symptoms of
hypoglycaemia in type 1 diabetic children, the practical importance of conveying
accurate information about the symptoms and possible manifestations of
hypoglycaemia to the parents of the children is paramount, as most children are
heavily reliant on parental assistance for treatment. This study examined the latent
structure of the symptoms ofhypoglycaemia experienced by type 1 diabetic children
and compared this with the signs observed by their parents.
Methods
One hundred consecutive children, all of whom were accompanied by at least one of
their parents, attending a paediatric diabetic out-patient clinic at the Royal Hospital
for Sick Children, Edinburgh, were recruited for this study. All 100 children and
100 parents gave informed consent to participate in the survey. All of the children
had type 1 diabetes and had experienced symptomatic hypoglycaemia. The children
were ofmedian (range) age 10.3 (1.5-16) years, with duration of diabetes 4.2 (0.3 -
13.0) years. At the time of questioning, mean (standard deviation) total glycated
haemoglobin for the study group was 10.3 (0.3) %.
The children and parents were questioned separately. Only one parent of each child
was interviewed. Each parent was questioned about the symptoms and signs of
hypoglycaemia, which they considered their child to have experienced on several
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occasions. Many of the diabetic children were too young, or not available, to
respond appropriately to the symptom questionnaire but 43 (43%) children were
sufficiently mature to document the symptom profile. This judgement on individual
capability was made by the interviewer at the time of examination and was based
upon a subjective assessment of the child's intellectual capabilities and maturity,
however it is possible that the responses of some of the younger children may have
been less reliable.
As expected the subgroup of children who were able to respond to the symptom
questionnaire were on average older than the non-responding group. No significant
differences were observed in duration of diabetes, total insulin dose or mean total
glycated haemoglobin concentration between either group (Table 4.1.1). Total
glycated haemoglobin was measured using high-speed liquid chromatography based
on an ion-exchange reverse-phase partition method (Hi Auto Ale 8121) (The non-
diabetic range for our laboratory was 4.5-8.0 %).
Structured questionnaire
The type 1 diabetic children and their parents were interviewed using a structured
questionnaire. The parent was asked to provide sociodemographic details of the
child's history of diabetes and management including total daily insulin dose,
number of injections and method of glycaemic monitoring. Parents were also asked
to rate their own ability to detect the onset of hypoglycaemia as it occurred in their
child using a 7-point linear scale (1 = always able to detect onset of hypoglycaemia,
7 = never able to detect onset of hypoglycaemia), and to compare this with their
ability to detect hypoglycaemia when their child had commenced insulin therapy
after diagnosis. The frequency and morbidity (e.g. broken bones, head injury etc) of
previous episodes of severe hypoglycaemia were documented. Severe
hypoglycaemia was defined by the requirement to treat with glucagon or glucose by
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injection, loss of consciousness, convulsion or transient hemiparesis. This differs
from the current definition used in adult diabetic patients in which severe
hypoglycaemia is determined by the need for external assistance to treat the patient.
In the present study it was considered inappropriate to apply the definition of severe
hypoglycaemia for adults to diabetic children because most young children require
assistance to treat hypoglycaemia of any degree of severity.
The parents, and where possible the children, were shown a list of 23 possible
symptoms of hypoglycaemia derived from published reports (Hepburn, 1993;
Pennebaker et al. 1981; Hepburn et al. 1992; Hepburn et al. 1991a; Deary et al.
1993b; Macfarlane et al. 1989; Aman et al. 1989) and were asked to indicate which
symptoms the child experienced regularly, and to indicate the intensity of each
symptom experienced on a 7-point scale. Two 'dummy' symptoms (itching and
having hiccups), unrelated to hypoglycaemia, were included in the questionnaire to
check the appropriateness of individual responses. The parents were asked in
addition to score two physical signs, pallor and bed-wetting, which were not shown
to the children. Symptoms which a child had difficulty in comprehending were
explained by the interviewer (e.g. 'nausea' was described as 'feeling sick').
Following completion of the questionnaire, the children and their parents were asked
to describe any other unlisted symptoms of hypoglycaemia relevant to them. In an
attempt to ascertain the typical symptom complex of individual children, both the
parent and the child were asked to describe the 'usual' symptoms of hypoglycaemia
with which they were familiar.
Statistical Analysis
Statistical analysis was performed on the Statistical Package for the Social Sciences
(SPSS/PC + 2.0), SPSS (Chicago, Illinois, U.S.A). Results are expressed as mean ±
standard deviation or median (90% ICR) as appropriate. The comparison of factors
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associated with hypoglycaemia was performed either by parametric statistical
methods (ANOVA), or non-parametric statistical methods (Chi - squared and
Kruskal - Wallis), as appropriate. Symptom frequency and intensity were compared
using Spearman's rank correlation for non-parametric data. Principal components
analysis, followed by an orthogonal varimax rotation was used in an attempt to
ascertain whether any latent structure could be identified in the responses of the
children and their parents to their hypoglycaemia symptom-profiles. The number of
factors was determined using the scree test, and a symptom loading of± 0.3 on any
factor was considered to be significant.
Results
The parents reported that forty-five (45%) children had experienced at least one
episode of severe hypoglycaemia, and 11 (11%) children had experienced five or
more episodes of severe hypoglycaemia at any time since commencing treatment
with insulin. Of those children exposed to severe hypoglycaemia, approximately
half had experienced nocturnal episodes with 8 (18%) patients having experienced 5
or more nocturnal hypoglycaemic events. Of those suffering a severe
hypoglycaemic event 22 (49%) had been treated in hospital and 5(11%) had
required multiple admissions to hospital. Six (6%) children had suffered some form
of hypoglycaemia-related injury, most ofwhich were minor head injuries. Twenty-
seven (27%) children had experienced problems at school, which were attributed to
hypoglycaemia (e.g. loss of schooling, poor educational performance or difficulty in
concentrating during classes).
Many of the hypoglycaemic events were related to simple errors in 'self-
management' of diabetes. A total of 98 (98%) of the parents were able to identify a
specific cause (e.g. delayed or missed food) which they had considered to be
responsible for many episodes of hypoglycaemia, but a retrospective analysis of
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causation was not undertaken because of dubiety about the reliability of accuracy of
recall. However, seven (7%) of the parents described their child as having
deliberately induced hypoglycaemia through manipulative behaviour (e.g. refusing
food) and two diabetic children (2%) were reported to have done this repeatedly.
Factors associated with severe hypoglycaemia
The frequency of severe hypoglycaemia was associated with age, with a trend
towards an increase in frequency with advancing age, although this did not reach
statistical significance (p=0.06). A higher frequency of severe hypoglycaemia was
reported in those children who had developed type 1 diabetes at an earlier age
(p=0.05), and in those children whose parents reported themselves as being less able,
compared with other parents, to perceive the onset ofhypoglycaemia in their child
(p=0.05). The ability of the parental group to perceive the onset of hypoglycaemia
improved with duration of the child's disease (p < 0.001). No correlations were
observed between mean total glycated haemoglobin or insulin dose at the time of the
survey, and the frequency of severe hypoglycaemia .
Symptoms and signs ofhypoglycaemia: Correlation ofsymptom-profiles ofchildren
and those observed by theirparents
The frequencies and mean intensities of the symptoms reported by the children and
signs observed by the parents are shown in Table 4.1.2. Pallor during
hypoglycaemia was observed by the parents with greatest mean intensity and
frequency (88% of children were affected). The signs that were observed by the
parents with the greatest intensity were irritability, sweating, tearfulness, hunger and,
being argumentative or aggressive. The most frequent signs reported by the parents
were sweating, tearfulness, irritability, hunger, and poor concentration. By
comparison the children reported weakness, hunger, sweating, trembling, and
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dizziness as having the greatest intensity, while their most frequent symptoms were
weakness, trembling, dizziness, sleepiness and poor concentration. When the
symptom frequency ranks for parents and children's estimations were compared
using Spearman's rank order correlation the value of rho was 0.65 (p<0.01). This
indicates a high level of agreement between children with type 1 diabetes and their
parents with respect to the prominence of different hypoglycaemic symptoms. The
dummy symptoms emerged with very low values for intensity and frequency for
both children and their parents.
To assess whether some relationship might exist between the individual differences
in the degree of intensity of symptoms perceived by the children and the same signs
observed by their parents, a correlation was computed between the symptom scores
of both groups using Spearman's rank correlation (Table 4.1.2). This analysis was
applied only to the 43 children (and their parents) who were able to complete the
symptom inventory. The symptoms of sweating, hunger, dizziness, headache,
abdominal pain, irritability, being argumentative and being naughty correlated
highly significantly (all p<0.001, Table 2). Most symptoms reported by children and
their parents showed significant correlations (range of rho corrected for ties 0.31-
0.70, Table 4.1.2), and the only symptoms for which no significant correlations were
noted were nausea, confusion, double vision and nightmares.
In summary, close agreement was observed between the reports of children with
type 1 diabetes and their parents with respect to a) relative frequencies, and b)
individual differences in intensities of symptoms of hypoglycaemia .
Symptoms ofhypoglycaemia: Principal Components Analysis
In the next series of analyses we sought to discover the latent structure of
hypoglycaemic symptoms in the reports of children with type 1 diabetes and their
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parents; i.e. do the children and their parents report symptoms as coherent groups,
and are these symptom groupings comparable between children and their parents ?
(1) Signs ofhypoglycaemia observed by the parents.
The parental ratings of signs ofhypoglycaemia observed in their children were
subjected to principal components analysis followed by varimax rotation. The first
unrotated principal component is 'general' in nature and is a means by which signs
can be assessed as to whether they are in fact associated with a 'general
hypoglycaemic factor'. Most symptoms demonstrated moderate to high loadings on
this component (Table 4.1.3) which suggests that the symptoms presented in the
questionnaire are related to the experience ofhypoglycaemia.
After orthogonal varimax rotation, an examination of the scree slope indicated that a
three factor solution offered the best description of the underlying symptom factors.
Factor 1 had moderate to high loadings (i.e. ± 0.30 or greater) on symptoms (listed
in descending order) of being argumentative, being aggressive, irritability,
abdominal pain, confusion, poor concentration, tearfulness, bed-wetting, nightmares
and headache. The nature ofmany of these symptoms indicates general behavioural
disturbance. Factor 2 had moderate to high loadings for weakness, dizziness,
sleepiness, sweating, slurred speech, trembling, pallor and convulsions. This factor
would appear to comprise a mixture of neuroglycopenic and autonomic symptoms.
Factor 3 had moderate to high loadings for blurred vision, double vision, headache,
being aggressive, dizziness and slurred speech. The symptoms of nausea and hunger
failed to load highly on any of the factors.
(2) Symptoms ofhypoglycaemia reported by children with type 1 diabetes
The first unrotated principal component for each symptom again showed moderate
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to high loadings for almost all symptoms. Application of the scree test to the
unrotated principal components matrix suggested a two factor model (which
accounted for 23.7% and 14.7% respectively, of the total variance). This model was
subjected to an orthogonal varimax rotation and the result of this analysis is shown
in Table 4.1.4. Factor 1 showed moderate to high loadings (given in descending
order) for double vision, blurred vision, poor concentration, dizziness, confusion,
weakness, sweating, hunger and trembling. These represent both neuroglycopenic
and autonomic symptoms, which appeared to cluster together in this analysis. Factor
2 showed moderate to high loadings for being argumentative, irritability, being
aggressive, being naughty and headache, suggesting general behavioural
disturbance.
The Edinburgh Hypoglycaemia Scale for insulin-treated adult patients has proposed
11 key symptoms of hypoglycaemia which segregate into three distinct subgroups.
Three of these symptoms (palpitations, odd behaviour, incoordination) were not
included in our study because it was thought that the children might have difficulty
in understanding the nature of these symptoms, and because they are not usually
reported as hypoglycaemic symptoms by type 1 diabetic children (Macfarlane et al.
1989; Aman et al. 1989). In addition the terminology was modified to use
'sleepiness' instead of drowsiness, and 'trembling' rather than shaking. To compare
directly the common symptoms ofhypoglycaemia experienced by adults with type 1
diabetes (Deary et al. 1993b) with those of the type 1 diabetic children factor
analysis was applied to the 8 remaining symptoms in the Edinburgh Hypoglycaemia
Scale which had been reported by the subgroup of 43 children who were able to
respond to the questionnaire. Three factors were extracted (Table 4.1.5) from this
analysis. Factor 1 showed moderate to high loadings for hunger, confusion,
sweating, slurred speech and trembling. This factor comprises a mixture of
neuroglycopenic and autonomic symptoms. Factor 2 showed moderate to high
loadings for nausea and headache. This may be interpreted as representing a non-
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specific malaise factor. Factor 3 showed a high loading for trembling and a high




Table 4.1.1. Clinical details of children with type 1 diabetes.
Children able to Children not Significance
complete symptom completing symptom
profile (n = 43) profile (n = 57)
Median Range Median Range
Age (years) 11.4 3.0-16.0 9.0 1.5-14.0 p<0.01
Age at diagnosis 6.7 1.5-13.0 5.2 1.0-13.5 p < 0.05
(years)
Duration of diabetes 4.5 0.3 -12.0 4.1 0.5 -13.0 NS
(years)
Mean SD Mean SD
Insulin dose (unit/kg 1.0 0.3 0.9 0.3 NS
body weight)
Total glycated 10.5 1.4 10.3 1.4 NS
haemoglobin (%)
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Table 4.1.2. Frequency and mean intensity ofhypoglycaemic symptoms reported by
the diabetic children and observed by their parents, and correlations (Spearman's
rho) between the symptom scoring of the children and their parents.
Symptom Frequency' (%) Intensity Rho
Parent Child Parent Child
poor
concentration
69 67 3.5 3.3 0.3 p<0.05
headache 47 64 2.9 2.7 0.6 p<0.01
nausea 33 19 1.7 1.5 0.1 ns
sweating 77 63 4.0 3.6 0.6 p<0.01
confusion 60 60 3.2 2.7 0.2 ns
trembling 64 72 3.4 3.6 0.4 p<0.01
sleepiness 67 67 3.6 3.3 0.5 p<0.01
tearfulness 74 42 4.0 2.0 0.4 p<0.01
tummy pain 43 45 2.5 2.2 0.6 p<0.01
irritability 73 42 4.0 2.3 0.5 p<0.01
dizziness 51 70 2.8 3.6 0.5 p<0.01
weakness 64 81 3.2 4.1 0.4 p<0.01
hunger 69 65 3.8 3.9 0.6 p<0.01
aggressive 64 51 3.8 2.9 0.5 p<0.01
blurred vision 19 45 1.6 2.1 0.4 p<0.05
convulsion 16 9 1.3 1.2 0.5 p<0.01
double vision 11 28 1.3 1.6 0.2 ns
argumentative 69 55 3.8 2.9 0.7 p<0.01
naughty 40 30 2.4 2.0 0.5 p<0.01
nightmares 20 7 1.5 1.1 0.2 ns
slurred speech 29 30 1.9 1.9 0.3 p<0.05
pallor * 88 5.3
bed-wetting * 10 1.3
* signs of hypoglycaemia observed by the parents of type 1 diabetic children
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FACTOR 1 FACTOR2 FACTOR 3
Poor concentration .581 .490 .295 .123
Tearfulness .452 .449 .319 -.286
Tummy pain .377 .532 .031 OOOl*
Irritability .554 .628 -.008 .243
Argumentative .575 .694 -.055 .265
Naughty .528 .653 .044 .001 1
Nightmares .362 .383 .222 -.220
Aggressive .667 .644 .111 .395
Confusion .579 .508 .234 .193
Bed wetting .417 .472 .210 -.247
Trembling .295 .023 .435 .094
Sleepiness .393 .146 .572 -.181
Dizziness .358 -.119 .593 .388
Weakness .471 .021 .735 .111
Sweating .418 .154 .562 -.092
Slurred speech .412 .064 .479 .315
Convulsion .230 -.002 .373 .059
Pallor .360 .205 .388 -.080
Double vision .295 .051 .167 .583
Blurred vision .198 .015 -.014 .710
Headache .519 .382 .156 .496
Nausea .396 .235 .314 .123
Hunger -.087 -.134 .021 .014
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FACTOR 1 FACTOR 2
Headache .295 -.053 .598
Sweating .461 .549 .014
Confusion .609 .585 .223 1
Trembling .405 .384 .156
Poor concentration .690 .696 .205
Dizziness .531 .595 .071
Weakness .594 .569 .222
Hunger .530 .451 .278
Blurred vision .585 .726 -.024 |
Double vision .632 .770 -.005 j
Slurred speech .437 .576 -.066 j
Irritability .478 .043 .782
Aggressive .655 .278 .752
Argumentative .442 -.083 .901
Naughty .388 .005 .678
Sleepiness .229 .134 .210
Tearfulness .200 .088 .226
Tummy pain -.066 -.137 .082
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Table 4.1.5. Results of factor analysis applied to 8 symptoms ofhypoglycaemia










Sweating .67 .76 -.10 .16
Trembling .43 .36 -.07 .66
Hunger .66 .80 "3-o1* -.18
Confusion .69 .63 .34 -.03
Slurred speech .62 .52 .21 .35
Headache .31 -.04 .84 .06
Nausea .46 .13 .86 -.03
Sleepiness .02 .25 -.07 -.86
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Discussion
In the present study the symptoms of hypoglycaemia reported most frequently by the
children with type 1 diabetes were weakness, trembling, dizziness, poor
concentration and sleepiness. By comparison the parents of the children most
frequently observed signs of sweating, tearfulness, irritability, poor concentration,
being argumentative, and hunger. The parents also commonly observed pallor.
However, when correlations between the symptoms ofhypoglycaemia reported by
children and those observed by their parents were examined, a general agreement
emerged between the overall frequencies and individual differences in symptom
intensities obtained from the parents and their children. Most symptoms correlated
significantly (Table 4.1.2), contradicting the view that children are unable to
recognise the symptom-complex of acute hypoglycaemia.
Factor analysis of the symptoms of hypoglycaemia in this study indicated that both
parents and children identify a cluster of symptoms which represent a combination
of autonomic and neuroglycopenic symptoms (Tables 4.1.3 and 4.1.4). The
symptoms of trembling, sweating and hunger are usually classified as autonomic
symptoms, while poor concentration, slurred speech and confusion are grouped as
neuroglycopenic symptoms; physiological evidence exists to support this division
(Hepburn, 1993). In diabetic adults, drowsiness (or sleepiness) usually indicates
neuroglycopenia. Although the children did not report sleepiness with sufficient
frequency for its inclusion in a symptom cluster, it was reported by their parents as
an important indicator of hypoglycaemia, and it co-segregated with the
autonomic/neuroglycopenic group of symptoms. The childrens' symptoms of
blurred vision and double vision appeared to cluster with the
autonomic/neuroglycopenic group of symptoms, which is consistent with
observations reported previously in adults with type 1 diabetes (Hepburn et al. 1992;
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Hepburn etal. 1991a).
For both the children with type 1 diabetes and their parents factor analysis classified
weakness as an autonomic/neuroglycopenic symptom. This differs from factor
analysis ofhypoglycaemic symptoms in diabetic adults where weakness has been
grouped with the non-specific symptoms ofmalaise (Hepburn et al. 1992), although
in earlier studies weakness has been allocated both to autonomic and
neuroglycopenic groups (Hepburn et al. 1991a). Pallor, observed by the parents,
was allocated by factor analysis to the combined autonomic/neuroglycopenic group.
In the present study the clustering together of autonomic and neuroglycopenic
symptoms was unexpected as adult type 1 diabetic patients are able to distinguish
clearly between the two types of symptoms (Hepburn et al. 1992; Hepburn et al.
1991a; Deary et al. 1993b). It has been shown that the hormonal counterregulatory
response to hypoglycaemia is more vigorous in non-diabetic, and in type 1 diabetic
children compared with adults, with an epinephrine response of significantly greater
magnitude occurring with less profound hypoglycaemia (Jones et al. 1991).
Furthermore type 1 children with poor glycaemic control demonstrated a rise of
symptom scores at plasma glucose concentrations that were within the
normoglycaemic range (Jones et al. 1991). The most prominent symptom scores
were alleged to be autonomic in nature when the childrens' responses were compared
with those of adults with type 1 diabetes (Jones et al. 1991). A distinct cluster of
autonomic symptoms might therefore have been anticipated in an analysis of
hypoglycaemia symptomatology in children with type 1 diabetes. However, type 1
diabetic children develop abnormal cognitive function during mild hypoglycaemia,
and appear to be much more sensitive to neuroglycopenia than adults (Ryan et al.
1990). The clustering together of autonomic and neuroglycopenic symptoms may
either reflect very similar glycaemic thresholds for the activation of these groups of
symptoms, or may result from a disruption in cognition so affecting the child's
195
perception of hypoglycaemia.
An important observation in the present study is the significance, which the parents
of the children attached to a behavioural change in their child during hypoglycaemia.
It has been reported that behavioural change, as an early feature of hypoglycaemia,
occurs in only about 4% children with type 1 diabetes (Macfarlane et al. 1989),
although others have noted that irritability is more frequently reported during
hypoglycaemia (Aman et al. 1989). Behavioural changes have received little
attention as premonitory signs of a falling blood glucose. In the present study
behavioural change was common, and factor analysis indicated it accounted for a
significant amount of the total variance in each analysis. For both parents and
children this sub-group of hypoglycaemic symptoms associated with behavioural
change consisted of irritability, being aggressive and being argumentative. Of the
symptoms reported by the children headache and being naughty clustered with this
group, while the parental observations included tearfulness, tummy pain, poor
concentration , headache, nightmares, bed wetting and slurred speech. Some
symptoms segregated into more than one factor, which may be related to the
relatively small size of the study population. A third factor, formed within the factor
analysis of the parents' observations, included the symptoms of blurred vision,
double vision, headache, dizziness and being aggressive. This factor appears to
suggest that the parents were observing a particular pattern of neurological
dysfunction when their child was hypoglycaemic but this interpretation is open to
speculation.
The final analysis was to use the Edinburgh Hypoglycaemia Scale (Deary et al.
1993b) to compare the symptoms of type 1 diabetic children directly with those of
type 1 diabetic adults reported in previous studies from our department (Table
4.1.5). This analysis also demonstrated that the children did not differentiate
between autonomic and neuroglycopenic symptoms; instead they tended to combine
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these groups as a distinct cluster of symptoms. The second factor from this analysis
showed very high loadings for nausea and headache and clearly represents the non¬
specific malaise factor reported by Deary et al. (1993). This second factor is also
reported commonly by adult type 1 diabetic patients during hypoglycaemia. Thus,
the present study, would appear to confirm the existence of a hypoglycaemia-
associated non-specific malaise factor within a group of ambulant, type 1 diabetic
children. The third factor extracted from this final analysis appears to consist of two
apparently opposing states, namely that of trembling and sleepiness.
In common with other studies of type 1 diabetic children (Stern, 1995; Goldstein et
al. 1981; Bergada et al. 1989), a relatively high rate of severe hypoglycaemia was
recorded in the present survey. Almost half of this unselected cohort of type 1
diabetic children had experienced severe hypoglycaemia at some time. As the
present survey employed retrospective estimates it can not provide an accurate
measure of the true frequency of severe hypoglycaemia within this age group.
However, because a strict definition of severe hypoglycaemia was used in the
present survey, the estimated frequency is likely to be reasonably accurate as most
parents are unlikely to forget the traumatic experience of a severe episode. In a
recent survey Limbert et al. studied 74 type 1 diabetic children and adolescents
prospectively over a 12 month period and reported that 44 (59%) of their patients
experienced at least one episode of severe hypoglycaemic episode and almost all had
experienced symptomatic hypoglycaemia.
In adult type 1 diabetic patients, increased risk of severe hypoglycaemia is
associated with a past history of severe hypoglycaemia, increasing age and duration
of diabetes, strict glycaemic control, and loss of symptomatic awareness of
hypoglycaemia (MacLeod et al. 1993) Patients taking large doses of insulin, and
who have a low glycated haemoglobin concentration, experience a higher frequency
of severe hypoglycaemia (The Diabetes Control and Complications Trial Research
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Group, 1991). In the present study of type 1 diabetic children a positive association
was observed between the frequency of previous severe hypoglycaemia and an early
age of diagnosis. A significant association was observed between the frequency of
severe hypoglycaemia and the parents' self-reported ability to recognise the
symptom-complex of hypoglycaemia. Interestingly, the ability of the parental group
to detect hypoglycaemia in the children improved with time suggesting that this may
indicate deficiencies in the parents' knowledge of the manifestations of
hypoglycaemia early in the course of treatment with insulin. The question of
whether children develop impaired awareness ofhypoglycaemia remains
undetermined.
In summary:-
This study has documented the symptoms of hypoglycaemia most frequently
reported by type 1 diabetic children and observed by their parents, and has shown
general agreement between the parents and their children in the reporting of
symptoms of hypoglycaemia. Type 1 diabetic children and type 1 diabetic adults
clearly differ in their reporting of symptoms of hypoglycaemia, and factor analysis
of the parents' and the childrens' reported symptoms has identified two predominant
symptom clusters: a combined autonomic/neuroglycopenic group of symptoms and a
behavioural group of symptoms. This information may be of value when educating
newly diagnosed type 1 diabetic children and their parents about hypoglycaemia.
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In Chapter 2 of this thesis I reviewed the published literature on the effects of both
acute and chronic insulin-induced hypoglycaemia on cognitive function. In general it
can be inferred from this literature that almost all major modalities of cognitive
function (motor, verbal, memory, attention and executive functions) can become
significantly impaired during acute moderate hypoglycaemia (approx. 2.4-3.0
mmol/1). However, much of this data relied on cognitive tasks that are non-specific,
usually accessing more than one modality of cognitive function. It could not, for
instance, be inferred that more fundamental cognitive processes were being
significantly affected by hypoglycaemia, nor could the outcome of such studies be
translated directly into the everyday life of individuals. This distinction is important
because in cognitive terms the brain is not a single system that either functions
normally or abnormally when subjected to certain stresses. If the brain were able to
re-direct glucose or alternative substrates to more essential cognitive processes
during the physiological stress of hypoglycaemia it could maintain normal
metabolism and hence these cognitive functions would be preserved. If this were
true, it would imply that fundamental cognitive processes would be unaffected by
moderate hypoglycaemia and that an individual exposed to this physiological state
could function normally. In order to address these issues studies needed to be
designed that would examine the impact ofmoderate hypoglycaemia on more
fundamental cognitive processes, and on the performance of everyday activities (e.g.
driving).
Hypoglycaemia and cognitive function: Sensory information processing
The first and principal aim of this thesis was to examine the impact of acute
moderate hypoglycaemia on two essential cognitive processes, namely visual and
auditory information processing. These two aspects of sensory perception were
chosen because of their importance to humans engaged in daily activities, and
because tests have been developed which provide an accurate index of these
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processes. Non-diabetic subjects rather than subjects with type 1 diabetes were
chosen for these studies because, in general, fewer variables influence this
population that might effect cognitive performance during hypoglycaemia (e.g.
previous experience of hypoglycaemia and glycaemic control). The impact of
hypoglycaemia per se on these tasks could, therefore, be more clearly documented.
Studies 1 and 2
The outcome of Studies 1 and 2 suggest that moderate hypoglycaemia does have a
significant disruptive effect on basic sensory information processing (visual and
auditory information processing). All three tasks of visual information processing
(Inspection Time, Visual Change and Visual Movement Detection) and two of the
four tasks of auditory information processing (Temporal Order and Single-Tone
Loudness discrimination) showed significant disruptions during moderate
hypoglycaemia. This indicates that essential brain functions are not protected from
the disruptive effect ofmoderate hypoglycaemia.
Studies 1 and 2 provide evidence of significant disruption to fundamental cognitive
processes in non-diabetic individuals during acute moderate hypoglycaemia.
Because humans make use of auditory and visual perception during most daily
activities, the impairment of these processes may translate to impaired performance
on these activities. An even greater impact may be seen on those activities that rely
predominantly on visual perception because of the clearer effects ofhypoglycaemia
found on visual information processing tasks and the added effect of disrupted
contrast sensitivity. However, before such a conclusion can be drawn studies need to
be conducted that will directly assess performance during hypoglycaemia on
different everyday activities. Cox et al. (1993) demonstrated significant disruption
to driving ability in individuals with type 1 diabetes during moderate hypoglycaemia
which indirectly supports the findings of Studies 1 and 2. However, the studies of
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this group on driving are isolated investigations and more studies on other activities
need to be completed before the scientific community can be certain of the
importance of this data.
It should be recognised that individuals with type 1 diabetes form a much more
heterogeneous population than non-diabetic individuals. Glycaemic control,
antecedent hypoglycaemia and hypoglycaemia unawareness have all been shown to
affect cognitive performance during acute hypoglycaemia. It is possible that 1
individuals with type 1 diabetes might be protected from the disruptive effects of
hypoglycaemia on visual and auditory information processing. This is a
controversial area of research, with some type 1 individuals showing preserved
function on some cognitive tasks (in general those individuals with a short duration
of disease and near-normal glycaemic control) during hypoglycaemia, while others
(e.g. those with poor glycaemic control or hypoglycaemia unawareness) exhibit a
greater deterioration of cognitive function. Further studies designed to examine the
impact ofmoderate hypoglycaemia on visual and auditory information processing in
individuals with type 1 diabetes would help to clarify this issue.
Hypoglycaemia: Effects on mood and emotion
The second major aim of this thesis was to examine the effect ofmoderate
hypoglycaemia on measures of anger, mood and appraisal. The literature on the
effect of hypoglycaemia on human emotions and mood is limited. A review of that
literature suggests that both in non-diabetic individuals and in people with type 1
diabetes hypoglycaemia leads to a negative mood state. There was also evidence to
suggest that hypoglycaemia might result in some non-diabetic individuals displaying
aggressive or violent behaviour. In Study 3 it was hypothesised that hypoglycaemia
might lead to an increase in anger-state, and in Study 4 it was hypothesised that
hypoglycaemia, through the induction of a negative mood state, would result in the
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expression of negative emotions, and negative appraisals of a life event. These
studies served two purposes. On the one hand they provided further useful
information on the effect of hypoglycaemia on human emotion and mood, and on the
other they provided further validation of the usefulness of hypoglycaemia as a model
for inducing the theoretically important state of tense-tiredness.
Studies 3 and 4
In Study 3, individuals asked to rate feelings of anger in the non-confrontational and
artificial setting of the laboratory, reported a small, but significant, increase in anger-
state during acute hypoglycaemia. Considerable inter-individual variability was
observed with a marked increase in anger-state in a few individuals. It is possible
that the increase in anger shown by these individuals during hypoglycaemia may
lead to aggressive behaviour depending on the provocation or other aspect of the
situation. No correlations were found between the increase in anger-state and
measures of anger-trait and general anger-expression. However, the number of
subjects in the study was probably insufficient to exclude a possible association.
Hypoglycaemia-associated anger is a poorly understood phenomenon but one which
may adversely effect an individual's social and work relationships and may explain
why some subjects with type 1 diabetes refuse assistance with the treatment of
hypoglycaemia when it is preferred.
In Study 4, hypoglycaemia was demonstrated to induce a negative mood state in
non-diabetic individuals, which was characterised by decreased happiness and
increased tension. Moreover, these individuals reported more negative appraisals of
a life-event. Importantly, personality dimensions remained stable during
experimental hypoglycaemia indicating that the effects on mood and emotion were
situational in nature i.e. induced by the experimental condition. As with the increase
in anger-state such negative moods and emotions might have an adverse impact on
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an individual's social and work interactions.
Taken together with previous studies ofmood and emotion during hypoglycaemia it
can be concluded from the findings of Studies 3 and 4 that acute hypoglycaemia has
a negative impact on these aspects of human behaviour. Whether these findings, for
the reasons stated earlier, can be translated directly to people with type 1 diabetes is
not certain. However those investigators who have studied individuals with type 1
diabetes have reported similar findings (Gold et al. 1995c, Hepburn et al. 1995,
Gonder-Frederick et al. 1989). Two other important questions arise from this work
that could be addressed in future studies. Firstly, what determines the marked
individual variability noted in the change in mood and emotion during
hypoglycaemia? Greater comprehension of this may enable more specific therapy to
be directed to such individuals, and may provide useful information for their
families and work colleagues. Secondly, what is the impact of recurrent
hypoglycaemia on mood? It is possible that recurrent hypoglycaemia may have a
potential psychomorbidity and, given the current drive to achieve near-normalisation
of glycaemic control in type 1 diabetes, this could have important implications for
the subsequent mental health of individuals with type 1 diabetes.
Hypoglycaemia: Symptomatic response to hypoglycaemia
In the final section of this thesis the symptomatic response to hypoglycaemia was
examined in two different situations: the pattern of symptoms reported during
experimental hypoglycaemia induced by either the hyperinsulinaemic glucose clamp
or the insulin-infusion technique in type 1 diabetic and non-diabetic individuals
(Study 5), and the symptoms reported by type 1 diabetic children and observed by
their parents (Study 6).
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Study 5
In Study 5, data was pooled from the studies in this thesis and from others conducted
in Edinburgh during the last 10 years, to show that individuals with type 1 diabetes
and non-diabetic individuals reported the same pattern of symptoms during
hypoglycaemia and that this pattern did not differ when hypoglycaemia was induced
using either the hyperinsulinaemic glucose clamp or the insulin-infusion techniques.
From this large data set the symptoms which were reported with the greatest
frequency and intensity during experimental hypoglycaemia were also extracted and
may usefully lead to the refinement of a symptom questionnaire for hypoglycaemia,
with development of a questionnaire specifically for experimental hypoglycaemia.
The importance of this relates mostly to establishing a degree of uniformity between
centres such that studies between different research groups can be more readily
compared.
Study 6
In Study 6 it was shown that children with type 1 diabetes clearly differed from
adults in their reporting of hypoglycaemia symptoms with much more emphasis
being placed on behavioural changes. However, it is also evident from the literature
that little emphasis has been placed on determining the behavioural effects of acute
hypoglycaemia in the adult population with type 1 diabetes. Taken together with the
findings of Studies 3 and 4, which suggested acute hypoglycaemia may have
significant effects on mood and emotion in people with type 1 diabetes, it is possible
that the differences noted in Study 6 were exaggerated because adults with type 1
diabetes are rarely asked about, or know to report, behavioural changes during acute
hypoglycaemia. The findings of Study 6 do have practical implications for the
management of children with type 1 diabetes and may be of value when educating
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newly diagnosed children and their parents about hypoglycaemia. Future research
aimed at exploring specific effects of hypoglycaemia on the behaviour of type 1
diabetic children could provide further useful information for the parents who
provide their daily care.
Summary
The original studies described in this thesis provide evidence that:
(1) Acute insulin-induced hypoglycaemia provokes a significant impairment
of visual and auditory information processing in non-diabetic individuals.
(2) That acute insulin-induced hypoglycaemia in non-diabetic individuals
can induce a behavioural state characterised by increased anger, increased
tension and decreased happiness, and that this state leads to the reporting
ofmore negative appraisals of a life event.
(3) Experimental hypoglycaemia tends to generate the same pattern of
symptoms in individuals with or without type 1 diabetes irrespective of
the method used to generate hypoglycaemia.
(4) Children with type 1 diabetes who experience hypoglycaemia in the
community tend to express more signs of behavioural change than do
adults with type 1 diabetes.
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